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Abstract
Neuronscarry information via the action potential. As well as travelling down
the axon, this can back-propagate into the dendrites, informing them ofthe firing
status of the neuron. This is important for the synaptic plasticity underlying long
term potentiation that contributes to learning and memory. The back-propagation
of action potentials is regulated by the Kv4 family of voltage-gated potassium
channels. To be functional, these channels must be trafficked to the plasma
membrane. This requires interactions with accessory proteins, a major family of
which are the potassium channelinteracting proteins, or KChIPs. Previous work
had shown that the trafficking of Kv4.2 and KChIP1 from the endoplasmic
reticulum to the plasma membrane occurs via a non-conventional, COPII-
independent exocytic pathway. This pathway has, however, not been fully
characterised.
The aim ofthis thesis was to further characterise the traffic of Kv4.2 channels to
the plasma membrane. The non-conventional trafficking pathway used by Kv4.2
and KChIP1 was investigated. Confocal fluorescence microscopy using
fluorescently tagged proteins or immunofluorescence was used to visualise the
localisation of these proteins in transfected HeLa and Neuroblastoma 2A cells
under varying conditions. These experiments confirmed that Kv4.2 expressed
alone in thesecells was localised to the Golgi apparatus, but was trafficked to the
plasma membranein the presence of KChIP1. This trafficking required the Rab
GTPase Rabl, and required KChIP1 to have functional EF-hand domains, able to
bind Ca’*/Mg”". In addition, KChIP1-EYFPalone localised to punctate vesicles
which were co-localised with the SNAREs VAMP7and Vtila. Use of RNAi to
knockdown these two SNARESsin cells inhibited Kv4.2 trafficking, but had no
effect on the conventionally trafficked protein VSVG. Thusthe trafficking of
Kv4.2/KChIP1 appears to occur via a non-conventional, Rabl-, VAMP7- and
Vtila-dependent pathway.
Other potential binding partners of the Kv4 channels and the KChIPs were
investigated. A possible interaction of KChIP1 with 14-3-3y, detected in yeast
two-hybrid assays, was investigated but it was not possible to confirm this
interaction. It was confirmed, however, that SAP97 could promote Kv4.2
channel trafficking to the plasma membrane in HeLa cells, but inhibited the
trafficking of the channel to the plasma membranein the presence of KChIP1. In
addition, three isoforms of PSD-93 were foundto havethis inhibitory effect. One
possible explanationforthis inhibition oftraffic is an interaction between SAP97
or PSD-93 and KChIP1. This was investigated further, and it was shown that
KChIP1 could alter the cellular localisation of SAP97, suggesting that they
interact. Together, these experiments shed light on the varied ways in which
neurons can regulate Kv4 channeltrafficking and function. Further studies of
these newly characterised pathways and interactions will be important to our
understanding of the molecular regulation of neuronalsignals.
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Chapter 1
Introduction
1.1 An overview of neuronalsignalling
Multi-cellular organisms need to be able to both sense their external
environment, and respond to it. This requires co-ordination between different
parts of the organism’s body, its organs andtissues. In less complex organisms,
and in slow moving organismssuchasplants, this co-ordination can be achieved
through the local actions of chemical hormonal messengers. Animals too have
these slow hormonal signalling pathways. However, these typically require the
hormones to circulate around the organism, taking time to reach their target
organs, needing specialist receptors to give specificity to the signal, and lasting
until the hormones can be degraded. To co-ordinate movement and rapid
responses to changing environmental stimuli, animals have instead developed
specialised cells capable of transmitting rapid electrical signals. In addition, with
increasing complexity comes a need to fully co-ordinate all aspects of an
organism in a central processing area — the brain and central nervous system. The
cell type responsible for processing this data is the neuron. These neurons are
elongated cells, specialised in the transmission of electrical signals (Figure 1.1)
(Alberts et al. 2008). However, these electrical signals are generated by the
movement of ions, and at the connection between two neurons, the electrical
signal causes chemical release, causing further electrical signals in the next
neuron.
Terminal
Dendrites branches ofaxon
a Axon —__—_—_>
 
Soma
1.1: Diagrammatic representation of a neuron.
Neurons are elongatedcells, specialised for the rapid transmission of electrical signals along
their length. Inputs are received at the dendrites, before undergoing summation at the soma(cell
body). The signal then travels along the axon, which finishes in many terminal branches,
forming synapses with other neurons, or other cell types. Red lines indicate this direction of
information flow. Adapted from Alberts et al. 2008.
Neuronsreceive a variety of inputs, which can be excitatory or inhibitory, onto
highly branched dendrites and the cell body (soma). These then undergo a
process of summation.If the incoming signal at a given time is great enough, an
action potential is triggered, and the plasma membrane is depolarized
sequentially along the length of the axon. This is achieved through the influx of
Na’ ions at a region of the membrane, depolarizing it away from a negative
resting potential, and triggering Na’ influx in neighbouring regions of membrane.
This is followed by a delayed efflux of K” out ofthe cell, repolarizing that area
of the membrane so that it is ready to fire again. When the action potential
reaches the presynaptic nerve terminal, it then triggers an influx of Ca’* ions,
causing the fusion of synaptic vesicles with the presynaptic membrane, and the
release of neurotransmitter into the synaptic cleft. The binding of
neurotransmitters to their receptors on the postsynaptic membrane can then
trigger membrane depolarisation in the next neuron,or in a muscle cell (Alberts
et al. 2008).
The three ions, Na’, K* and Ca’*, are thus essential for the processesofelectrical
transmission in neurons. Beyondthis, they also play a role in many other vital
cellular processes, such as the influx of nutrients, the regulation of cellular
volume, and the secretion of electrolytes (Gouaux and MacKinnon 2005).
However, these ions are unable to cross the plasma membrane without ion
channels, pumps and exchangers, which form an aqueous channel or pocket
within a trans-membrane protein allowing passage of an ion (Gouaux and
MacKinnon 2005). In neurons, these channels are often voltage-gated, opening in
responseto the firing state of the cell. This can in turn help shape theelectrical
properties of the cell, and the processing of signals (Bloodgood and Sabatini
2008; Kim and Hoffman 2008).
One important property of neuronsis that they can modulate the strength of their
firing in response to previous levels of input. This synaptic plasticity is
modulated by long-term potentiation (LTP) and long-term depression (LTD) and
is thought to be the molecular mechanism underlying learning and memory
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(Alberts et al. 2008). At a basic level, LTP is evoked when a short period of
presynaptic firing potentiates a postsynaptic membrane, so that further inputs
generate a greater response, whilst LTD is the inverse of this (Alberts etal.
2008). This dependson the interplay between the opening of AMPAreceptors in
response to the excitatory neurotransmitter glutamate, depolarisation of the
membrane, and the opening of glutamate- and depolarisation-sensitive NMDA
receptors, which allow an influx of Ca** (Bloodgood and Sabatini 2008).If this
calcium influx is short lived (a few seconds) but the cytosolic Ca’* elevation is of
high concentration (the micromolar range), then LTP is induced, whilst longer
duration of a lower concentration cytosolic Ca** signal (a few hundred
nanomolar) induces LTD (Yanget al. 1999(2)).
The resting level of intracellular Ca** in a neuronis in the range of 40-100nM,
but this can rise due to influx from outside the cell, or the release of Ca”* from
internal stores such as the endoplasmic reticulum (ER) (Burgoyne 2007). As
discussed above, this rise can lead to the release of neurotransmitter into the
synapse,and to synapticplasticity. In addition, changes in Ca?* concentration can
modulate ion channel activity, induce gene expression, and even regulate
apoptosis (Burgoyne 2004). This is not limited to neuronalcells, and Ca** signals
and signalling networks can have a wide range of effects in many cell types,
comprehensively reviewed in Berridge et al. (2000). The way in which this
elevation in the concentration of a single ion within the cell can have so many
varied effects can be due to differences in signal magnitude and duration, as
discussed above for LTP and LTD. In addition, the localisation and spatial
regulation of the concentration rise may be important (Berridge et al. 2000).
However, a major mechanism for the transduction of a calcium response is
through the action of calcium sensor proteins (Burgoyne 2007). These can
increase the complexity of the calcium signalling network by having different
Ca”*affinities, subcellular localisations or tissue expression patterns, by targeting
specific downstream effectors, or by having different kinetics of action
(Burgoyne 2007). One major family of sensors in the brain are the neuronal
calcium sensor (NCS) proteins (Burgoyne 2004).
In addition to calcium, potassium also has vital role to play in neuronalactivity,
and influences LTP. Whilst the main nerve impulse travels from dendrite to soma
to axon, action potentials from the axonal hillock can also movein a retrograde
manner back into dendrites, so called backpropagating action potentials (bAPs)
(Jerng et al. 2004a). The bAPshelp to inform a neuronofits firing status (Jerng
et al. 2004a) and as timing is important in determining whether LTP or LTD is
induced, the regulation of bAPs is important in regulating the strength of
synapses (Miglioreet al. 1999). This regulation is achieved through the action of
potassium channels. As the distance from the soma increases, action potentials
are attenuated by the action of voltage-gated potassium channels (Hoffmanetal.
1997; Ramakers and Storm 2002). Currents through these channels repolarise the
membrane, limiting the firing frequency of action potentials (Hoffman etal.
1997), and in fact, the internalisation of these regulating potassium channels has
been proposed as a secondary methodofaltering synaptic strength (Kim and
Hoffman 2008).
Alteration of the levels of voltage-gated potassium channels at the plasma
membrane, by the regulation of both protein synthesis and trafficking to and
from the cell surface, thus gives the neuron a further way to regulate neuronal
activity. In addition, a neuron is a highly polarised cell, and trafficking to
dendrites must be differentiated from that to axons. This can be achieved through
protein motifs specific for trafficking to certain compartments, by the directed
trafficking of vesicles containing newly synthesised proteins, or by regulating the
endocytosis of proteins out of particular membranes (Arnold 2006). Toaid in the
regulated synthesis of proteins in an elongated cell, the ER of neurons is
distributed throughout the dendrites and soma (Horton and Ehlers 2003). In
addition, some dendrites, usually the longest (Horton et al. 2005), have outposts
of the Golgi apparatus (Ehlers 2007), usedin the trafficking of both secretory and
integral membrane proteins (Horton and Ehlers 2003). It should also be noted
that proper dendritic growth requires classical ER-Golgi-plasma membrane
trafficking (Ehlers 2007; Yeet al. 2007).
The particular voltage-gated potassium channels involved in the regulation of
firing frequency and bAPswill be introduced in the next section, followed by a
discussion oftheir interacting partners, and howtheseinfluencethetrafficking of
channels to the plasma membrane.
1.2 Voltage-gated potassium channels
There are four known types of potassium channel: voltage-gated, Ca’*-activated,
inward rectifier and potassium leak channels (Kim and Hoffman 2008). In
general, these channels have a long aqueous pore through the plasma membrane,
connected to a short selectivity filter, to keep the rate of ion flux high (Gouaux
and MacKinnon 2005). The crystal structure of the similar bacterial KcsA
potassium channel showsacidic residues at the mouth of the channel to promote
the entry of cations (Doyle et al. 1998). The selectivity filter contributes oxygen
atoms to compensate for the dehydration of the ion as it passes through the
channel, and the spacing ofthese helps differentiate between Na* and K* (Doyle
et al. 1998; Gouaux and MacKinnon 2005). Finally, the presence of multiple K*
ions in the selectivity filter creates an electrical repulsion to promote the flow of
ions (Doyleet al. 1998; Gouaux and MacKinnon 2005).
The voltage-gated potassium channels werefirst discovered through the Shaker
mutation of hyperexcitable Drosophila (Papazian et al. 1987). The Shaker
superfamily is now known to contribute to potassium currents in both the brain
and heart (Birnbaum et al. 2004). These proteins are encoded by the KCN genes,
and in modern nomenclature form 12 families of Kv channels (Gutmanet al.
2003). The Kv superfamily are characterised by having 6 transmembrane
domains per a subunit, and are sensitive to phrixotoxin and 4-aminopyridine (4-
AP). They also inactivate rapidly and recover quickly (Birnbaum et al. 2004). To
form an active channel, four « subunits must multimerise. This seems to require a
130 amino acid T1 tetramerisation domain (Birnbaum et al. 2004), with one
monomer co-ordinating a Zn** ion via two cysteines and a histidine, and an
adjacent monomercontributing a cysteine residue from its T1 domain (Bixbyet
al. 1999). Interestingly two of these cysteines may form a disulphide bond inthe
presence ofNO,allowing redox regulation of the potassium channel (Wangetal.
2007(1); Covarrubias et al. 2008). The T1 domain also prevents different
members of the Kv family from forming heteromultimers, with a 20 amino acid
section of the A and B region of T1 contributing to subfamily specificity (Shen
and Pfaffinger 1995; Xuet al. 1995).
K” channels in neuronsare responsible for the resting potential of the cell, can
oppose depolarisation away from this resting potential, and repolarise action
potentials (Kim and Hoffman 2008). As such, mutations in these channels have
been suggested as a cause of the hyperexcitability found in epilepsy (Birnbaum et
al. 2004). In support of this, drug-induced seizure in rats was seen to reduce
levels of both Kv1.2 and Kv4.2 in the hippocampus3-6 hours post trauma (Tsaur
et al. 1992). Also, a patient with temporal lobe epilepsy had a premature stop
codon in the KCND2 gene for Kv4.2, and when expressed in cells this mutant
channel produced a lower current density than the wild-type (Singh et al. 2006).
However, it should be noted that a Kv4.2 knockout mouse did not show any
innate epilepsy, suggesting other channels or factors may also have a role (Chen
et al. 2006(2)).
The large number of Kv channel proteins is reflected in the wide variety of
currents they are known to produce. For example, in cardiac myocytes, at least 5
potassium currents with different characteristics are known, mediated by the Kv
channels (Patel and Campbell 2005). These may differ in their kinetics. In the
rodent cardiac ventricle there are both fast and slow transient outward currents
(It) mediated by Kv4.2/Kv4.3 and Kv1.4 respectively (Patel and Campbell
2005). Alternatively, they may differ in their subcellular localisation. The A-type
currents in neurons may be mediated by Kv1.4 or Kv3.4 in the axon, and by the
Kv4 family in the somatodendritic compartment (Kim and Hoffman 2008). It is
the Kv4 family that are the focus of this thesis.
1.2.1 Kv4 family
The Kv4 family were first characterised in 1971 (Maffie and Rudy 2008), and
three membersof this family are now known (Gutman etal. 2003). Theyall have
6 exonsof similar size, although their introns differ (Isbrandt et al. 2000). They
have a cytoplasmic N-terminus, followed by the T1 tetramerisation domain, and
then six transmembrane helices (S1-6). Of these, S4 has positive arginine and
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1.2: Schematic representations of a Kv4 channel.
Thefigures indicate the arrangementof a helices in a Kv4 a subunit.
A) The arrangementof a single a subunit, with six transmembrane domains, and large N-
and C-terminal cytoplasmic tails. Helix S4 is thought to be the voltage-sensor,as it is
highly charged. Helices S5 and S6, and their connecting P-loop, contribute to the pore
through the membrane.
B) The arrangementofhelices from four a subunits in a complete tetramer. Each subunit
is displayed in a different colour. The N- and C-termini of each subunit, and the
connecting loops between helices, have been removed for clarity. Voltage-sensing
helix S4 is represented by the + symbol, and helices S5 and S6 from each subunit,
contributing to the pore through the membrane,are representedby thestar.
Adapted from Birnbaum etal. 2004.
lysine residues at every third position, and is therefore thought to be the voltage
sensor. Finally, helices S5 and S6 from each a subunit contribute to the pore
through the membrane, with their connecting P-loop forming the selectivity pore
(Figure 1.2) (Birnbaum et al. 2004). Potassium channels are often glycosylated
at their S1-S2 linker, but none of the Kv4 channels have the consensus sequence
for this, and do not seem to be glycosylated (Isbrandt et al. 2000; Birnbaum etal.
2004). They can, however, be highly phosphorylated (Misonou and Trimmer
2004). The Kv4 channels also contain a 16 amino acid dileucine motif, which
seems to be involved in their targeting to the somatodendritic compartment of
neurons (Birnbaum etal. 2004; Arnold 2006).
The Kv4 family of channels are mainly responsible for A-type currents in the
brain and fastI, in the heart, and there is much evidenceto support this. Firstly,
Kv4.2 and Kv4.3 are expressed at high levels in the brain (Misonou and Trimmer
2004) and are presentin the heart (Isbrandtet al. 2000). Both the A-type currents
and the Kv4 proteins are sensitive to 4-AP, arachidonic acid and
heteropodotoxin, but not tetraethylammonium (TEA) (Tkatch et al. 2000;
Ramakers and Storm 2002). Both channel and current are activated at
hyperpolarised, subthreshold potentials, are completely inactive at -40mV, and
are then rapidly inactivated (Tkatch et al. 2000; Kim and Hoffman 2008).
Finally, both recover rapidly from inactivation, in tens to hundreds of
milliseconds (Tkatch et al. 2000; Covarrubias et al. 2008). All of this confirms
the important role of Kv4 family proteins in generating both I,, and A-type
currents.
The general role of these currents is to regulate cellular excitability. This is
highlighted in the hearts of hypertensive rats, which have lowerIj. due to fewer
Kv4.2 and Kv4.3 channels (Goltz et al. 2007). In the brain, the role of the A-type
current is to pace the firing of action potentials during repetitive firing, in
particular delaying excitation, and regulating the delay between depolarisation
and firing, and the delay between twoaction potentials (Maffie and Rudy 2008).
They also attenuate the amplitude of bAPs with increasing distance from the
soma (Hoffman et al. 1997), and so as discussed above, suppressing A-type
currents reduces the threshold for LTP induction (Ramakers and Storm 2002).
The different Kv4 proteins are not equivalent, however, and have specific roles
and functions. They are, for example, expressed in different brain regions
(Birnbaum et al. 2004), and whilst both Kv4.2 and Kv4.3 are affected in
hypertensive epicaridal myocytes, it seems only Kv4.2 is affected in the
endocardium (Goltz et al. 2007). Also, in a Kv4.2 knockout mouse, levels of
Kv4.3 in the brain were completely unaltered (Guo et al. 2005; Menegola and
Trimmer 2006). It is the better characterised Kv4.2 that has been studied in this
thesis, and is discussed below.
1.2.2 Kv4.2
Kv4.2 mRNAis found in human brain by Northern blot andalsoin the heart and
other tissues by RT-PCR(Isbrandtet al. 2000). In rodent brain,it is found on the
plasma membrane of the soma and dendrites, but is not in the axon or
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presynaptic membranes (Alonso and Widmer 1997). It is especially foundatsites
of axonal contact (Alonso and Widmer 1997), and is seen as punctae in the
postsynaptic side of some GABAergic synapses (Jinno et al. 2005), whilst being
excluded from non-GABAergic synapses (Burkhalter et al. 2006).
There is much evidenceto highlight the specific role of Kv4.2 channels in A-type
and I,. currents, as well as in the regulation of LTP. Firstly, estimates of Kv4.2
mRNA abundancecorrelate with levels of maximal A-type conductance (Tkatch
et al. 2000), reduction in Kv4.2 levels by RNAi reduced hippocampal A-type
currents (Lauver et al. 2006), and overexpresion of Kv4.2 decreased cell
excitability (Kim et al. 2005). In addition, the knockout of Kv4.2 in mice
eliminated the cardiac fast I,, (Guo et al. 2005). The role of Kv4.2 may be more
important in rodent heart, and Kv4.3 may play a larger role in dogs and humans
(Dixon et al. 1996; Niwa et al. 2008). Moreover, Kv4.2 channels regulate
neuronal bAPsso that each dendritic compartment can act semi-independently as
a signalling unit (Cai et al. 2004). Overexpression of Kv4.2 decreased the
propagation of bAPs, whilst a dominant negative mutant had the opposite effect
(Kim et al. 2005). Also, in Kv4.2 knockout mice, A-type currents are eliminated
in the majority of cortical pyramidal neurons (Nerbonne et al. 2008), the
amplitude of bAPsis larger, and the threshold for the induction of LTP is lower
(Chenet al. 2006(2)). Kv4.2 channels also seem to be internalised in response to
LTP (Kim et al. 2007). It therefore seems clear that Kv4.2 channels havea vital
role in the correct functioning of the heart and brain.
The expression of Kv4 channels in heterologous systems however, such as
Xenopus oocytes, produced channels with kinetics that did not match with those
observed in native systems (Maffie and Rudy 2008). Also, neurons with similar
expression patterns of Kv4 channels have different A-type currents (Tkatchetal.
2000). It was observed that heterotetramers (e.g. of Kv4.2 and Kv4.3) are more
similar to native channels than homotetramers (Guoet al. 2002). A major factor,
though,is the regulation of Kv4 channels by accessory proteins.
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1.3 KChIPs
The KChIPs (K* channelinteracting proteins) were discovered in 2000, after a
yeast two-hybrid screen for binding partners interacting with the N-terminal 80
amino acids of rat Kv4.3 revealed three new proteins (An et al. 2000). KChIP3
wasalso separately discovered as calsenilin, a binding partner of the presenilins
(Buxbaum et al. 1998), and an N-terminally extended variant is known as the
transcriptional repressor DREAM (Carrion et al. 1999; Spreafico et al. 2001).
KChIP4 was discovered in 2002, also as a binding partner of the presenilins
(Morohashiet al. 2002).
As well as binding to Kv4 proteins in yeast two-hybrid assays, the KChIPs were
also seen to co-localise with Kv4 channels at the plasma membrane and alter
current density, as will be discussed in more detail below (An et al. 2000). The
crystal structure of KChIP1 has been solved, revealing a hydrophilic face and a
hydrophobic face important for channel interactions (Scannevinet al. 2004). The
importance of the KChIPs in normal channel function is revealed by the fact that
Kv4.2 knockout mice show reduced levels of KChIPs 1-3 (Guoetal. 2005; Chen
et al. 2006(2); Nerbonneetal. 2008), that the Kv4 channels are only sensitive to
arachidonic acid in the presence of a KChIP (Birnbaum etal. 2004), and that the
requirement for Zn** in channel assembly and tetramerisation can be overcome
by co-expression with KChIPs (Kunjilwar et al. 2004; Wanget al. 2007(1)).
The four KChIP genesgive rise to many splice variants (Misonou and Trimmer
2004). There are three splice variants of KChIP1 (Pruunsild and Timmusk 2005).
KChIP2 has 8 isoforms (Decheret al. 2004), expressed mostly in the heart (Kuo
et al. 2001). KChIP3 has two predominant isoforms (although more have been
described), whilst KChIP4 has 6 isoforms (Pruunsild and Timmusk 2005). Whilst
the general effects of the KChIPs seem to be similar, there is much evidence that
the different splice isoforms differ in the details of their actions (Bahringet al.
2001; Patel et al. 2002a; Decher et al. 2004). A major example of this is
KChIP4a, and the newly discovered KChIPs 2x and 3x, which contain K*
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channel inactivation suppressor (KIS) domains (Holmqvist et al. 2002; Trinkle-
Mulcahy et al. 2008). This domain appears to be a putative transmembrane
domain (Jerng and Pfaffinger 2008) which mayalter the interaction site with the
Kv4 channel (Trinkle-Mulcahy et al. 2008), and causes the KChIP to slow Kv4
channel opening and disrupt the channel’s rapid inactivation, in contrast to the
actions of other KChIPs (Jerng and Pfaffinger 2008).
It seems that different KChIPs may be expressedin different brain areas, or work
in conjunction with different Kv4 channels. For example, KChIPs 2, 3 and 4 are
expressed with Kv4.2 in excitatory CAl pyramidal cells, whilst KChIP1 and
Kv4.3 are expressed in inhibitory interneurons (Rhodes et al. 2004). The
situation in vivo is likely more complicated than this, however, as some brain
regions express multiple Kv4 proteins (Rhodes et al. 2004). There is also
evidence that the same KChIP may havediffering effects on different members
of the Kv4 family (Nakamuraet al. 2001a). Also, it seems that the individual
KChIPs maynot beessential, as KChIP1, KChIP2 or KChIP3 knockout mice are
not embryonic lethal. They do, however, have various phenotypes, that seem to
differ depending on the KChIP knocked out, suggesting that the KChIPs are not
fully redundant (Kuoet al. 2001; Lilliehook et al. 2003; Xiong etal. 2009).
1.3.1 KChIPs and Kv4 channels
Oneofthe main roles of the KChIPsis to interact with Kv4 channels, to promote
their trafficking to the plasma membrane,to alter the kinetics of the channel at
the plasma membrane, and thus to regulate the currents produced by these
channels. A variety of studies have given insights into each of these aspects of
KChIP function.
The major interaction of a KChIP with a Kv4 a subunit is through the N-
terminus of the channel (Bahring et al. 2001). Structures of human KChIP1 with
rat Kv4.3 (Figure 1.3A) reveal that four KChIPs bind to the four Kv4 a subunits
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 1.3: Interactions between KChIP1 and Kv4 channels.
KChIP1 binds to the N-terminus ofKv4 a subunits, and increases the channel’s current density.
A) Crystal structure of KChIP1 and the N-terminus T1 domain of Kv4.3. The view is
looking down onthe central pore, showing the cross-shaped octamerstructure of Kv4 a
subunits in orange, and KChIPsin blue. There are Zn”’ ions at the interface between
Kv4 subunits, shown as grey spheres, and each KChIP is bound to two Ca”* ions,
shown as pink spheres. From Pioletti et al. 2006.
B) Thefirst interaction site between Kv4.3 and KChIP1. The Kv4.3, shown as a ribbon,
binds into a hydrophobic groove on the surface of KChIP1, shown as a surface
representation. The residues of Kv4.3 important for the interaction are shown in
magenta. From Wanget al. 2007(2).
C) Thesecondinteraction site between Kv4.3 and KChIP1. Residues 70-78 of Kv4.3 T1
domain are shown as a blue ribbon, whilst the KChIP1 is shown as a surface
representation. The interaction is mediated by hydrophobic residues and salt bridges.
The residues of Kv4.3 important in this interaction are shown in magenta. From Wang
et al. 2007(2).
forming an intact channel, in a cross-shaped octamer (Pioletti et al. 2006). Each
KChIP is bound to two neighbouring Kv4 subunits. The first interaction is
between a helix of hydrophobic residues 6-21 of the N-terminus of human Kv4.3,
and a hydrophobic pocket of human KChIP1 formed from a 40° movement of
helix H10 (Figure 1.3B) (Wanget al. 2007 (2); Wang 2008). Tryptophan 8 and
phenylalanine 11 seem to be particularly important Kv4 residues in this
interaction, and this hydrophobic helix appears to kink around a highly conserved
proline residue at position 10 (Zhou et al. 2004). This interaction seems to be
important for the KChIP’s effects on channel trafficking (Pioletti et al. 2006).
The second region of binding is due to salt bridges and hydrophobic interactions
forming between helix 2 of KChIP1, and amino acids 70-78 in the Tl
tetramerisation domain of Kv4, and this helps mediate KChIP’s effects on
channel gating (Figure 1.3C) (Pioletti et al. 2006; Wanget al. 2007 (2)). It seems
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1.4: Effects of KChIPs on Kv4 currents.
Electrophysiology experiments performed using rat Kv4.2 and rat KChIP1 in Chinese hamster
ovary (CHO)cells.
A) Current-voltagetraces ofcells transiently transfected with Kv4.2 alone(top panel), or
Kv4.2 with KChIP1 (bottom panel), revealing the increase in current density in cells
co-transfected with KChIP1. From Anetal. 2000.
B) Graph showing peak current conductance at various voltagesin cells transfected with
Kv4.2 alone(black circles) or with KChIP1 (white squares). This highlights the
increased peak conductancein cells co-transfected with KChIP1. From Anetal. 2000.
C) Graph showingthe percentageofpeak current recovered overtime in cells transfected
with Kv4.2 alone(black circles) or with KChIP1 (white squares). This highlights the
morerapid recovery from inactivation in cells co-transfected with KChIP1. From An et
al. 2000.
that both these regions of Kv4 are necessary for the interaction, and the second
region is sufficient (Scannevin et al. 2004). The C-terminusof the channel may
also be important, as mutations in the C-terminus of the Kv4 channel have effects
on the binding of KChIP andits ability to alter channel kinetics (Callsen et al.
2005; Han et al. 2006). Finally, mutations in the inner pore of Kv4.3 had a
different response to KChIPs, suggesting this region may also be important
(Wangetal. 2002). In addition, three regions around the EF-hand domainsofthe
KChIP are important for forming the hydrophobic crevice that the channelbinds
— the EF1-EF2 linker, the EF3-EF4 linker, and the C-terminal region of the
protein after EF4 (Renetal. 2003).
In the absence of KChIPs, Kv4.2 channelsare retained in the cell, where they are
hypophosphorylated, andrelatively unstable (Misonou and Trimmer 2004). The
15
binding of KChIPs (without KIS domains) to a Kv4 channel stimulates its
trafficking to the plasma membrane (O’Callaghan et al. 2003; Shibata et al.
2003). This increases current density in the region of 12-fold (Figure 1.4A) (An
et al. 2000). Once expressed at the plasma membrane, the KChIP remains bound
to the channel, and alters its kinetics (Figure 1.4B-C). This includes
hyperpolarising the voltage required for activation, slowing the time constant of
inactivation, but accelerating the kinetics of recovery from inactivation (An etal.
2000). In particular, it seems that KChIP1 slows the fast inactivation of Kv4.2
from its open state, whilst promoting inactivation from the closed state by
increasing the rate of channel closing (Beck et al. 2002). It should be noted that
those KChIP isoforms with a KIS domain do not promote the surface trafficking
of Kv4 channels (Covarrubias et al. 2008), and slow the time courses of both
activation and inactivation (Figure 1.5) (Morohashi et al. 2002; Jerng and
Pfaffinger 2008).
The importance of the KChIPs can be seen from the effects of KChIP knockout
mice. KChIP2 knockout mice lack cardiac Ij, and are more susceptible to
induced arrhythmias (Kuoet al. 2001). This links with the observation that both
dogs and humanshavean|, gradientacross their left ventricular wall. This is not
caused by a gradient in Kv4 channel distribution, but rather in KChIP2 (Kuoet
al. 2001). KChIP3 knockout mice had reduced fast-inactivating currents in the
brain, and this increased LTP (Lillichook et al. 2003). This reflects the
— Kv4.2+ KChIP3a Kv4.2 + KChIP3x
250 ms 250 ms
1.5: Graphs showing the inactivation of Kv4.2 channels.
Xenopus oocytes were transfected with Kv4.2 and an isoform of KChIP3. Cells were then
depolarised by differing amounts, and the outward currents measured overtime.
A) Representative current trace from cell co-transfected with Kv4.2 and KChIP3a.
B) Representative current trace from cell co-transfected with Kv4.2 and the KIS domain-
containing KChIP3x.
The graphs reveal the slower inactivation of the Kv4.2 channel when co-expressed with a KIS
domain KChIP. From Jerng and Pfaffinger 2008.
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observation that it is the actions of Kv4.3 and KChIP3 together that control the
pacemaker activity of dopaminergic neurons in the substantia nigra, a brain
region implicated in Parkinson’s disease (Liss et al. 2001). Also in the brain,
KChIP1 knockout mice appear to be more susceptible to drug-induced seizures,
likely through the reduction in Kv4 trafficking in these animals (Xiong et al.
2009).
1.3.2 Alternative functions of KChIPs
KChIP3 wasseparately discovered as downstream-regulatory-element-antagonist
modulator, or DREAM (Spreafico et al. 2001), a DNA-binding transcriptional
repressor. It has since been shown that all 4 KChIPs can bind to DRE
(downstream-regulatory-element) motifs in DNA (Link et al. 2004), although
KChIPs 1 and 2 are not localised to the nucleus (Venn et al. 2008). KChIP3
appears to bind DNA as a monomer (Osawaet al. 2001), and this represses
transcription. However, the KChIPs can bind Ca’* ions, and this causes a
conformational change in the KChIP, and possibly dimerisation, causing it to
dissociate from DNA (Carrionet al. 1999; Osawaet al. 2001). DREAM has been
implicated in the regulation of the genes for prodynorphin, important for pain
and emotional memory, the immediate early transcription factor c-fos (Carrion et
al. 1999), and NCX3, involved in neuronal viability and Ca** homeostasis
(Gomez-Villafuertes et al. 2005; Venn et al. 2008). In addition,all four KChIPs
mayhave a role in the regulation of a range of genes involved in circadian day-
night oscillations (Link et al. 2004).
KChIP3 wasalso discovered as calsenilin, and KChIP4as calsenilin-like protein
(CALP)dueto their ability to bind to presenilin-1 and presenilin-2 (Buxbaum et
al. 1998; Morohashi et al. 2002). This involves residues 421-431 at the C-
terminusof presenilin, and the C-terminus of the KChIP (Morohashi et al. 2002).
The presenilins are commonlythe site of mutations responsible for early-onset
familial Alzheimer’s disease, and these mutations increase the production of B-
amyloid (AB), as well as inducing apoptosis (Buxbaum et al. 1998). Binding of
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KChIP4 with presenilin-2 changed the localisation of both proteinsto a reticular
and perinuclear distribution (Morohashi et al. 2002). Also, overexpression of
KChIP3 increased levels ofAB42 and apoptosis, an effect that was potentiated by
co-expression with presenilin-2 (Jo et al. 2001), whilst KChIP3 knockout mice
showed decreased levels of AB40 and AB42 in the brain, compared to wild-type
mice (Lilliehook et al. 2003). This may be due to the ability of calsenilin to
increase the activity of y-secretase, one of the cleavage enzymes responsible for
the production of Af, an effect potentiated by presenilin (Jo et al. 2005).
Interestingly, though, overexpression of KChIP4 with presenilin-2 seemed to
have no effect on the secretion of AB (Morohashi et al. 2002), suggesting
KChIPs 3 and 4 mayhavediffering activities. The effects of KChIP3 may be
physiologically relevant, as Alzheimer’s disease patients show increased
expression of KChIP3 in the brain (Jo et al. 2004), and calsenilin co-localised
with AB42 in a mutant mouse Alzheimer’s disease model (Jo et al. 2004).
Finally, KChIPs 3 and 4 have been proposed to have several other, seemingly
unrelated, roles in cells. Firstly, KChIP3, in its Ca**-bound form, can bind to
hormone-activated vitamin D receptors, so may have a role in vitamin D
disorders (Lusin et al. 2008). Secondly, KChIP3 can stimulate the ATP-induced
exocytosis of dense core granules in neuroendocrine cells (Venn et al. 2008).
Finally, both KChIP3 and KChIP4 can bind Golgi glycosyltransferases, affecting
their ER-Golgi trafficking (Quintero et al. 2008). Many of these varied roles may
reflect cell type specific activities, or be due to differences in intracellular
localisation of proteins. Much further work will be needed to identify their
physiological relevance, and the molecular mechanismsoftheir actions, although
manyofthese roles mayreflect the ability of KChIPsto act as calcium sensors.
1.3.3 KChIPs are part of the NCS family and can bind Ca”*ions
The KChIPs form one of five classes of proteins belonging to the neuronal
calcium sensor (NCS) family, and were the most recent to evolve, being present
during evolution from fish onwards (Burgoyne 2004). Like all NCS proteins,
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they can bind Ca** with micromolar or submicromolar affinities, and this causes
a change in their conformation, allowing interaction with other proteins to
change and regulate their physiological function (Burgoyne 2004). The KChIPs
have an N-terminal basic region, which shows most variability, and a more
conserved C-terminal region, containing the Ca**- binding regions (Figure 1.6A)
(Osawa et al. 2001; Burgoyne 2007). The crystal structure of KChIP1 shows
similarities to other NCS proteins (Scannevin et al. 2004). This showed 10 a
helices with the N-terminal H1 and C-terminal H10 flanking the Ca’” binding
sites (Figure 1.6B).
The NCSproteins bind to Ca’* via EF-hand domains, highlighted in Figure 1.6B.
These are 29 amino acid helix-loop-helix motifs, named after the helices in
parvalbumin,and it is residues 1, 3, 5, 7, 9 and 12 that are involved in actually
co-ordinating the Ca** ion (Burgoyne 2007). Perhapsthe best known ofcalcium
binding proteins is calmodulin, and like calmodulin, NCSproteinsall have 4 EF-
hand domains. However, the most N-terminal EF hand (EF hand 1) is non-
H8  
  EF4o0 ©a EFI = EF3 a_eeKChIPL
H9
EF3
KChIP44KChIPa 5KChIP4 62 H1  =N-terminal Conserved EF-damainvariable region NA Myristoylation site tr Palmitaylationsite
1.6: Structure of the KChIPs, and their EF-hand domains.
A) Schematic of the domain organisation of isoforms of the four KChIPs, showing their EF
hands and conserved C-terminus, with more variable N-termini. From Burgoyne 2007.
B) Thecrystal structure of KChIP1 showsits 10 a helices, and fourEF-hand domains. In
this structure, two of the EF hands, EF3 and EF4, had bound Ca** ions, represented by
yellow spheres. From Scannevin et al. 2004.
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functional in all NCS proteins, due to a cysteine-proline substiution in the
putative Ca** binding loop (Hwangetal. 2004). Typically, EF-hand proteins are
inactive at 107-10°M Ca", andactive at higher concentrations of 10°-10°M,
but different EF-hands can have different Ca** affinities (Ikura 1996). In
addition, the levels of Mg”" in cells at rest is much higher than Ca’*, suggesting
the possibility of EF-hand domains activating by swapping from a Mg"*- to Ca’*-
bound state (Aravind et al. 2008). This in fact seems to be the case with the
KChIPs, with EF-hand 2 being a low affinity site with a preference for Mg”* due
to a glutamate to aspartate changeat position 12 of the EF-hand. EF-hand 2 may
even be completely inactive in KChIP1 (Osawaet al. 2005; Chenet al. 2006(1);
Schwenk etal. 2008). One of the remaining sites seemsto be a high-affinity Ca’*
bindingsite, likely EF4 in KChIP1, with the remaining EF-handa slightly lower
affinity site, but still Ca’* bound in the activated protein (Craig et al. 2002;
Changet al. 2003; Zhouet al. 2004). It therefore seems likely that the KChIPs
exist in two physiological states, with 3Mg’* bound at resting Ca”
concentrations, and in a 2Ca’*/IMg”* state at higher intracellular Ca”
concentrations (Schwenk etal. 2008).
Thebinding of Ca’to the EF-hands of a KChIP changes the arrangement of EF-
hands, and its helical content, as shown by circular dichroism (Osawaet al.
2001; Changet al. 2003), and it has been confirmed that it is only the binding of
Ca’*, not Mg”,that hasthis effect (Craig et al. 2002). The binding of KChIP3 to
DNA,in its role as the transcriptional repressor DREAM,is abolished by binding
Ca", which leads to its multimerisation (Craig et al. 2002; Osawa et al. 2005),
although there is some debate about whether this requires binding of Ca** to a
single EF-hand (Osawa et al. 2005), or at multiple sites (Craig et al. 2002).
Interestingly, 3D structures have also revealed that the C-terminus of KChIP3
contains a unique helix which maystabilise it in a dimeric formation, and
contribute to its specific functions compared to KChIP1 (Yuet al. 2007; Lusin et
al. 2008).
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The binding of Ca** to EF-hands also appears to be important to the role of
KChIPsin trafficking and regulating Kv4 channels. When the KChIPs werefirst
discovered, it was shown that a form of KChIP1 mutated in EF-hands 2, 3 and 4
(EF2-4) did not bind Ca’*, but could still bind and co-immunoprecipitate with
Kv4 a subunits. However, the mutant KChIP lost its ability to modulate Kv4.2
currents (An et al. 2000). This separation of binding from kinetic modulationis
also seen in mutants of the Kv4 channel (Callsen et al. 2005). The distribution of
Kv4.2 also changed when co-expressed with mutant EF2-4 KChIP1, althoughit
could no longertraffic to the plasma membrane, and this again suggests binding
is not impaired in the mutant protein (Hasdemiret al. 2005). However, an EF2-4
mutant of KChIP4 has been shown not to bind Kv4.2 by co-immunoprecipitation
(Morohashi et al. 2002), and mutating the EF-hand of KChIP2d, a shortened
isoform with just one EF-hand,did not prevent it from modulating the kinetics of
Kv4.3 channels (Patel et al. 2002b). In a major structural paper, Pioletti et al.
(2006) agreed that the triple EF2-4 mutant was unable to modulate Kv4.3
channel kinetics. However, they argued that although single and some double
EF-hand mutants were able to bind an N-terminal section of Kv4.3, both the
EF3/EF4 double mutant, and EF2-4 triple mutant could not. This was suggested
to be because of unfolding of the mutant proteins, although this is in contrast to
the findings of Hasdemir et al. (2005), where both wild-type and EF2-4 mutant
KChIP1 were present in the same intracellular structures. Therefore, the
requirements for Ca**-binding by KChIP1, for both interaction with Kv4
channels, and modulation of their kinetics, still needs to be fully elucidated,
especially contrasting single or double EF-hand mutations with the better
characterised EF2-4 triple mutant.
1.3.4 Post-translational modifications and localisations of KChIPs
The localisation of isoforms of all 4 KChIPs, expressed alone in cells, has been
determined. KChIP1 shows an unusual punctate distribution, in COS-7 cells,
HeLacells, and neurons (O’ Callaghan et al. 2003; Hasdemiret al. 2005; Venn et
al. 2008). KChIP2 is usually found associated with the plasma membrane (Venn
et al. 2008), due to the palmitoylation of larger isoforms. This palmitoylation is
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not necessary for interaction with the Kv4 channel, but is required for trafficking
of the Kv4 channel, and for the KChIP2 to be localised to the plasma membrane
in the absence of channel (Takimoto et al. 2002). KChIPs 3 and 4 are diffusely
cytoplasmic in COS-7 cells, and found in both the cytoplasm and nucleus of
PC12 cells. KChIP3 can also be isolated from HEK293 cell nuclear extracts,
fitting its proposedrole in transcriptional regulation. KChIP3 induced cell death
in HeLacells (Jo et al. 2001; Venn et al. 2008). One isoform of each of the four
KChIP proteins was seen to co-localise with Kv4.2, stimulate its traffic to the
plasma membrane, and then co-localise with the channel at the cell surface
(Venn etal. 2008).
The interesting punctate distribution of KChIP1 expressed alone in cells made
this an interesting target for further investigation. In order to show this punctate
localisation, the KChIP1 has to be myristoylated on glycine 2, but this is always
exposed, in contrast to other NCS proteins where the myristoyl tail is exposed
only in response to Ca** binding (O’Callaghan et al. 2003). In fact, KChIP1 does
not need to bind Ca?* to access these vesicular structures, and an EF2-4 mutant
can redistribute Kv4.2 channels into these vesicles (Hasdemiret al. 2005). These
vesicles were shown to be mobile, and to be closely distributed with dendritic
Golgi outposts in hippocampal neuron preparations (Hasdemiret al. 2005). In
addition, the best co-localisation of these punctate vesicles was seen with
ERGIC-53, a marker of the ER-Golgi intermediate compartment, and there was
no co-localisation with constituents of the COPII coat, or with endosomal Rab
proteins (O’Callaghanet al. 2003). This suggests a role for these vesicles in ER-
Golgitrafficking, as discussed in more detail below.
As well as some isoforms being myristoylated or palmitoylated, there is
evidence that the KChIPs can be regulated by phosphorylation. KChIP3 can be
phosphorylated on serine 95 by the kinases GRK2 and 6, and can be
dephosphorylated in a Ca’**-dependent manner. This phosphorylation inhibits the
trafficking of Kv4.2 to the plasma membrane (Ruiz-Gomez et al. 2007). This
post-translational modification adds another level of regulation to the tightly
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controlled expression of Kv4 channels. There are a range of other known
modulators of these channels, and these are discussed in moredetail below.
23
1.4 Alternative regulators of Kv4 channels
It is of vital importance to the neuron or cardiac myocyte that it is able to fully
regulate Kv4 channels, in order to regulate A-type currents and hence cellular
excitability. In addition to the KChIPs, a number of other proteins have been
found that can interact with the Kv4 a subunits andalter their properties. Like the
KChIPs, these proteins can exert their influence by regulating channel
trafficking, by modulating channel kinetics, or by affecting both. In fact, there is
growing evidence that multiple regulators may affect Kv4 channels together,
forming ternary complexes (Jernget al. 2005). Those proteins regulating channel
function and kinetics will be discussed first, then those with a role in trafficking
Kv4 channels, followed by a discussion of the membrane-associated guanylate
kinase (MAGUK)family of proteins, and their potential interactions with Kv4
channels.
1.4.1 Regulating channel function and kinetics
A large numberofproteins have been discovered that can influence Kv4 channel
kinetics. However, it should be noted that many of these make the kinetics less
like those seen in native channels (Maffie and Rudy 2008), and it still remains
unclear what role these proteins may play. One example comes from the KvB
subunits, which are known to be important in trafficking and regulating Kvl
channels, and can induce fast inactivation in non-inactivating Kv channels
(Pongset al. 1999). These can bind Kv4 channels, and have effects similar to
KChIP2, but so can a Na’ channel B subunit and the physiological relevance for
many of these interacting partners remains unclear (Deschenes and Tomaselli
2002).
Other proteins seem to compete with the KChIPs for binding to the Kv4 a
subunit. These include syntaxin 1A, which has been shown to modulate the
magnitude of Kv4 currents, and their gating (Yamakawaet al. 2007). It should be
noted, however, that syntaxin 1A has been shown to bind sepahrose and agarose
beads in biochemical experiments, increasing the chance of false positive results
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in interaction studies (Fletcher et al. 2003). Syntaxin 1A also has a clearly
defined role in the SNARE fusion machinery of neurotransmitter vesicle release
(Schiavo and Stenbeck 1998), so the purpose of, and the mechanism underlying,
any interaction with Kv4 channels remains unclear. The KCNEJ-4 genes encode
the heart specific minK, and the minK-related proteins, MiRP1-3. These can all
bind Kv4.2 and Kv4.3, and slow the time constants of both activation and
inactivation (Zhang et al. 2001). MiRP1 has also recently been shown to have a
transmembrane domain like the KIS domain in some KChIP isoforms, which
may explain how it can have similar kinetic effects to KChIP4a (Jerng and
Pfaffinger 2008). Another NCS family member, NCS-1, can also bind to Kv4
channels, slowing their rate of inactivation, and increasing their surface
expression, but the physiological significance of this is not clear (Nakamuraetal.
2001b; O’Callaghan et al. 2003).The KChIPs are certainly more effective at
binding Kv4 (Renetal. 2003), likely due to a LFxxVM motif in helix H10 of
KChIP1, which formspart of the Kv4 binding site (Zhouet al. 2004).
One problem with the role of KChIPs as the major modulators of Kv4 channelsis
that they slow the kinetics of inactivation, making currents less like fast-
inactivating native currents. This led to the discovery of a protein expressed from
a brain mRNAthat could accelerate inactivation (Nadal et al. 2001), and paved
the way for the identification of dipeptidyl-peptidases (DPP) 6 and 10 (Radicke
et al. 2005; Clark et al. 2008). These are type II membrane glycoproteins, with a
single transmembrane domain, large extracellular C-terminus, and alternately
spliced intracellular N-terminus (Clark et al. 2008). They are expressed in both
brain and heart (Radicke et al. 2005) with a distribution that matches Kv4.2.It
should be noted, however, that DPP6 wasalso seen in the striatum lucidum ofthe
hippocampal mossy fibre, a brain structure lacking Kv4.2 or Kv4.3 expression,
suggesting an alternative function for DPP6 (Clark et al. 2008). The DPPs can be
immunoprecipitated by Kv4.2 subunits (Jerng et al. 2004b), and appear to bind to
Kv4.2 extracellularly near the channel’s first transmembrane domain (Kim and
Hoffman 2008). The effect of this interaction is to promote voltage-dependent
activation, possibly via interaction with the channel’s voltage sensor (Dougherty
and Covarrubias 2006). Both DPP6 and DPP10 also increase the trafficking of
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Kv4 channels to the plasma membrane (Zaghaet al. 2005). However, it should
be noted that the two DPP proteins can have subtly different quantitative effects
on channel kinetics (Jerng et al. 2004b), and DPP6 may predominatein the heart,
with DPP10 in the brain (Zagha et al. 2005). However, it seems that native
currents can be most closely matched by a ternary complex of Kv4 channel, DPP
protein and KChIP (Radicke et al. 2005). In this complex, channel trafficking is
not further enhanced from expression with either accessory protein alone, but the
channel kinetics are different from either binary complex (Jerng et al. 2005).
Even so, this does not completely match the characteristics of the native neuronal
A-type current, suggesting yet another level of regulation (Jerng et al. 2005).
The common cellular process of phosphorylation is also important in Kv4
channel regulation, and the channel a-subunits contain 2 PKA (protein kinase A)
sites, 3 C-terminal ERK (extracellular signal-regulated kinase) sites, 2 C-terminal
PKC (protein kinase C) sites, and 2 C-terminal CaMKII (Ca”*/calmodulin-
dependent kinase) sites (Kim and Hoffman 2008). The kinase c-Sre can also
interact with Kv4.3 and inhibition of this kinase reduced peak Kv4.3 currents
(Gomes et al. 2008). Phosphorylation by either PKA or PKC reduces the
probability of channel opening (Birnbaum et al. 2004), and phosphorylation of
serine 616 by ERK decreases A-type currents (Hu et al. 2007). Interestingly,
PKA phosphorylation seemsto require that the channel have bound KChIP (Patel
and Campbell 2005).
Finally, a variety of both physiological and exogenous chemicals can affect
channelactivity. These include some fatty acids and arachidonic acid, which can
influence channel currents (Holmqvist et al. 2001). In fact, part of their kinetic
effects requires the presence of the KChIP, suggesting that arachidonic acid may
bind to both the Kv4 channel and the KChIP (Holmqvist et al. 2001). There are
also several Kv4-specific toxins. These include heteropodatoxin, which exerts its
effects through modulating channel gating, as well as occluding the channel pore
(Zarayskiy et al. 2005), and the Taiwan cobra cardiotoxin CTX3, which binds to
KChIP1 and enhancesits interaction with Kv4 channels (Lin et al. 2004). The
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small molecule CL-888 can also decrease peak and steady state currents, and can
bind via KChIP1 to Kv4.3 (Bowlbyet al. 2005).
1.4.2 Regulating channel trafficking
Someproteins interact with the Kv4 channels and influence both their kinetics
and trafficking. This includes the KChIPs and DPP proteins, as well as MiRP1,
which influences channel kinetics as discussed above, and channel progression to
the plasma membrane (Chandrasekhar et al. 2006). Alternatively, there are other
modulators of the Kv4 channelsthat exert their functions solely on the trafficking
of the channel to the plasma membrane. These include the actin binding protein
filamin, which increases channel trafficking (Petrecca et al. 2000) and the
microtubule motor Kif17 (kinesin family member 17), which may be important
for the trafficking of Kv4 channels to dendrites (Chu et al. 2006). The
depolymerisation of actin by cytochalasin D also causes the channel to
redistribute to the cell surface (Wanget al. 2004), highlighting the importance of
the cytoskeleton in trafficking. Monocultures of cerebellar granule cells also
need to make contact with mossyfibre cells in order for Kv4 channels to target to
dendrites, and require glutamate signalling for clustering of these channels
(which may link with the role of MAGUKproteins discussed below) (Shibasaki
et al. 2004).
Whilst phosphorylation on some residues can inhibit Kv4_ channels,
phosphorylation of serines 438 and 459 by CaMKII promotes surface expression
of Kv4.2, and also increasestotal levels in the cell (Varga et al. 2004). The K”
channel associated protein (KChAP) can also bind Kv4.3, and increases the
plasma membranelocalisation of a range of Kv channels (Wible et al. 1998;
Kuryshev et al. 2000). Meanwhile, neuronal interleukin-16 (NIL-16) reduces
surface expression of Kv4.2 (Fenster et al. 2007), and PPTX (protein with
pentraxin domain) binds Kv4.2 andtrapsit intracellularly (Duzhyy etal. 2005).
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1.4.3 MAGUKproteins
The MAGUK family of proteins are characterised by having several PDZ
domains, named for the three proteins where they were originally discovered:
post-synaptic density 95 (PSD-95), Drosophila disc large tumour suppressor
(DlgA) and zona occludens-1 (zo-1). Over 400 PDZ-domain containing proteins
are known in mammals (Kim and Sheng 2004). These are often expressed in the
brain, but also, for example, in the heart (Muller et al. 1995). The PDZ domain
has six B strands, forming partially opened barrel, topped on each side with an
a helix (Feng and Zhang 2009).This can bind to the C-terminusoftarget proteins
(Kim and Sheng 2004). In addition, the PDZ-domains are found in tandem
arrays, and in conjunction with other protein interaction motifs. For example, one
of the best studied families of MAGUKproteins are the PSD-95 family (Figure
1.7), which have 3 PDZ domains, plus an SH3 domain and a guanylate kinase-
like domain (although this lacks enzymatic activity) (Kim and Sheng 2004). This
allows these proteins to bind to many other proteins, and bind together as
multimers, in order to cluster and scaffold other proteins (Kim and Sheng 2004;
Feng and Zhang 2009).
There are four members of the PSD-95 family: PSD-95 (also known as SAP90),
PSD-93 (also known as chapsyn-110), SAP102 and SAP97 (Kim and Sheng
2004). Of these, PSD-95 and PSD-93 are enriched in the post-synaptic density,
where they cluster NMDAreceptors, and may be importantin synaptic function.
PSD-95
PSD-93
SAP102
SAP97
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1.7: The PSD-95 family of MAGUK proteins.
Schematic representations of the domains found in four members of the PSD-95
family, PSD-95, PSD-93, SAP102 and SAP97. Each has three PDZ domains, an
SH3 domain, and a GK guanylate kinase-like domain. In addition, SAP97 has an
L27 domain. These allow for each PSD-95 protein to make interactions with
several other proteins and effectors. Adapted from Kim and Sheng 2004.
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Meanwhile, SAP97 and SAP102 are found in dendrites, axons, the cytoplasm
and synapses of neurons, and may be involved in trafficking to the plasma
membrane (Kim and Sheng 2004). These different proteins have various
isoforms, and these can have a range of post-translational modifications. For
example, SAP97 has two known splice isoforms (Muller et al. 1995). PSD-93
has many isoforms, of which PSD-936 has a cysteine residue for palmitoylation
(also seen in PSD-95 for post-synaptic targeting), PSD-93¢ has an L27 domain
(also used by PSD-95f to target to synapses via protein-protein interactions), but
PSD-93e has neither (Parker et al. 2004). Thus different isoforms may have
different intracellular roles. It has also been shown that PSD-95 and PSD-93a/B
can only cluster neuronal ion channels when palmitoylated, whilst SAP97 and
SAP102 are unpalmitoylated, and cannot cluster channels (El-Husseini et al.
2000).
PSD-93 and PSD-95 seem to share many functions, and are found in the same
synapses by electron microscopy (DeGiorgis et al. 2006). PSD-93 localises to
neuronal cholinergic synapses, and might have a role in stabilising nicotinic
acetylcholine receptors. However, recent work with PSD93 knockout mice has
shown them to be normal, and clustering of nicotinic acetylcholine receptors was
unaffected (Parker et al. 2004), suggesting the presence of a compensatory
protein, possibly PSD-95. PSD-95 is found at the post-synaptic density, and is
found on the plasma membrane when expressed in COS-1 cells (Tiffany et al.
2000). It has well characterised binding to AMPA receptors, preventing their
lateral diffusion in the synaptic membrane (Bats et al. 2007), and can cluster
NMDAreceptors (Kim and Sheng 2004). SAP97 was discovered in the
presynaptic terminals of excitatory synapses in the hippocampus, whereit exists
in both a hydrophilic and membrane-associated form (Muller et al. 1995). In
COS-1 cells it was seen to be perinuclear (Tiffany et al. 2000). Electron
microscopy work has also identified SAP97 at the edges of post-synaptic
densities, near AMPA receptors (DeGiorgis et al. 2006). Recent work has also
shown a role for SAP97 in the non-conventionaltrafficking of NMDAreceptors
from the ER to dendritic Golgi outposts in neurons (Jeyifous et al. 2009).
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Both SAP97 and PSD-95 can bind to potassium channels, including inward
rectifier (Kir) channels (Leyland and Dart 2004), increasing the number of them
at the cell surface and causing them to cluster (Horio et al. 1997). There is also
evidence they can have roles beyondtrafficking and clustering, as PSD-95 can
reduce Kir2.3 channel conductance (Kim and Sheng 2004). They can also bind to
Kv1 channels, where interestingly PSD-95 can cluster Kv1 channels and prevent
their internalisation (Jugloff et al. 2000; Tiffany et al. 2000), whilst SAP97
retains the channel within membrane-boundorganelles in the cell, preventing its
trafficking (Tiffany et al. 2000). More importantly for this study, PSD-95 and
SAP97can also bind to Kv4 channels, as shown by co-immunoprecipitation and
co-localisation by immunohistochemistry in brain slices (Gardoni et al. 2007).
This interaction requires the PDZ domain of PSD-95 or SAP97, and a valine-
serine-alanine-leucine PDZ-binding motif in the C-terminus of Kv4.2 (Wong et
al. 2002; Gardoniet al. 2007; El-Haouet al. 2009). This interaction also requires
the palmitoylation of PSD-95 (Wonget al. 2002). Both SAP97 and Kv4.2 can be
phosphorylated, but this does not affect their interaction (Gardoni et al. 2007).
However, phosphorylation of SAP97 by CaMKII (Kim and Sheng 2004) does
promotethetrafficking of both SAP97 and Kv4.2 to dendritic spines (Gardoniet
al. 2007). It seems that SAP97 can promotetrafficking of Kv4.3 to the plasma
membrane (El-Haouet al. 2009), although this was in cells stably transfected
with KChIP2, and the separate contributions of the SAP97 and KChIP2 to
channel trafficking were not fully assessed. The SAP97 also increased the
channel’s current density, although to a lesser extent than the KChIPs (El-Haou
et al. 2009). In addition, SAP97 knockdown by RNAi reduced the levels of
Kv4.2 in the postsynaptic compartment, suggesting this PDZ-domain protein
may be important in Kv4 trafficking (Gardoni et al. 2007). On the other hand,
PSD-95 increases the surface expression of Kv4.2 and causesit to cluster, so
maybe a key anchorat the synapse membrane (Wongetal. 2002; Gardoni etal.
2007). This may have a role physiologically, by bringing the Kv4 channels close
to NMDAreceptors, thus influencing LTP (Wong et al. 2002). It has also been
shown that a mutation in the Kv4.2 channel causing epilepsy is missing the PDZ-
domain binding site (Singhet al. 2006). These proteins thus seem to be another
important class of Kv4 regulators in vivo.
30
1.5 Traffic through the secretory pathway
It is apparent from the work described abovethat the trafficking of Kv4 channels
to the plasma membraneis vital in regulating their function, and hence neuronal
activity. Although association with accessory proteins, especially the KChIPs,
can promotethis trafficking, many of the molecules and mechanismsfacilitating
this trafficking are likely to be those used by the standard secretory pathway.
Protein synthesis and trafficking via this conventional pathway will be
introduced, with sections on two important groups of proteins regulating this
pathway, the Rabs and SNAREs. However, there is growing evidence of non-
conventional trafficking pathways in cells, and these will be discussed, before
focussing on the evidence for the non-conventionaltrafficking of Kv4 channels.
1.5.1 Protein synthesis and retention at the ER
The first step on the secretory pathway is the endoplasmic reticulum. Proteins
with transmembrane domains, for example Kv4 channels, have a signal sequence
at the N-terminus of their sequence. This consists of at least one basic residue,
followed by a stretch of 6-20 hydrophobic residues. This is recognised by the
signal recognition particle (SRP), a cytoplasmic ribonucleoprotein. This binds to
the signal sequence as it emerges from the ribosome, temporarily inhibiting
elongation. The SRP then binds to the SRP receptor on the ER membrane,
causing the displacement of the SRP. The ribosome can then recommence
translation, with the newly synthesised protein being inserted across the ER
membrane co-translationally. This is more fully reviewed in Wilkinson etal.
1997.
Oncetranslated, multispan transmembraneproteins are often retained within the
ER (Trombetta and Parodi 2003). In particular, there are ER quality control
checks, designed to degrade proteins that are synthesised but not folded into their
native state. This involves chaperones and other folding factors, in a regulated
network for protein folding and retention (Trombetta and Parodi 2003). Beyond
this, misfolded proteins can exit from the ER if they present a correct ER exit
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signal (Kincaid and Cooper 2007), and there is evidence for Golgi quality
control, but the mechanismsof this are unclear (Trombetta and Parodi 2003). In
fact, proteins can have a range of signals for trafficking to, or retention in,
various organelles, but these are not well understood (Rothman and Wieland
1996). One of the best known is the dilysine ER retention motif, first identified in
yeast, but shown to also be functional in mammalian cells. Some potassium
channels instead have dibasic RXR motifs. These bind to the COPIcoat, to allow
proteins to recycle back from the Golgi to the ER (Cosson and Letourner 1994;
Zerangue et al. 1999). Alternatively, there are three known ER-exit signals,
which likely bind to parts of the COPII coat to promote ER-to-Golgitrafficking
(Watanabe and Riezman 2004). G-protein coupled receptors have these export
signals (Donget al. 2007) and some ion channels may have them as well, but
very little is known about specific signals in Kv4 channels (Misonou and
Trimmer2004).
1.5.2 Conventional ER-to-Golgi trafficking
Early work on the exocytic trafficking of newly synthesised proteins came from
pioneering work on characterising intracellular organelles and determining their
function. The important contributions of three of the founders of modern cell
biology — Albert Claude, Christian de Duve and George E Palade — were
acknowledgedby the award of the 1974 Nobel Prize for Physiology or Medicine.
This was awarded for Claude’s development of methods for preparing cells for
electron microscopy, which were later refined by Palade. It also acknowledged
Claude’s developmentof the technique ofcell fractionation by centrifugation to
separate different organelles, used by de Duve for characterising lysosomes
(Edstrom 1992). Palade combined electron microscopy with cell fractionation to
study intracellular trafficking, and developed pulse-chase experiments with
radiolabelled amino acids, to follow newly synthesised protein in the cell, with
an improved time resolution. This work showed that proteinstraffic from the
rough ER to the cis- and then trans-Golgi, and that this process requires ATP.
Palade also suggested that proteins were trafficking between organelles in
vesicles (Palade 1975). Following on from this work, Rothman and colleagues
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started to use vesicular stomatitis viral glycoprotein (VSVG) to study the
synthesis and trafficking of transmembrane proteins. This showed that such
proteins were being inserted across the membrane of the ER during, or
immediately after, protein synthesis. These studies also laid the foundation for in
vitro reconstitution experiments, studying protein synthesis and trafficking in
cell-free systems (Katz et al. 1977a; Katz et al. 1977b). Later work by Rothman
also identified different populations of trafficking vesicles, distinguishing
between those for ER-Golgi traffic, and those involved in the Golgi-plasma
membrane step (Rothman and Fine 1980). VSVGcontinues to be used to study
the dynamics of ER-Golgi trafficking, and temperature sensitive mutants and
GFP-tagged versions of the protein have been developed (Presley et al. 1997).
These can be trapped in the ER or Golgi at different temperatures, and their
onwardtrafficking visualised using fluorescence microscopy.Finally, much early
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1.8: The secretory pathway.
The diagram represents the typical secretory trafficking pathway in a vertebrate cell. The
various organelles on the secretory pathway are shown, with trafficking occurring in the
direction of arrows. Traffic between organelles occurs in coated vesicles, with COPII and
COPIbeing important coats for ER-Golgitrafficking.
ER = endoplasmic reticulum, ERGIC = ER Golgi intermediate compartment, TGN = trans-
Golgi network.
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work in identifying the important proteins involved in exocytic trafficking came
from Schekman and colleagues using yeast. In a seminal paper from 1980, they
identified 23 secretory yeast mutants, with these genes later identified with the
Sec proteins (Novicket al. 1980). This work proved to be important, as much of
the machinery and numberof coats is conserved,although the numberofproteins
in humansis greatly expanded (Bock et al. 2001; Bonifacino and Glick 2004).
Thetypical vertebrate pathway is shown in Figure 1.8.
The pathwaystarts at specific, relatively immobile regions of the ER, which are
cleared of ribosomes. Theseare called either ER exit sites, or the transitional ER,
and it is here that newly synthesised proteins are packaged into COPII-coated
vesicles (Figure 1.9) (Glick 2000; Stephenset al. 2000). This involves somelevel
of cargo sorting, as VSVGis concentrated 5-6-fold on ER exit (Bannykh etal.
1996). The first component of the COPII coat to bind the ER is the GTPase Sar1.
Mammals have two isoforms ofthis, which are largely redundant, but the traffic
of some cargoes may be Sarlb specific (Shoulderset al. 2004). Sec12 is needed
as a Sarl GEF (guanine nucleotide exchange factor) converting Sarl to its GTP
bound form (Barlowe et al. 1994). This releases the N-terminal tail of Sarl,
which allows it to bind membranes, and allows it to recruit Sec23/Sec24
(Rothman and Wieland 1996; Shoulder et al. 2004). These proteins, especially
& Sar1
| Sec23/Sec24 complex COPII-coated
e™Sec13/Sec31 complex vesicle
GDP
   Sec12 ER lumen
Cargo
1.9: The assembly of a COPII-coatedvesicle.
This showsthe conventional model of the assembly of a COPII coat on the membrane
of the endoplasmic reticulum (ER). The guanine nucleotide exchange factor Sec12
converts Sarl from its GDP- to GTP-boundform,allowingit to interact with the ER
membrane. Sec23/Sec24 are then recruited, and can interact with cargo molecules.
Finally, the Sec13/Sec31 complex binds, and induces membrane curvature, allowing
the vesicle to bud from the membrane. Adapted from Kuehn and Schekman 1997.
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Sec24, are thought to form a complex with cargo and/or ER export signals, and
mayplay role in sorting and concentrating proteins in COPII-coated vesicles
(Kuehn et al. 1998). Next, Secl3 and Sec31 bind. These form the protein
scaffold, and can even self-assemble into a lattice in vitro (Gurkan et al. 2006;
Stagg et al. 2006), deforming the membrane into a bud (Matsuokaet al. 1998).
Thevesicle then traffics away from the ER, in ~60nm diameter vesicles (Barlowe
et al. 1994). This requires microtubules and the motor proteins dynein/dynactin
(Presley et al. 1997), and Sec23 interacts with dynactin to facilitate this (Watson
et al. 2005). Finally, an arginine finger from Sec23 promotes the GTPaseactivity
of Sarl (Bonifacino and Glick 2004), and this causes first Sarl and then the rest
of the coat to disassemble from the membrane (Barlowe et al. 1994; Rothman
and Wieland 1996). The COPII coat is not required for traffic to or through the
Golgi (Kugeet al. 1994; Stephenset al. 2000).
In vertebrates, the next step in the trafficking pathway seems to be the ER-Golgi
intermediate compartment (ERGIC), also known as vesicular tubular clusters
(VTCs) (Glick 2000). Once uncoated, COPII vesicles may homotypically fuse to
form the ERGIC (Glick 2000), and ER exit sites face towards the ERGIC
(Bannykh et al. 1996). 3D ultra-rapid freezing electron microscopy reveals
branched tubules and flattened sacs, separate from the ER or Golgi, surrounded
by uncoated budding and fusing vesicles (Ladinsky et al. 1999). Most tested
proteins pass through the ERGIC on route from ER to Golgi (procollagen is an
exception, as will be discussed below), and the greater the level of protein
production, the larger the ERGIC (Stephens and Pepperkok 2004; Simpsonetal.
2006).
There is much debate about the next step in trafficking to the Golgi. Individual
ERGIC clusters may move towards the cis-Golgi on microtubules and then
aggregate to give the first Golgi cisterna (Scales et al. 1997; Glick 2000).
Alternatively, COPI coated vesicles, which are required for retrogradetrafficking
in yeast (Cosson and Letourner 1994), may act as both anterograde and
retrograde carriers in vertebrates (Rothman and Wieland 1996; Roweetal.
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1996). There is evidence for two populations of COPI vesicles, one containing
anterograde markers, and the other proteins for retrograde traffic (Nickel et al.
1998). Also, antibodies against B-COP, a constituent of the COPI coat, blocked
VSVGin the ERGIC(Peter et al. 1993). Knockdown of the GEF for the COPI
GTPase ARF1, or locking ARF1 in the GTP-bound form using a Q71L mutation,
blocked VSVG in the ERGIC,as well as disrupting the cis-Golgi and ERGIC
(Dascher and Balch 1994; Szul et al. 2007). Also, COPI vesicles have been
observed trafficking from the cell periphery to the Golgi (Stephenset al. 2000),
and a variety of tested cargoes require COPI for anterograde trafficking
(Stephens and Pepperkok 2004). A big question is how thecell sorts anterograde
and retrograde cargoesinto different populations of COPI vesicles (Glick 2000),
although this may involve the ERGIC53/VIP36 family of proteins (Nickelet al.
1998).
COPI coat assembly shares similarities with the COPII coat. Firstly, the GTPase
ARF1 undergoes GDP-GTP exchange, with the assistance of soluble GEFs with
Sec7 domains, and with ARF1 bound to membranesvia a myristoy] tail (Franco
et al. 1996; Goldberg et al. 1998). However, unlike COPII, ARF1 then recruits
all other members of the COPIcoat togetheras a single complex (Bonifacino and
Glick 2004). This coatomer complex consists of a-COP, B-COP, B'-COP, y-COP,
5-COP,e-COP and ¢-COP (Bednareket al. 1995). Like Sarl, ARF1 is vital both
for recruiting the COP coat, and triggering its disassembly by GTP hydrolysis
(Rothman and Wieland 1996). This step is sensitive to non-hydrolysable GTPyS
(Pepperkok et al. 1998). ARF1 may also be required for COPII/COPI coat
exchange (Roweet al. 1996), and for maintaining Golgi structure (Dascher and
Balch 1994). Once delivered to the Golgi, transmembraneproteins then appear to
move through it in sequential steps (Balch et al. 1984), with COPI required for
traffic between Golgi cisternae (Orciet al. 1997). Proteins then exit in secretory
vesicles for traffic to the plasma membrane. The exact organisation and route
through the Golgi is controversial, however (Mironovetal. 1998; Pattersonetal.
2008), but will not be discussed further here.
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1.5.3. Rab GTPases
The process of vesicular secretory trafficking must be highly regulated and
compartment specific and one group ofvital proteins is the Rab GTPase family.
These are Ras-related proteins found in the brain, and around 20-25kDain size
(Schwartz et al. 2007). The family is encoded by about 11 genes in budding
yeast, and 60 human genes, reflecting the evolutionary increase in trafficking
complexity (Bock et al. 2001; Lee et al. 2009). Even essential Rabs, such as
Rab1, may have different isoforms, and there are different expression profiles of
these isoforms in different cell types (Gurkan et al. 2005). Rab proteins are
GTPases, and as such exist in an inactive, GDP-bound form, and a GTP-bound
active form. In this active form they can associate with membranes through
(usually) two C20 prenyl groups, attached to C-terminal cysteine residues. This
is essential to their function (Lee et al. 2009). They mayalso be phosphorylated,
and thus be downstream ofsignalling pathways (Schwartz et al. 2007).
The activation of Rabsis tightly regulated. Guanine nucleotide exchange factors
(GEFs) allow the exchange of GDP for GTP, at which point the Rab-GTP can
associate with a range of protein effectors (Grosshans et al. 2006). This may
include recruiting the GEF for another Rab. However, the Rab can catalyse the
GTP back to GDP, a process accelerated by the GTPase activating proteins
(GAPs). Rab GDPdissociation inhibitors (RabGDJ) then promote the removal of
Rab-GDP from membranes, and are themselves dissociated from the Rab by Rab
GDIdisplacement factors (RabGDFs) (Lee et al. 2009). Most Rab GAPs have a
TBC (Tre-2, Bub-2, Cdcl6) domain, of which there are ~51 in the human
genome (Bernards 2003). Some of these have been matched to their specific
Rabs, including TBC1D20, which was shown to be specific for Rabl in vivo
(Haasetal. 2007).
Different Rabs are found throughoutthe cell (Schwartz et al. 2007), but specific
Rabs have specific localisations and functions. In general, this involves
organizing membrane domainsthatcontrol the trafficking of cargoes to different
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destinations (Schwartz et al. 2007). Often this involves regulating the fusion of
SNARE complexes, and possibly proofreading them, or regulating the tethering
of vesicles in the step prior to SNARE fusion (Rothman and Wieland 1996;
Bonifacino and Glick 2004). They may also interact with motor proteins, to
direct the transport of vesicles (Hammer and Wu 2002). In fact, it has been
proposed that they act at the centre of trafficking hubs, regulating SNAREs,
tethers and motor proteins (Gurkan et al. 2005). It is Rabs la, 1b and 2 that are
vital for vesicular trafficking from ER to Golgi (Tisdale et al. 1992). Rab2 may
have a role in the formation of COPI-coated vesicles (Buffa et al. 2008), is found
in the ERGIC, and mayplay a role in anterograde/retrograde cargo segregation
(Tisdale and Balch 1996). Meanwhile, depletion of Rabl, or using a mutant
inactive version of its RabGAP TBC1D20,inhibited the trafficking of VSVG to
the plasma membrane, disrupted COPII localisation, and fragmented the Golgi
and ERGIC (Haaset al. 2007), highlighting Rab1’s importance in ER-Golgi
trafficking.
1.5.4 SNARE proteins
There are more than 36 human SNARE (soluble NSF attachment receptor)
proteins, each containing a 60-70 amino acid SNARE motif, and typically a C-
terminal transmembrane domain to anchor them to membranes (Jahn and
Scheller 2006). Three, or more usually four, SNARE proteins come together, and
their SNARE motifs form one of four o helices that assemble into a coiled coil,
as shown in Figure 1.10. If these SNARE proteins are on two different
membranes(a trans configuration), then it is thought that formation ofthis coiled
coil produces a mechanical force that drives membrane fusion (Jahn and Scheller
2006). Each fusion machine consists of between 3 and 15 SNARE complexes.
Once membranefusion is complete, the SNARE complex is disassembled by the
actions of SNAPproteins and NSF, using energy obtained from the hydrolysis of
ATPby NSF(Jahn and Scheller 2006).
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The fusion of two membranes needs controlling, in order to keep proteins
compartmentalised correctly, and to ensure that secretion of proteins can be
controlled. It is therefore important to have specificity and regulation. The
central ‘0’ layer of the interacting SNARE complex contains four conserved
residues, 3 glutamines and 1 arginine. Each SNARE protein contributes one of
these residues, and can therefore be classified as a Q or R SNARE, and the
majority of in viio SNARE complexes have a QaQgpQcR arrangement (Jahn and
Scheller 2006). However, it has been shown in vitro that as long as this
glutamine and arginine distribution is obeyed, that any SNARE complexes can
form (Fasshauer et al. 1999; Yang et al. 1999(1)). Whilst there is certainly
evidence that SNARE proteins can drive membrane fusion without requiring
other accessory proteins (Hu et al. 2003), it seems that specificity may also
depend on tethering factors, Rab proteins, and the localisation of SNAREsin the
cell (Yang et al. 1999(1); Hong 2005). Nevertheless, the complement of
SNAREson a membraneor vesicle does help determine which other membranes
it can bind with, and hence to some extent defines that compartment (Jahn and
Scheller 2006).
The SNAREsfor ER-Golgitrafficking seem to be highly conserved from yeast
onwards (Kloepperet al. 2007). The conventional trafficking pathway involves a
complex of syntaxin 5, membrin and rBetl, which is then bound by Sec22b to
form the complete SNARE complex (Xuet al. 2000). Both Sec22b and rBet1 are
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1.10: The formation of a SNARE complexallows fusion of two membranes.
Four SNARE proteins come together to form a complete SNARE complex. In this case, one
SNARE is shown onthe vesicle and three on the acceptor membrane, each coloured separately.
As the SNARE helices interact to form a coiled coil, the SNARE proteins, and the membranes
they are bound to, come closer together. Eventually this leads to the formation of a fusion pore,
and the joining of the two membranes. Adapted from Jahn and Scheller 2006.
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enriched at ER exit sites, whilst membrin is seen on small vesicles moving from
ER to Golgi (Chao et al. 1999), and syntaxin 5 is required for the fusion of
COPII-coated vesicles to form the ERGIC (Bentley et al. 2006). It therefore
seems that this SNARE complex is required on COPII- and COP!I-coated
vesicles, and the ERGIC (Dascheret al. 1994; Hayet al. 1998).
Alternatively, a SNARE complex containing Ykt6, GOS28, syntaxin 5 and rBet1
has been described in theliterature in the Golgi (Zhang and Hong 2001). GOS28
showsa steady-state localisation in the Golgi (Hay et al. 1998), where it has a
role in the docking and fusion of vesicles with the cis-Golgi (Subramaniam etal.
1996). Ykt6 is also an interesting SNARE, as it contains a profilin-like 5
stranded antiparallel sheet surrounded by three a helices, known as a longin
domain (Hong 2005). Ykt6 can be prenylated to allow interaction with
membranes (Zhang and Hong 2001), but this is masked by the longin domain
(Hasegwaet al. 2004), which also inhibits SNARE complex formation (Hong
2005; Wang and Tang 2006). This longin domain also directs Ykt6 to an unusual
punctate distribution in PC12 cells, which correspondsto neither the ERGIC nor
endosomes (Hasegwaetal. 2003; Hasegwaetal. 2004).
Finally, there is a third SNARE complex implicated in ER-Golgitrafficking, this
time in the non-conventional trafficking of prechylomicron transport vesicles
(PCTVs) in the intestine. This involves the SNAREs VAMP7, Vtila, rBetl and
syntaxin 5 (Siddiqi et al. 2006a), and antibodies against VAMP7prevented the
delivery of triacylglycerol from ER to Golgi (Siddiqi et al. 2006b). In these
studies, VAMP7 was found in the ER and Golgiofintestinal cells, but not in the
ERofthe kidneyorliver, suggestingthis is a tissue-specific pathway (Siddiqi et
al. 2006b). It should also be noted that VAMP7 is not expressed in the heart
(Advaniet al. 1998).
This ER localisation of VAMP7is surprising, as this SNARE is more commonly
associated with lysosomes, and many studies have found it co-localised with
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lysosomal markers (Advani et al. 1998; Advani et al. 1999; Martinez-Arcaetal.
2003). Both VAMP7 and Vtila seem to be more typically involved in
endosome/lysosome or lysosome/lysosomefusion, in complex with syntaxins 7
and 8 (Bogdanovic et al. 2002; Pryor et al. 2004; Casey et al. 2007). However,
immunogold electron microscopy has shown VAMP7to be mostassociated with
the ERGIC (Cocoet al. 1999), and in a proteomic map of the secretory pathway
VAMP7wasin COPI-coated vesicles, and Vtila in the smooth ER, Golgi and
COPI-coated vesicles (Gilchrist et al. 2006). VAMP7 wasalso in small vesicles
dispersed throughout the cytoplasm of CaCO-2 cells, which were not associated
with Golgi or lysosome markers (Galli et al. 1998). VAMP7also appears to have
an important role in neuronal growth, and is enriched in neurons (Wang and
Tang 2006), where it regulates neurite outgrowth (Martinez-Arca et al. 2000).
This could explain its localisation to both punctate structures within the cell body
of neurons, and to the leading edge of the growth cone (Coco et al. 1999). Like
Ykt6, VAMP7is a longin-domain SNARE andthis domain both inhibits SNARE
complex formation, and influences the protein’s localisation (Martinez-Arca et
al. 2003; Uemuraet al. 2005).
1.5.5 Non-conventionaltrafficking pathways
Whilst the bulk ofcellular protein traffic goes via the standard pathway described
in section 1.5.2, and is under the commonregulation of the protein families
discussed above, there are examples of other non-conventional routes through the
cell, some of which will be discussed below. Although manyof the underlying
mechanisms of trafficking are conserved from yeast to humans, there are
differences in trafficking, not least that both COPII- and COPI-coated vesicles
can bud from the ER in yeast (Bednarek et al. 1995). In fact, yeast seem to have
three populations of ER-Golgi vesicles, for soluble cargoes, GPI-anchored
cargos, and transmembraneandotherproteins, regulated by cargo adaptorsorting
(Castillon et al. 2009). This segregation of GPl-anchored proteins requires
ceramide synthesis, but seems to be due to protein-protein interactions rather
than lipid partitioning, possibly by interacting with individual SNARE proteins
41
(Muniz et al. 2001; Morsommeet al. 2003; Watanabe et al. 2008). This pathway
is also still COPI-dependent (Sutterlin et al. 1997).
Mammalian GPI-anchored proteins are also trafficked via a non-conventional
route, requiring the cargo adaptor p24 proteins (Takida et al. 2008). However,
there is evidence that GPI-anchored proteinsstill require Sarl GTP hydrolysis
for sorting into COPII-coated ER exit sites, as does another unusual cargo,
procollagen (Stephens and Pepperkok 2004). Procollagen is an interesting cargo
as it is too large for standard COPII vesicles. Indeed, although it buds at or near
to ER exit sites, requiring COPII, it may then traffic in microtubule-dependent
spherical structures that are not COPII coated, and do not go via the ERGIC
(Stephens and Pepperkok 2002; Stephens and Pepperkok 2004). Alternatively,
and more controversially, uncoated tubules and sacs may form from distended
regions of the ER, 600-800nm in diameter (Mironov et al. 2003). Onward
trafficking may or may not then require COPI (Mironovetal. 2003; Starkuviene
and Pepperkok 2007).
In the intestine, triacylglycerol is resynthesised in the ER, and transported to the
growing chylomicron by prechylomicron transport vesicles (PCTVs) (Kumar and
Mansbach 1997). These are 100-500nm in diameter, and in contrast to
procollagen vesicles, can bud from the ER in a COPII-independent manner,
whilst requiring COPII for later fusion with the Golgi (Siddiqi et al. 2003). As
discussed in section 1.5.4, the trafficking of these vesicles from ER-to-Golgi also
requires a novel SNARE complex (Siddiqi et al. 2006a). The PCTVsalso appear
to lack COPI (Siddiqiet al. 2003). Meanwhile, viral primary membrane proteins
can traffic from the ER in a completely COPII-independent manner (Husain and
Moss 2003).
The cystic fibrosis transmembrane conductance regulator (CFTR) also seems to
have a COPI-independenttrafficking route, although it does require COPII. What
is interesting about this protein is that it can traffic from the ER to the distal
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Golgi, and then back to the cis-Golgi, and that this unusual pathway is Rab1 and
Rab2-independent (Yoo et al. 2002). The a2p-adrenergic receptor also seems to
traffic in a Rabl-independent manner (Wuet al. 2003). Finally, the protein H-
Ras can traffic via both the standard pathway and a COPII/COPI-independent,
non-vesicular pathway (Zheng et al. 2007), and a mutant GABAtransporter-1
(GAT-1) can traffic in a COPII/COPI/ERGIC-independent manner, althoughthis
mutation prevents it from sorting to axons correctly (Reiterer et al. 2008). Even
more extremely, both the simian rotavirus RRV, and K-Rascan traffic directly
from the ER to the plasma membrane, without transiting the Golgi (Jourdanetal.
1997; Apolloni et al. 2000).
1.5.6 ER-retention of K* channels
Many ion channels, and particularly K” channels, are localised to the ER when
expressed alone in non-neuronal cells, as discussed in Section 1.5.1. One
mechanism for this is through RXR ER retention motifs. These direct the
recycling of the protein from the Golgi back to the ER, by allowing the protein to
interact with the COPI coat (Cosson and Letourner 1994; Zerangueet al. 1999).
An important family of proteins in regulating this are the 14-3-3 proteins.
Humanshave seven isoforms of 14-3-3 proteins (f, y, ¢, ¢ 1, 7, 6), which form
homo- or heterodimers, in order to bind to phosphorylated target proteins
(Shikano et al. 2006). This binding can be to specific sequences as ModeI
binding (R(S/Aromatic)(Basic)(pS/T)XP) or Mode II binding
(RX(Aromatic)(Basic)(pS/T)XP) (Aitken et al. 2002). Alternatively, there is
growing evidence for ModeIII binding to a C-terminal SWpTY motif, using the
same 14-3-3 binding groove (Coblitz et al. 2005). There is also evidence in vitro
of binding to non-phosphorylated substrates, again via the same binding pocket,
but it is not clear if this is significant in vivo (Tzivion and Avruch 2001; Aitken
et al. 2002).
The 14-3-3 proteins do not have an enzymatic function. Rather, it is thoughtthat
they exert their effects through scaffolding proteins together, clamping enzymes
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to their targets, or masking retention signals. They may in fact have multiple
roles with one substrate (Shikano et al. 2006; Tzivion et al. 2001). 14-3-3
proteins have been shown to have manyroles associated with ion channels, and
in particular regulating their trafficking. This includes promoting the surface
expression of 2-pore-domain TASK channels, KCNK leak channels, and, in
plants, outward rectifying K” channels (O’Kelly et al. 2002; Rajan et al. 2002;
Berg et al. 2003). One mechanism suggested for this, and shown to be active for
ATP-sensitive K* channels, is that binding of 14-3-3 proteins to phosphorylated
residues near to RXR ER-retention motifs competes with binding to the COPI
coat for retrieval of the channel back to the ER (Trombetta and Parodi 2003;
Heusseret al. 2006). It is not clear if the different isoforms have differing roles in
this (Tzivion and Avruch 2001). In fact, the high level of sequence conservation
in the protein binding pocket argues either against isoform specificity, or for the
importance of other regions in the dimer (Aitken et al. 2002). It does seem that
14-3-3y is the major isoform in the Golgi, with a role in protein trafficking and
the secretory pathway (Roth et al. 1994; Aitken et al. 2002). A 14-3-3y knockout
mouse did show changes to some protein expression, however it had no
phenotype, and general exocytosis seemed not to be impaired (Steinackeretal.
2005), suggesting some redundancyofaction.
Whenexpressed alonein cells, Kv4.2 showsa perinuclear pattern of localisation.
As many other K” channels are retained in the ER when expressed alone in non-
neuronalcells, it has been argued that this is also the case for Kv4.2. In support
of this, studies have shown co-localisation with the ER-resident marker calnexin
(Shibata et al. 2003). However, this paper also showed that mutation of the only
RXR ER-retention motif in Kv4.2 had no effect, implying it is non-functional.
Furthermore, other studies have shown that ECFP-Kv4.2 does not co-localise
with the ER markers calnexin or protein disulphide isomerase, but showsclearer
co-localisation with the cis-Golgi marker B-COP and Golgi-targeted EYFP
(O’Callaghan et al. 2003; Hasdemir et al. 2005). These data would therefore
argue that usually the Kv4.2 channel is localised to the Golgi when expressed
alone in non-neuronalcells.
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1.5.7 Trafficking of Kv4.2 channels
Many of the proteins in section 1.5.6 that use non-conventional trafficking
pathways are unusual, because of their viral origins, large size, or specific
membrane anchor.In contrast, the Kv4.2 channel would be expected to follow a
conventional trafficking route, but there is evidence to suggest that this is not the
case.
Asdiscussed above, the Kv4.2 channelis localised to the Golgi when expressed
alone in cells. Co-expression with KChIP1 causestrafficking of both the KChIP
and Kv4.2 channel to the plasma membrane (O’Callaghan et al. 2003). The
requirement for COPIin this trafficking was shown using a dominant negative
mutant of ARF1. This blocked Kv4.2/KChIP1 trafficking, as well as VSVG,
used as a control for conventional trafficking. However, although a dominant
negative form of Sarl blocked VSVGtrafficking, and inhibited Kv4.2 from
reaching the Golgi when expressed alone, it did not completely block
Kv4.2/KChIP1 trafficking to the plasma membrane (Hasdemiret al. 2005). This
suggests that Kv4.2/KChIP1 traffic via a different pathway to the bulk COPII-
dependent route. However, this has not been further characterised. In neurons,
Kv4.2 trafficking is polarised to the dendrites, due to a 16 residue dileucine motif
(Rivera et al. 2003). The channels then cluster on the neuronal membrane,atsites
distinct from synapses or gap junctions, in a way that is not mechanistically
understood (Kollo et al. 2006). However, it seems likely that this will require
further protein interactions that have yet to be characterised.
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1.6 Aims and Objectives
The focus of this study was onthe trafficking of Kv4.2 channels, with their
accessory protein KChIP1, to the plasma membrane. Several questions were to
be addressed. Firstly, the KChIPs can bind to Ca" ions, and this appears to be
important for promoting the trafficking of Kv4 channels to the plasma
membrane. There is debate in the literature, however, about whether EF-hand
mutantproteins can still bind to the Kv4 channel a-subunits, and how many EF-
hand domainsare required for this. One aim wastherefore to comparethe effects
on Kv4.2 of a single EF-hand mutant of KChIP1 to the better characterisedtriple
EF-hand mutant. Secondly, previous work had suggested that Kv4.2 and KChIP1
were trafficking to the plasma membrane via a non-conventional, COPII-
independent pathway. However, this had not been further characterised. One area
of particular interest was in the proteins that could regulate this intracellular
trafficking, and in particular Rabl and ER-Golgi SNAREs.This led to several
aims: to investigate whether Rab1 is required for Kv4.2/KChIP1 trafficking; to
identify SNARE proteins associated with KChIP1-positive punctae in cells; to
use RNAito look for the functional effects of such SNAREs on Kv4.2/KChIP1
trafficking. Thirdly, many other proteins are known to be able to regulate Kv4.2
trafficking and function. Two families of proteins were of interest. The 14-3-3
proteins have been implicated in the regulation of ion channel trafficking, but
there are no studies in the literature focussed on possible interactions with Kv4
channels. One aim was to see whether 14-3-3 isoforms could bind to Kv4
channels. Meanwhile, the PSD-95 family of MAGUKs,especially SAP97, are
known to interact with Kv4 channels, and promote their trafficking and
clustering. However, little is known about the effects of SAP97 in a ternary
complex with KChIP1 and Kv4.2, and how these two accessory proteins might
jointly affect the channel. A final aim was therefore to compare the effects of
KChIP1 and PSD-95 family proteins on Kv4.2, when expressed separately, or
together.
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Chapter 2
Materials and Methods
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2.1 Plasmids
The KChIP1-EYFP plasmid is of KChIPla (GenBank® accession number
AF199597) in an enhanced yellow fluorescence protein vector (EYFP)
(O’Callaghan et al. 2003).
The peDNA-KChIP1 vector encoded the same KChIP1 sequence as above, but
inserted into a pcDNA3.1(-) vector (O’Callaghan etal. 2003).
The KChIP1-pHcRed plasmid took the KChIP1 sequence from above, and
insertedit into the pHcRed-Tandem-N1 vector (Hasdemiret al. 2005).
The KChIP1-EF3-EYFP plasmid had mutations at positions D135A and
G140A,corresponding to positions 1 and 6 of EF hand 3. This wasa kindgift of
Dr B. Hasdemir.
The KChIP1-EF2-4-EYFP plasmid had Ala substitution mutations for the Asp
at position 1 and Gly atposition 6 in EF hands2, 3 and 4. This corresponded to
KChIP1 (D99A, G104A, D135A, G140A, D183A, G188A)-EYFP (Hasdemiret
al. 2005).
The KChIP1-EF2-4-pHcRed plasmid took the same KChIP1-EF2-4 mutant
sequence as described above, and inserted this into the pHcRed-Tandem-N1
vector. This was a kind gift of Dr B. Hasdemir.
The KChIP2-ECFP encodes human KChIP2.3 (Gen Bank®accession number
DQ148481) in the pECFP-N1 enhanced cyan fluorescence protein vector (Venn
et al. 2008).
The FLAG-KChIP2 plasmid took the same KChIP2 sequence as discussed
above,andinserted it into a pFLAG-CMV-4 vector (Venn etal. 2008).
The KChIP3-EYFP plasmid encodes human KChIP3.1 (Gen Bank®accession
number DQ148485) in an EYFP vector (Venn etal. 2008).
The KChIP4-ECFP plasmid contains the sequence for human KChIP4.1 (Gen
Bank®accession number DQ148487) in an ECFP vector (Venn et al. 2008).
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The peDNA-Kv4.2 plasmid has human Kv4.2 (NM_012281) in the
pcDNA3.1(+) vector (Hasdemiret al. 2005).
The mCherry-Kv4.2 plasmid was made by cutting out the Kv4.2 sequence from
the pcDNA-Kv4.2 sequence, and inserting it into an mCherry-Clvector
(Clontech, CA, USA), using the endonucleases EcoRI and Kpnl.
The construct of ARF1-EYFP waspreviously described in Handleyet al. 2007.
The EYFP-Golgi plasmid consists of the EYFP fluorescence tag attached to the
N-terminus of B1,4-galactosyltransferase. This gives targeting to the trans- and
medial-Golgi. This was obtained from Clontech.
The VSVG-GFP plasmid encoded a temperature sensitive ts045 version of
vesicular stomatitis viral glycoprotein in a green fluorescent protein vector and
was a gift from Dr J. Presley (Presley et al. 1997).
The plasmid of TBC1D20 [TBC (Tre-2/Bub2/Cdc16) domain family, member
20] was a gift from Prof F. Barr. This was shown to be a Rab1 GAP (GTPase-
activating protein) in Haaset al. 2007.
The VAMP7-GFPplasmid was a kind gift from Prof T. Galli, and encodes the
SNARE protein VAMP7in a GFP plasmid (Martinez-Arcaet al. 2003).
A plasmid wasalso obtained encoding the longin domain of VAMP7fused to
GFP,a kind gift of Prof T. Galli (Proux-Gillardeaux et al. 2007).
The EGFP-SAP97 plasmid encodes SAP97 in a pEGFP-C1 construct, and was a
kind gift of Prof L-Y. Lian, University of Liverpool.
The plasmids encoding PSD-935-GFP, PSD-93e-GFP and PSD-93¢-GFP were
all in pEGFP-N1 vectors, and wereall kind gifts from Prof L-Y. Lian.
An mCherry-PSD-95 plasmid, encoding human PSD-95 in an mCherry vector,
was a kind gift from Dr L. Haynes.
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2.2 Antibodies
The antibodies used in this thesis are shown in Table 1. This includes their
source, and the dilution used for immunofluorescence and Western blotting as
appropriate.
Table 1: List of antibodies andtheir dilutions.
 
 
 
     
Immuno- Western
Antibody Description Supplier fluorescence blotting
Dilution Dilution
. Prof A. Aitken14-3-3B Easel (University of N/A 1:3000poly Edinburgh, UK)
. Prof A. Aitken14-3-3y aye (University of 1:500 1:5000poly Edinburgh, UK)
B-Actin Mouse SigmaAldrich ;(A-5441) monoclonal (MO, USA) nil Lae
Mouse Clontech ;GFP (JL8) eacubeloual (CA, USA) N/A 1:1000
GOSRI1 Mouse Abcam .
(GOS28) monoclonal (Cambridge, UK) 1:500 NIA
Rabbit Exalpha Biologicals ;Kv4.2 ialvalendt (MA, USA) 1:500 N/A
Rabbit Affinity Bioreagents .LAMP!1 palvelonal (CO, USA) 1:500 N/A
. Mouse Abcam ;
iemibrit monoclonal (Cambridge, UK) cd BUA
Sec22L1 Mouse Abnova ;
(Sec22b) monoclonal (Taipei, Taiwan) ia Ne
. Synaptic Systems
Syntaxin 7 Rabbit (Goettingen, 1:750 N/Apolyclonal G.ermany)
: Synaptic Systems
Syntaxin 8 sebbt (Goettingen, 1:750 N/Apolyclonal G.ermany)   
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 Mouse Abcam
Vas? monoclonal (Cambridge, UK) n00 Bins
. Prof T. GalliVAMP7 en (Institut Jacques 1:500 N/A
poly Monod,France)
. Mouse BD Biosciences ; ;Vtila foodsual (CA, USA) 1:500 1:2000
Dr J. Hay
. (University of ;Ykt6 Chicken Montana, USA) 1:500 N/A
Hasegwaetal. 2003       
For immunofluorescence, five secondary antibodies were used in this thesis.
Anti-mouse andanti-rabbit IgG conjugated to TRITC (tetramethylrhodamine B-
isothiocyanate) were obtained from Sigma-Aldrich (MO, USA). These were used
at a 1:80 dilution, in PBS (phosphate buffered saline) with 3% BSA (bovine
serum albumin). A goat anti-chicken Texas Red conjugated antibody (Abcam,
Cambridge, UK) was used at a 1:80 dilution for experiments with the anti-Ykt6
antibody. Alexa® Fluor-488-conjugated anti-mouse antibody and Alexa® Fluor-
594-conjugated anti-rabbit antibody were obtained from Molecular
Probes/Invitrogen (CA, USA), andused at a 1:250 dilution. For Western blotting,
the secondary antibody was an HRP- (horse radish peroxidase) conjugated anti-
mouse oranti-rabbit antibody from Sigma. This was diluted 1:400 in PBS with
3% skimmed milk powder.
2.3 HeLa cell culture
HeLacells were cultured in 75cm? flasks, in 20ml Dulbecco’s modified Eagle’s
medium (Gibco/Invitrogen, CA, USA), with 5% foetal bovine serum (Gibco),
1% non-essential amino acids (Gibco), and 1% penicillin-streptomycin (10000
units/ml penicillin, 10000yg/ml streptomycin, Gibco). Cells were kept at 37°C,
in a 5% CO atmosphere. For immunocytochemistry, cells were grown in 24-
well plates, with glass coverslips. Cells were plated at ~4x10° per well, in 1ml
supplemented media, and incubated 5-24 hours before transfection. To obtain
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samples for SDS-PAGE gels, HeLa cells were grown in 6-well plates, with
~1.2x10° cells per well, in 3m] supplemented media. Again, cells were left 5-24
hours before transfection.
For the transfection reaction mixture, 31 per pg DNA of GeneJuice
(Novagen/Merck, Darmstadt, Germany) was incubated for 5 minutes at room
temperature with OptiMEM serum-free media (Gibco) to give a total reaction
volume of 1001 for immunocytochemistry experiments, and 300yl for larger
wells for SDS-PAGE samples. Either lug (for immunocytochemistry) or 3ug
(for SDS-PAGEsamples) of each plasmid DNA wasthen added, and the mixture
incubated for a further 15 minutes, before being added dropwiseto thecells.
Cells were thenleft for 24-72 hours post-transfection.
2.4 PC12cell culture
PC12 cells were cultured in suspension in 20ml RPMI1640 media (Gibco),
containing 10% horse serum (Gibco), 5% foetal bovine serum, and 1%
penicillin/streptomycin. Cells were incubated at 37°C in a 5% CO atmosphere.
Fortransfection, cells were trypsinized the day before transfection, and added to
poly-D-lysine coated coverslips (BD Biosciences, CA, USA)in 24-well plates.
Cells were transfected using 31 Lipofectamine2000 (Invitrogen, CA, USA) per
ug plasmid in 100] OptiMEM media (Gibco), following the manufacturer’s
instructions. After addition of DNA,the final reaction mixture was incubated for
20 minutes at room temperature. Growth media was removedfrom thecells, and
the transfection mixture added to each well, with 400u] serum-free RPMI. After
4-6 hours, this was removed, and replaced with 1ml RPMI media supplemented
with serum. Cells were left for 24-48 hours post-transfection.
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2.5 Neuro2A cell culture
Neuroblastoma 2A (Neuro2A) cells were cultured in 75cm” flasks, in 20ml
Dulbecco’s modified Eagle’s medium, with 10% foetal bovine serum, and 1%
penicillin-streptomycin. Cells were kept at 37°C, in a 5% CO, atmosphere. For
immunocytochemistry, cells were plated on glass coverslips in wells of a 24-well
plate, in 1ml media, at a density of ~4x10°cells per well. For SDS-PAGE
samples, cells were grown in 3ml supplemented media, in wells of a 6-well plate,
at a density of ~1.2x10° cells per well. Cells were transfected with a GeneJuice
reaction mix, as outlined for HeLa cells above, 24 hoursafter plating, and then
left for a further 24-72 hours.
2.6 Immunocytochemistry
After transfection, cells on coverslips were gently washed three times in
phosphate buffered saline (PBS): 137mM NaCl, 2.7mM KCl, 10mM Na,HPO,,
2mM NaH>PO,, pH 7.4. Cells were then fixed in PBS with 4% formaldehyde at
4°C overnight. For coverslips of cells only transfected with colour-tagged
constructs, the coverslips were then washed in PBSagain,before beingair dried,
and mounted on ProLong Gold Antifade (Invitrogen).
For immunofluorescence, cells were washed in PBS after fixation, and then
permeabilised in PBT (PBS, 0.1% Triton X-100, 0.3% bovine serum albumin)
for 30 minutes at room temperature. Cells were then incubated with the primary
antibody overnight at 4°C. Antibodies were diluted as listed in Table 1 in PBS
with 0.3% BSA. The primary antibody was then removed, cells washed three
times in PBT, and the secondary antibody added for one hour at room
temperature. The secondary antibodies were diluted as discussed above. Cells
were washed again in PBT, and then dried, before mounting on ProLong
Antifade Gold.
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2.7 Confocal Microscopy
Transfected cells were viewed using a Leica TCS-SP2-AOBS confocal
microscope (Leica Microsystems, Heidelberg, Germany), using a 63x water
immersion objective with a 1.2 numerical aperture. The pinhole wasset to Airy,
to be optimal for each fluorescence setting used. The wavelengths used for
excitation, and the emission ranges recorded, are shown for different
combinationsof fluorophores in Table 2.
Images were viewed using LCSLite software (Leica), and this software was used
to draw regions of interest to obtain data for further analysis. The first region of
interest was drawn around the perimeter of the cell, visible from background
fluorescence. The second was drawn ~1um within this, to give the region of the
plasma membrane. The total fluorescence from the fluorophore of interest in
each region was recorded. Data from these experiments was plotted and
statistically analysed in Excel 2007 (Microsoft, WA, USA). The percentage of
total cellular fluorescence found in the plasma membrane region was calculated
for each cell, and the mean and standard error of the mean (S.E.M)forall cells
under a given condition were calculated. To normalise the data, any background
samples were subtracted, for example the percentage of Kv4.2 fluorescence at
the plasma membranein cells expressing Kv4.2 alone. Data was then normalised
to one of the conditions, often to cells expressing Kv4.2 with KChIP1, as
discussed in the figure legend. The normalised data is always shown astheleft-
most column on graphs. Data sets were statistically compared using Student’s
unpairedf test. Images were manipulated in CorelDraw Graphics Suite X4 (Corel
Corporation, Ottawa, Canada). All fluorescence quantitation combines data from
2 or more experimental repeats.
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Table 2: Fluorophoresused in confocal microscopy, and the excitation and emission spectra
used.
 
 
 
 
 
Fluorophore Exerting maeisney* Emission spectra, nm
ECFPalone 405 448-510
EYFPalone 488 500-550
EGFPalone 488 505-615
TRITC alone 543 570-680
mCherry alone 594 620-700
405 450-510eae 543 570-680
488 500-540EYFP/EGFP & TRITC 543 570-680
405 450-510ECFP & mCherry 594 620-700
488 500-540EYFP/EGFP & mCherry 594 620-700
488 515-585eee 594 610-700
488 500-535EYFP & Texas Red 594 600-720
Alexa® Fluor 488 & 488 500-550
Alexa® Fluor 594 594 605-670
405 440-485rae 488 505-550
476 480-510BOPP AcESPE 514 565-590
405 440-485
ECFP & EGFP & mCherry 488 505-550
594 620-660
476 480-510
EGFP & EYFP & TRITC 514 530-560
543 570-680
476 480-510
EGFP & EYFP & mCherry 514 530-560
594 620-700    
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2.8 siRNA knockdown
Expression of SNARE proteins was inhibited using siRNA constructs. These
were obtained from Ambion/Appelera Europe (Ambion, TX, USA), as pre-
designed siRNAs from their Silencer range. These were designed against the
human genes of interest. The name of each construct as used in this thesis, is
given with their Ambion siRNA ID# and their 5’-3’ sense sequence in Table 3.
In addition, Silencer negative control siRNA #1 was used for negative controls in
this thesis. All constructs were resuspended in nuclease free water, to give a final
concentration of 100nM whenusedfortransfection.
Table 3: List of siRNA constructs used in this thesis.
* Sec22 construct 2 was noteffective in this study (see Chapter3)
 Gene AmbionThesis name 5’-3’ Sense sequencename siRNA ID#
sunt Construct 1 241467 UGAGAGAACAAGGAGUUAAtt
Construct 2 241468 CGGUUCAAGAGCACAGACAtt(VAMP7)
Construct 3 241469 GACAAAGUGAUGGAGACUCtt
Construct 1 37855 GGGAUGUACAGCAACAGAAtt
Vtila Construct 2 37946 GGGCACAUCUGCUCGAUAAtt
Construct 3 38033 GGAGGAAUUUAAAUGAGCUtt
 GOSRI1 Construct 1 111531 GCGGCAUAGAGACAUAUUGtt
(GOS28) Construct 2 111532 GCAAACUUUAUGGCAAUVACtt
Construct 1 15641 GGCUAACAAUUUGUCCAGUtt
Construct 2* 15549 GGAGCCAUGACUUUUCACUttSec22      
Cells were transfected (as described above) with the siRNA constructs of
interest, along with untagged-Kv4.2 and KChIP1-EYFP, VSVG-GFP, or Kv4.2
and SAP97-GFP, as described in the text. Coverslips were then processed for
immunocytochemistry 72 hours post-transfection and images obtained, as
discussed above. The percentage of fluorescence at the plasma membrane was
also calculated and normalised as discussed above.
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Several methods were used to confirm the efficacy and specificity of the siRNA
constructs. Firstly, cells were transfected with KChIP1-EYFP, and VAMP7
visualised using anti-VAMP7 immunostaining, in cells both in the absence and
presence of RNAi. Forthis experiment, all microscopesettings,in particular gain
and offset levels, were kept identical between cells. A region of interest was
drawn aroundthe perimeterofthe cell, and the mean cellular fluorescence for the
VAMP7 immunostaining wasrecorded for cells from both conditions. Secondly,
real-time PCR was performed to look for changes in the expression levels of the
mRNAfor the protein being knocked down. The methodfor this is described in
section 2.9 below. Finally, Western blots were performed to look for changes in
protein expression levels in lysates from cells in the absence or presence of
siRNA. These were performed as described in section 2.10 below, using anti-
Vtila antibodies.
2.9 Real-time PCR
HeLacells were left for 72 hours post-transfection. mRNA wasextracted using
TRIzol reagent (Invitrogen) according to the manufacturer’s instructions. Briefly,
ml TRIzol was added per 9.5cm” well ofcells, and passed several times through
a pipette before being transferred to an eppendorf. This wasleft for five minutes
before 0.2m] chloroform was added, vigorously mixed, and left for a further 2
minutes. This was then centrifuged at 12000g for 15 minutes at 4°C. The
aqueous phase was mixed with 0.5ml isopropanol, and incubated at room
temperature for 10 minutes, before centrifugation at 12000g for 10 minutes at
4°C. The supernatant was then discarded, and the pellet washed in 1ml 75%
ethanol. This was then centrifuged at 7500g for 5 minutes at 4°C, the supernatant
discarded and the pellet air-dried. mRNA was resuspended in 30ul RNase free
water (Sigma) by heating at 60°C for 10 minutes, and stored at -80°C.
cDNAwasproduced using ImProm-II reverse transcriptase (Promega, WI, USA)
following manufacturer’s instructions. For each reaction, lul of mRNA was
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mixed with 20pmol/0.5ug Oligo (dT)15 primers (Promega) and 31 nuclease free
water (Sigma). This was incubated at 70°C for 5 minutes, then quick chilled to
4°C for 5 minutes, and held on ice. To this was added 4ul ImPromlI 5X buffer
(Promega), 2.4ul MgCl. (Promega, to give a final reaction concentration of
3mM), lul dNTPs (Promega, to give a final concentration of 0.5mM of each
dNTP), along with l1yl ImPromlII reverse transcriptase (Promega), and water
added to bring the final volume to 20ul per reaction. The reaction proceeded with
5 minutes annealing at 25°C, 60 minutes at 42°C to extend the first strand, and
15 minutes of heat inactivation at 70°C.
For real-time PCR, cDNA was diluted 1:10, and 2p used per well. In a total
volume of 15yl, 7.54] SYBR Green PCR master mix (Applied Biosystems,
Warrington, UK) was used with 1ul primer mix (50mM each of forward and
reverse primers). Each primer and cDNA combination wasrepeatedin triplicate.
Experiments were run on a Bio-Rad iQ5 thermal cycler (Bio-Rad, CA, USA).
Cycles were performed as follows: 95°C for 15 minutes, then 55 cycles of 95°C
for 10 seconds and 60°C for 30 seconds, 1 cycle of 95°C for 30 seconds and
55°C for 30 seconds, finally followed by 81 cycles of 30 seconds at increasing
temperatures, starting at 55°C, to obtain a melt curve. After checking each run
had completed correctly, the threshold cycle (Ct) was recorded, and averaged for
each primer and cDNAset. Therelative levels of mRNA for each primer and for
each cDNA were calculated by comparison to results with primers for B-actin,
using the 2°“method (ACt=Ctrarget mrna-Ctp-actin, AACt=ACtrnai or control —
ACteontrot). The mean 2“4Ct value for each siRNA treatment over 5 runs was then
calculated and plotted, along with the standard error of the mean.
2.10 SDS-PAGE and Westernblotting
Transfected cells grown in a 6-well plate were lysed in 200ul of 2xSDS Laemmli
buffer (Sigma). Samples were boiled for 5 minutes, and then loaded onto a 10%
SDS-PAGE gel. Gels were also loaded with See Blue® Plus 2 Prestained
Standard molecular weight markers (Invitrogen). The separated proteins were
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then transferred from the gel to a nitrocellulose membrane. This wasstained with
Ponceau-S_ solution (Sigma) to confirm successful protein transfer. All
incubations were carried out at room temperature, with agitation. Membranes
were washedin distilled HO, and then twice in PBS. Following this, they were
incubated in blocking solution (PBS with 3% skimmed milk powder) for 1 hour.
Membranes were then incubated in a primary antibody solution for 1 hour. This
consisted of PBS with 3% skimmed milk powder, and antibodies diluted as
shown in Table 1. Membranes were then washed three times in PBS with 0.05%
Tween'™-20 (Sigma), and then with PBS alone. After this, the membrane was
incubated for 1 hour in a solution of the appropriate secondary antibody
conjugated to horseradish peroxidise (Sigma), diluted 1:400 in PBS with 3%
milk. Following this, the membranes were washed a further three times in PBS
with 0.05% Tween'™-20, and once with PBS alone, then incubated with PBS
containing 0.5M NaCl for 30 minutes. Finally, the membranes were washed
twice in distilled H,O, before being dried. Signals were detected using the ECL
Plus Western Blotting Detection System (Amersham Biosciences,
Buckinghamshire, UK), and imaged using a Bio-Rad ChemiDoc XRSsystem.
Images were processed with Bio-Rad Quantity One software.
2.11 Production of GST and GST-KChIP1 protein
BL-21 cells transformed with plasmids to express either GST protein, or GST-
KChIP1 protein, were a gift from Dr B Hasdemir. These were streaked on agar
plates with 100ug/ml ampicillin, and a colony picked and grown overnight in
100ml superbroth (0.5% w/v NaCl, 1.5% w/v tryptone, 2.5% w/v yeast extract)
with antibiotics. The next day, this was added to 900ml superbroth with
antibiotics. Protein production was induced at OD¢o9 with 1mM isopropy]1-1-thio-
B-D-galactopyranoside (IPTG, Sigma). After 3-4 hours, cells were pelleted by
centrifugation for 20 minutes at 4000rpm and 4°C, and then lysed in breaking
buffer (500mM KCl, 100mM HEPES, 5mM ATP, 5mM MgCh, 2mM 2-
mercaptoethanol, pH 7.0). Protease inhibitor cocktail (Sigma) was also added.
The samples were kept at -80°C until further use. Thawed samples were then
passed through a Constant Systems Ltd cell disruptor (Constant Systems,
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Northamptonshire, UK). Samples were then spun in an ultracentrifuge for 1 hour
at 33000rpm (100000g) at 4°C. The supernatant was added to washed
Glutathione-Sepharose 4B beads (GE Healthcare Europe, Uppsala, Sweden), and
incubated for 1 hour at 4°C, with agitation. The unbound fraction was removed
by centrifugation at 1000rpm for 30 seconds. The beads were washedthree times
in ice-cold PBS. The protein of interest was eluted in three 1ml samples of GST-
elution buffer (65mM Trizma® base (Sigma) and 10mM reduced glutathione
(Sigma), pH 8.0). In each case, 1ml of elution buffer was added to the beads, and
incubated for 10 minutes at 4°C with agitation, then spun at 1000rpm for 30
seconds. The protein from each elution step was removed andstored at -80°C
until needed. The concentration of protein in each elution was determined by
comparison to standard concentrations of bovine serum albumin run on an SDS-
PAGEgel.
2.12 Pull down assays
Around 7.5mg of each protein (GST alone as a control, and GST-tagged
KChIP1, both prepared as above) were diluted 1:10 in 0.5M Tris-HCl (pH8.0)
and bound to washed Glutathione-Sepharose 4B beads (GE Healthcare Europe)
for one hour at 4°C. The beads were again washed in 0.5M Tris-HCl, before
~20mgbovine brain sample (a kind gift of Dr M. Graham and Dr L. Haynes) was
added. Initially, dialysed whole brain lysate was used. This was incubated with
the beads overnight at 4°C. Otherwise, the experiment was performed as
described below, but without ATP or MgCl,in the buffer solutions. Bovine brain
cytosol was used in a second experiment. This was dialysed against cytosol
buffer containing NagATP (Sigma) and MgCl), in the presence of 1uM free Ca**
(25mM Tris-HCl, 50mM KCl, 5mM EGTA, 5mM NTA, I1mM DTT, 2.67mM
MgCh, 1mM ATP, 5.07mM CaCh, pH7.8). The bovine brain cytosol was
incubated with the beads for 30 minutes at room temperature, to allow the
phosphorylation of proteins by the endogenous kinases in the cytosol. In both
cases, the beads were then packed into a Sigma 1.5cm diameter gravity flow
column, and washed in ~100ml cytosol buffer with 1M free Ca”* to remove any
unboundproteins. Proteins which were bound in a Ca”*-dependent manner were
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then eluted using 6ml cytosol buffer with no Ca", in the presence of EGTA,
using a flow rate of ~0.2ml/minute. The column was then washed with another
6mlof this solution, before any proteins bound in a Ca”*-independent manner
were eluted using a high salt cytosol buffer, with 1M NaCl, at a flow rate of
~0.2ml/minute. To concentrate the eluted proteins, they were methanol
precipitated. Briefly, 6001 aliquots of eluted protein and 600u1 methanol(pre-
chilled to -20°C) were mixed, and 25ul of 2.5mg/ml soybean trypsin inhibitor
(Sigma) was added. Samples were incubated at -20°C for 30 minutes, and then
centrifuged for 4 minutes at 4°C, at 13000rpm. The supernatant was removed,
and the pellet left to air dry at room temperature. Each pellet was resuspended in
15ul SDS Laemmli sample buffer (Sigma), and boiled for 5 minutes, before
samples for each protein and elution step were pooled. These were then run on
SDS-PAGEgels, and either transferred to nitrocellulose membrane for Western
blotting, or stained with Coomassie blue stain to visualise the proteins present.
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Chapter3
Characterising the non-conventional
trafficking pathway used by KChIP1 and
Kv4.2
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3.1 Introduction
The Kv4 family of voltage-gated potassium channels is responsible for the
rapidly-inactivating outward potassium currents in a variety of neurons (Hoffman
et al. 1997; Lauver et al. 2006), as well as in cardiac myocytes (Dixonetal.
1996). By allowing a flow of potassium ions out ofa cell, they regulate the
frequency with which action potentials can fire (Hoffman et al. 1997). Also, the
localisation of these channels to the somatodendritic compartment of neurons
(Birnbaum et al. 2004) means that such effects are limited to certain cellular
compartments, giving these channels a specific role in regulating post-synaptic
membrane excitability, confining action potentials to specific regions of the
dendritic arbour (Ramakers and Storm 2002; Caiet al. 2004), and influencing the
plasticity underlying long-term potentiation, learning and memory at a molecular
level (Ramakers and Storm 2002; Chen et al. 2006(2)). Mutations in these
channels have also been implicated in some forms of temporal lobe epilepsy
(Singhetal. 2006).
To have its effects, a channel must be correctly trafficked to the plasma
membraneofa cell. Understanding the process by which this occurs, and howit
is regulated, could therefore be very important for understanding brain function
in both health and disease. The trafficking of Kv4 channels to the plasma
membrane is influenced by a variety of accessory proteins (Birnbaum et al.
2004). In particular, the KChIPs were the first family of proteins identified with
this role (An et al. 2000). It is now known that four KChIPs bind to the four a-
subunits of a complete Kv4 channel, in a cross-shaped octameric structure
(Pioletti et al. 2006). This promotes channeltrafficking (Shibata et al. 2003), as
well as altering channel kinetics (Birnbaum etal. 2004). Much previous work has
concentrated onthetrafficking of Kv4.2 with KChIP1, and has revealed that they
use a non-conventional pathway (Hasdemiretal. 2005).
Most channels and transmembrane proteins, when unfolded or unable to fully
traffic to the plasma membrane, will be retained within the ER (Misonou and
Trimmer 2004). It is known that Kv4.2 expressed alone in non-neuronalcells has
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a perinuclear localisation, and some papers have argued that this corresponds to
the ER (Bahring et al. 2001; Shibata et al. 2003). However, other work has
shown overlap between the channel and markers for the Golgi (O’Callaghan et
al. 2003), suggesting that the channel is able to exit the ER when expressed
alone, but is trapped at a later stage in the exocytic pathway. The localisation of
fluorescently-tagged KChIP1 expressed alone is also unusual, being associated
with punctate, mobile vesicles (O’Callaghan et al. 2003; Hasdemiret al. 2005).
The identity of these vesicles is not clear, although they partially overlap with
markers of the ERGIC (O’Callaghan et al. 2003). Finally, when both the Kv4.2
channel and KChIP1 are expressed together, andtraffic to the plasma membrane,
they do so in a COPII-independent manner, contrasting with the standard marker
of ER-Golgi-plasma membrane trafficking, VSVG (Hasdemir et al. 2005).
Together, these data suggest that Kv4.2/KChIP1 trafficking is occurring via a
non-conventional cellular pathway.
There are several aspects of this non-conventional pathway that arestill not
characterised. Firstly, the KChIP proteins, as members of the NCS family, are
able to bind to Ca”* ionsvia their EF hand domains (An et al. 2000). However,it
is not clear whether this binding has a regulatory role, allowing the protein to
respond to changesin calcium levels in the cell, or a structural function, allowing
the protein to correctly fold. It seems that Ca?* binding is required for correct
trafficking of Kv4.2 to the plasma membrane by KChIP1 (An et al. 2000;
Hasdemir et al. 2005). However, there is debate in the literature about whether
the KChIP needs to have bound Ca”* in order to bind Kv4.2 channel proteins,
and how manyof the EF-hands mustbe intact (Pioletti et al. 2006). The effect of
such mutant proteins on general cellular trafficking pathways is also unclear.
This was investigated by quantifying the percentage of fluorescence from anti-
Kv4.2 immunostaining found at the plasma membrane, in the presence of
fluorescently-tagged versions of wild-type and EF-hand mutant KChIP1.
The other aspect of this investigation concernedthe regulation of the trafficking
and fusion of KChIP1/Kv4.2 containing vesicles, in particular in the ER-to-Golgi
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step oftrafficking, en route to the plasma membrane.Proteins known to regulate
VSVGtrafficking were investigated, as well as those implicated in other non-
conventional pathways. The Rab-GTPases have an important role in regulating
trafficking (Rothman and Wieland 1996; Hammer and Wu 2002; Schwartz etal.
2007), and Rab1is particularly associated with ER-Golgitrafficking (Tisdale et
al. 1992). Requirementfor this protein in the trafficking of both VSVG-GFP and
fluorescently-visualised Kv4.2/KChIP1 was investigated by over-expression of a
Rab-GAP specific for Rabl (Haas et al. 2007), to convert the Rab into its
inactive GDP-bound form. The SNARE proteins are more directly involved in
the fusion ofvesicles with their target membranes, forming the fusion machinery
(Jahn and Scheller 2006). These need to come together in the correct
combination in order for fusion to occur. Therefore, the complement of SNARE
proteins present on a membranehelps to define a given compartment (Jahn and
Scheller 2006). Antibodies against various SNAREs implicated in ER-Golgi
trafficking were used to visualise these proteins in cells, and look for co-
localisation between them and KChIP1-EYFP containing vesicles. SNAREs of
interest were then assessed for functional activity, using RNAi to reduce their
levels in cells, and to look for effects on the trafficking of both the marker
VSVG-GFP, and the Kv4.2 channel with KChIP1. Finally, the trafficking of
Kv4.2 by KChIP1 was also compared tothat of the related protein KChIP2. This
work reveals some similarities between the trafficking of the well-characterised
marker VSVG and that of Kv4.2/KChIP1, but also characterises several novel
aspects of this non-conventional pathway.
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3.2 Results
3.2.1 Characterising KChIP1 and Kv4.2
To begin this study, it was necessary to characterise the localisation of KChIP1
and Kv4.2 when expressed both alone and together in cells, to confirm that
previousfindings could bereplicated.
Previous work had shown KChIP1 to have an unusual punctate distribution in a
variety of cell lines, and primary hippocampal neuronpreparations (O’Callaghan
et al. 2003; Hasdemiret al. 2005; Venn etal. 2008). An EYFP-tagged version of
KChIP1 was available in the lab (O’Callaghan et al. 2003), and could be
ARFI1-EYFP Overlay 
3.1: Localisation of Kv4.2 and KChIP1in HeLacells.
HeLa cells were transfected with KChIP1-EYFP or Kv4.2, and the localisation
of Kv4.2 assessed using Golgi markers.
A) HeLa cell transfected with KChIP1-EYFP.
B-D) HeLa cell transfected with EYFP-Golgi (Green) and Kv4.2 (Red),
with co-localisation shown as yellow in the overlay.
E-G) HeLacell transfected with ARF1-EYFP (Green) and Kv4.2 (Red),
with co-localisation shown as yellow in the overlay.
In all cases, Kv4.2 localisation was determined using anti-Kv4.2
immunostaining with a TRITC-conjugated secondary antibody, and scale
bars represent 10um.
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visualised in fixed cells using confocal fluorescence microscopy. Figure 3.1A
shows a representative HeLa cell expressing only KChIP1-EYFP. The KChIP
showed a punctate distribution throughoutthe cell, but was especially clustered
in the perinuclear region.
Thelocalisation of Kv4.2 has been suggested in some papers to be conventional
ERretention of an un-trafficked channel (Shibata et al. 2003). However, the ER
retention signal in Kv4.2 is inactive (Shibata et al. 2003), and the localisation
seen in previous workis moreperinuclear than reticulate. This suggested that the
channel is trapped in the Golgi when unable to traffic to the plasma membrane
(O’Callaghan et al. 2003; Hasdemir et al 2005). To further confirm this,
untagged Kv4.2 was expressed in cells, which were then fixed, and
immunostained with an anti-Kv4.2 primary antibody, and TRITC-conjugated
secondary. Experiments were performed to look for co-localisation between
Kv4.2 and EYFP-Golgi, a fluorescently-tagged Golgi-targeting sequence from
Clontech, or ARF1-EYFP, a Golgi-resident protein (Handley et al. 2007).
Figures 3.1B-G show the results of this in HeLa cells. There was clear co-
localisation between the channel and both of the Golgi markers, shown in yellow
in the colour overlays. Neither channel nor KChIP werelocalised to the plasma
membrane whenexpressedalone.
Whilst HeLa cells are amenable for transfection and microscopy, the Kv4
channels are normally expressed in neurons or cardiac myoctyes (Hoffman etal.
1997; Dixonet al. 1996), and it is conceivable that the localisation seen above
mightbe cell-type specific. To address this, mouse neuroblastoma Neuro2A cells
were obtained. This neuronal cell-line should be more representative of the cells
where the channel is natively expressed. The co-localisation experiment was
therefore repeated in this cell type, and representative images are shown in
Figures 3.2A and B. Again, the Kv4.2 localised to the perinuclear region, with
high levels of co-localisation with both of the Golgi markers. Together these
images confirm that Kv4.2 is indeed unusual in being localised to the Golgi when
nottrafficked to the plasma membrane.
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EYFP-Golgi cw Overlay
Overlay.
KEhIP4-ECFP  3.2: Localization of Kv4.2 and four KChIP isoformsiin Neuro2A cells.
Neuro2A cells were transfected with Kv4.2 or fluorescently-tagged KChIP isoforms to
determinetheir localisations.
A)  Neuro2A cell expressing EYFP-Golgi (Green) and Kv4.2 (Red), with co-localisation
shown as yellow in the overlay.
B) —Neuro2A cell expressing ARF1-EYFP (Green) and Kv4.2 (Red), with co-localisation
shown as yellow in the overlay.
In both cases, Kv4.2 localisation was determined using anti-Kv4.2 immunostaining, with a
TRITC-conjugated secondary antibody.
C-F) Neuro2A cells were transfected with C) KChIP1-EYFP, D) KChIP2-ECFP, E)
KChIP3-EYFP or F) KChIP4-ECFP.
In all cases, the scale bar represents 10um.
Thelocalisation of one isoform of each of the four KChIPs was also assessed in
this cell type. As shown in Figure 3.2C, KChIP1-EYFP waspunctate in Neuro2A
cells. These punctae were predominantly in the perinuclear region, although they
could also be seen further from the nucleus. They generally seemed less widely
distributed than in HeLa cells, however. The distribution of the other KChIPs
also replicated that seen previously in other cell types (Takimotoet al. 2002). In
Figure 3.2D, KChIP2-ECFP was localised to the plasma membrane, whilst in
Figure 3.2E KChIP3-EYFP showed some plasma membranelocalisation, whilst
some was more diffusely cytoplasmic. This likely reflects the post-translational
palmitoylation of KChIPs 2 and 3, allowing their plasma membraneassociation.
Finally, Figure 3.2E shows KChIP4-ECFP is also diffusely cytoplasmic,
although there is perhaps some brighter labelling in the perinuclear region. The
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ability to replicate the findings of previous studies in these cells helps to validate
their use for further work with the KChIPs.
Having characterised the intracellular localisation of Kv4.2 and KChIP1 when
expressed alone in cells, it was next necessary to confirm the effects of
KChIP1-EYFP Kv4.2 Overlay  
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3.3: Co-expression of KChIP1-EYFP promotes the trafficking of Kv4.2 to the plasma
membrane,in HeLacells.
HeLacells were transfected with Kv4.2, alone or with KChIP1-EYFP,andtrafficking of Kv4.2
to the plasma membrane was quantified.
A) HeLacell expressing Kv4.2.
B) HeLacell expressing KChIP1-EYFP (Green) and Kv4.2 (Red) with co-localisation
shown as yellow in the overlay.
Kv4.2 localisation was determined using anti-Kv4.2 immunostaining with a TRITC-
conjugated secondary antibody.In all cases, scale bars represent 10um.
C) The trafficking of Kv4.2 to the plasma membrane was quantified in terms of the
percentage of Kv4.2 fluorescence at the plasma membranein the presence or absence
of KChIP1-EYFP. Data shownasthe meansfor 20 cells for each condition, +S.E.M.
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expressing both together. There is much evidence to support the ability of
KChIPs to traffic Kv4 channels to the plasma membrane, using both
electrophysiology to measure increases in current density due to channel
trafficking (An et al. 2000), and fluorescence to observe the localisation of
channel and KChIP at the plasma membrane(Shibata et al. 2003; Hasdemiret al.
2005). Using the constructs described above in HeLa cells, Kv4.2 was detected
KChIP1-EYFP Kv4.2 Overlay
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3.4: Co-expression of KChIP1-EYFP promotes the trafficking of Kv4.2 to the plasma
membrane, in Neuro2Acells.
Neuro2A cells were transfected with Kv4.2, alone or with KChIP1-EYFP,andtrafficking of
Kv4.2 to the plasma membranewasquantified.
A) Neuro2A cell expressing Kv4.2.
B) Neuro2A cell expressing KChIP1-EYFP (Green) and Kv4.2 (Red) with co-
localisation shown asyellow in the overlay.
Kv4.2 localisation was determined using anti-Kv4.2 immunostaining with a TRITC-
conjugated secondary antibody.In all cases, scale bars represent 10m.
C) Thetrafficking of Kv4.2 to the plasma membrane was quantified in terms of the
percentage of Kv4.2 fluorescence at the plasma membranein the presence or absence
of KChIP1-EYFP. Data shownas the meansfor 20 cells for each condition, +S.E.M.
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by immunostaining, either alone (Figure 3.3A; red in the colour overlays), or
with KChIP1-EYFP (Figure 3.3B; green in the colour overlay). It is clear from
these images that KChIP1is able to redistribute Kv4.2 to the plasma membrane.
KChIP1 alsoalters its localisation, and is seen at the plasma membranein these
cells, reflecting its continued binding to the channel after trafficking, in order to
modulate the channel’s functions andkinetics (An etal. 2000). Kv4.2 trafficking
was quantified, using measurements of the percentage of TRITC cellular
fluorescenceat the plasma membrane,as described in Chapter 2.7. In the absence
of KChIP1, approximately 7.5% of TRITC fluorescence was at the plasma
membrane (Figure 3.3C). This background is likely due to both background
fluorescence due to the antibody approach used, and low level trafficking of the
channel in the absenceof accessory proteins, andis in line with previousstudies
using this method (Hasdemir et al. 2005). However, there was a significant
increase in plasma membranefluorescence in the presence of KChIP1-EYFP,to
around 20%. As expected from Figure 3.3B, the levels of KChIP1-EYFPat the
plasma membranealso increased significantly in the presence of Kv4.2 (data not
shown).
These experiments were repeated in Neuro2A cells (Figure 3.4). Again, Kv4.2
alone was perinuclear (Figure 3.4A), but trafficked to the plasma membrane in
the presence ofKChIP1-EYFP (Figure 3.4B). Thesimilarities in the localisations
of these proteins between HeLa and Neuro2Acellsare reflected in the quantified
data in Figure 3.4C. There is a background level of plasma membrane
fluorescence of around 14% in Neuro2A cells, and a significant increase in the
presence of KChIP1-EYFP to about 26% oftotal cellular fluorescence at the
plasma membrane.
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3.2.2 KChIP1 requires intact EF-hand domainsto traffic Kv4.2, but not to
access punctate vesicular structures
Having characterised the localisation of the Kv4.2 channel and wild-type
KChIP1 in two cell types, it was then possible to compare the effects on
trafficking of mutant versions of KChIP1 lacking active EF-hand domains. Two
constructs available in the lab were used (Hasdemiret al. 2005). One, designated
the EF3 mutant, had a mutation in just EF hand domain3, one of the high Ca**
affinity sites in KChIP1 (Craig et al. 2002). The other, designated the EF2-4
mutant, had mutations in all three of the potentially active EF hand domains.
Each of the mutant KChIP1 proteins was expressed in an EYFP-tagged form, and
visualised in HeLa cells. Figures 3.5 A and B showsa typical cell expressing
each protein. Both mutants of KChIP1 were punctate in HeLa cells, with a
similar distribution to wild-type KChIP1 (compare with Figure 3.1A).
 
WI EF3.. EF2-4
on ~55kDa
D ~42kDa
3.5: EF-hand mutants of KChIP1-EYFP show a punctate localisation in
HeLacells, and are expressedata level similar to wild-type.
HeLacells were transfected with EF-hand mutations of KChIP1-EYFP to
investigate their localisation, and their expression levels were compared to
wild-type KChIP1.
A) HeLacell transfected with KChIP1EF3-EYFP.
B) HeLa cell transfected with KChIP1EF2-4-EYFP.
Scale bars represent 10m.
C) Western blot of HeLacells transfected with either EYFP-tagged wild-
type KChIP1 (WT), KChIPIEF3 (EF3) or KChIPIEF2-4 (EF2-4)
mutants. Tagged KChIP protein was detected using an anti-GFP
antibody, showing similar expressionofall three proteins.
D) Western blot of B-actin expression in HeLa cells transfected as
described for C), showing equal loading of each lane.
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As a further control it was necessary to confirm that these proteins were being
expressed at the same level in cells. HeLa cells were therefore transfected with
wild-type or mutant EYFP-tagged KChIP1, and lysed 72 hours post-transfection
for use in Western blotting. An anti-GFP antibody was used to detect the EYFP
tag. As seen in Figure 3.5C, KChIP1-EYFP was detected in all cases at the
expected molecular weight of ~55kDa. Expression levels of all three proteins
were similar. A blot for B-actin (Figure 3.5D) confirmed the lanes were equally
loaded.
Previous work had shown that KChIP1EF2-4 was unable to traffic Kv4.2 to the
plasma membraneas effectively as wild-type KChIP1 (Hasdemir et al. 2005).
However, the effect of mutating just a single EF-hand had not been fully
characterised. HeLa cells were transfected with either Kv4.2 pcDNA alone, or
with one of the three KChIP1-EYFP constructs (wild-type, EF3 mutant, or EF2-4
mutant). Cells were fixed after 72 hours, and Kv4.2 visualised with antibodies.
Example cells are shown in Figures 3.6A to C. It can be seen from these figures
that whilst wild-type KChIP1 traffics Kv4.2 to the plasma membrane, in the
presence of either mutant the channelis not at the plasma membrane, but rather
has an intracellular punctate distribution. This is different from the normal
perinuclear distribution of Kv4.2 alone, but similar to the localisation of KChIP1
expressed alone. However, these effects could be due to a non-specific effect of
the mutant KChIP1 on general exocytic trafficking pathways. To investigate this,
the trafficking of the marker protein VSVG-GFP wasanalysed. Cells transfected
with VSVG-GFPalone showedtrafficking of this marker protein to the plasma
membrane,as can be seen in Figure 3.6D. This plasma membranelocalisation of
VSVG-GFP fluorescence was also seen in the presence of HcRed-tagged wild-
type KChIP1 (Figure 3.6E), and HcRed-tagged KChIP1EF2-4 (Figure 3.6F).
The trafficking in both cases was also quantified. The percentage of Kv4.2
fluorescence found at the plasma membrane was determined, the background
level of trafficking with Kv4.2 alone was subtracted, and results normalised to
those with wild-type KChIP1, as shown in Figure 3.6G. As expected from the
figures, trafficking of the channel with either mutant is significantly lower than
with wild-type KChIP1, andin fact notsignificantly different from background
73
  aeGri +KChIPIEF2-4 
J1.4oO   Normalised traffic to plasma as membraneNormalisedtraffic to plasma membrane   
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3.6: Effects of KChIP1 with EF-hand mutations on traffic of Kv4.2 and VSVG to the
plasma membrane.
HeLa cells were transfected with either Kv4.2 or VSVG-GFP,andthe effects of co-transfecting
with EF-hand mutants of KChIP1 were observed and quantified.
A-C) HeLa cells were co-transfected with Kv4.2 (detected using anti-Kv4.2
immunostaining) and either A) wild-type KChIP1-EYFP, B) the single EF-hand
mutant KChIP1EF3-EYFPor C) thetriple EF-hand mutant KChIP1EF2-4-EYFP.
D-F) HeLa cells were co-transfected with VSVG-GFP (detected by confocal imaging),
either D) alone, E) with wild-type KChIPl-HcRed, or F) with the mutant
KChIP1EF2-4-HcRed.
Scale bars represent 10um.
G-H) Normalised traffic of G) Kv4.2 or H) VSVG-GFPin the presence of various KChIP
proteins was quantified. Results are shown as meansfor 20 cells for each condition,
+$.E.M.
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levels of Kv4.2 trafficking. Levels of mutant KChIP1 at the plasma membrane
were also significantly lower (data not shown). This suggests that disruption of
even a single Ca”*-binding site is enough to prevent KChIP1 trafficking Kv4.2
correctly to the plasma membrane. This can be contrasted with the trafficking of
VSVG-GFP, quantified in Figure 3.6H, with results adjusted relative to the
percentage of fluorescence at the plasma membrane with VSVG-GFP alone.
There is no significant difference in plasma membrane fluorescence between
cells expressing VSVG-GFP alone, and those co-expressing KChIP1. This
confirms that KChIP1EF2-4 does not disrupt the general trafficking pathways of
the cell, but rather has a specific effect on Kv4.2 trafficking dueto its inability to
bind Ca”*/Mg”".
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3.2.3  Rabl is required for trafficking of both VSVG-GFP and
Kv4.2/KChIP1 to the plasma membrane
The above work on EF-hand mutants shows an effect on the trafficking of
Kv4.2/KChIP1, but not VSVG-GFP. Combined with previous findings that
COPII is required for VSVGtrafficking, but not for Kv4.2/KChIP1 (Hasdemiret
al. 2005), this suggested two separate exocytic trafficking pathways. This also
led to the question of whether proteins regulating the exocytic pathway of
VSVG-GFP would have a role in Kv4.2/KChIP1 trafficking as well. One key
regulatory protein in ER-Golgitrafficking is the Rab-GTPase Rab1 (Tisdaleetal.
1992). However, Rab1-independenttrafficking has been shown (Yooet al. 2002;
Wu et al. 2003). The role of this Rab in exocytic trafficking was therefore
investigated, by overexpression of the Rab1-specific GAP TBC1D20 (Haaset al.
2007). As a Rab1-GAP,this should promote the hydrolysis of the active Rab1-
GTPinto inactive Rab1-GDP.
Previous work using TBC1D20 had confirmed its ability to inhibit VSVG-GFP
trafficking to the plasma membrane (Haas et al. 2007). As a control, these
experiments were repeated in HeLacells, and fixed cells were visualised using
confocal microscopy. In HeLacells expressing VSVG-GFPalone (Figure 3.7A),
it was trafficked to the plasma membrane, whereas in cells co-transfected with
TBC1D20 (Figure 3.7B), the VSVG-GFP wastrapped intracellularly, in the
perinuclear region. Quantification of this data (Figure 3.7E) revealed a
significant inhibition of trafficking in the presence of the Rab1-GAP, confirming
previous work on the role of Rab1 in VSVG-GFPexocytosis (Haaset al. 2007).
Experiments were then performed in HeLa cells co-transfected with KChIP1-
EYFP and Kv4.2, in the absence (Figure 3.7C) or presence (Figure 3.7D) of
TBC1D20. Whilst both KChIP and channeltrafficked to the plasma membranein
control cells, this was inhibited by the Rab1-GAP. In these cells, both KChIP1
and Kv4.2 were trapped in the perinuclear region of the cell, which could be the
ER. Quantification of these results, shown in Figure 3.7F, showed that TBC1D20
significantly reduced the percentage of Kv4.2 at the plasma membrane in the
presence of KChIP1. This confirmsthat the trafficking pathways used by VSVG-
GFP and Kv4.2/KChIP1 to reach the plasma membrane are both Rabl-
dependent.
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3.7: Inhibition of Rab1 function prevents traffic of VSVG and Kv4.2/KChIP1 to the plasma
membrane.
HeLa cells were transfected with either VSVG-GFP or Kv4.2/KChIP1-EYFP andthe effects of
co-transfecting with the Rabl1-GAP TBC1D20were observed and quantified.
A) HeLacell transfected with VSVG-GFP,andits localisation visualised.
B) HeLacell co-transfected with VSVG-GFP and the Rab1-GAP TBC1D20.
C) HeLa cell co-transfected with KChIP1-EYFP (Green) and Kv4.2 (Red), detected by
immunostaining.
D) HeLa cell co-transfected with KChIPI1-EYFP (Green), Kv4.2 (Red, detected by
immunostaining) and the Rab1-GAP TBC1D20.
E) Normalised traffic of VSVG-GFP in the absence (Cont) or presence (GAP) of
TBC1D20 was quantified.
F) Normalised traffic of Kv4.2 in the presence of KChIP1-EYFP, and either the absence
(Cont) or presence (GAP) of TBC1D20 was quantified.
In the colour overlays, co-localisation is shown in yellow. In all cases, the scale bar
represents 10um. For the quantification, data is shown as the mean of 20 cells for each
condition, +S.E.M.
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3.2.4 KChIP1-EYFP-positive vesicles co-localise with the SNAREs VAMP7
and Vtila
Another important set of proteins in membranetrafficking are the SNARE
proteins. These are thought to form part of the machinery that allows vesicles to
dock and bind with their target membranes (Jahn and Scheller 2006). The
complement of SNAREs on a vesicle or membrane therefore determines which
other membranesit can bind to, and hence defines a cellular compartment (Jahn
and Scheller 2006). It was therefore interesting to determine which SNAREs
were co-localised with the vesicles seen in cells expressing KChIP1-EYFP alone.
HeLa cells were transfected with KChIP1-EYFP, and then fixed and
immunostained with antibodies against endogenous SNAREs of interest,
visualised using a TRITC-conjugated secondary antibody.Firstly, those SNAREs
implicated in the conventional ER-Golgi trafficking route used by VSVG-GFP
were investigated (Zhanget al. 1999; Xu et al. 2000). Whilst KChIP1-EYFP was
punctate in these cells, there was little to no punctate staining with an anti-
membrin antibody (Figure 3.8A) or an anti-Sec22b antibody (Figure 3.8B), and
no obvious co-localisation in the colour overlays, or enlarged regionsofthe cell.
Nor wasthere co-localisation between KChIP1-EYFP and membersof a second
ER-Golgi SNARE complex implicated in the fusion of vesicles with the cis-
Golgi (Zhang and Hong 2001), GOS28 (Figure 3.8C) and Ykt6 (Figure 3.8D).
Indeed, both of these were found with a pronounced perinuclear, Golgi-like,
localisation fitting their proposedrole in the cis-Golgi.
A third ER-Golgi SNARE complex, implicated in the trafficking of PCTVs in
the intestine (Siddiqi et al. 2006a), was then investigated in a similar manner.
Again, KChIP1-EYFP was punctate in fixed HeLa cells. However,
immunostaining with a mouse monoclonal antibody against VAMP7 (Figure
3.9A), also revealed a punctate distribution, clustered in the perinuclear region.
These two sets of punctae clearly overlapped, as shown in yellow in the colour
overlay, and in the enlarged inserts. To further confirm this, an alternative rabbit
polyclonal antibody against VAMP7 wasobtained from Thierry Galli, Institut
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3.8: Lack of co-localisation of KChIP1-EYFP with membrin, Sec22b, GOS28 or Ykt6.
HeLa cells were transfected with KChIP1-EYFP, then fixed and immunostained with
mouse monoclonal antibodies specific for:
A) Membrin
B) Sec22b
C) GOS28D) Ykt6
The images show the localisation of KChIP1, and the indicated SNARE proteins,
visualised using a TRITC-conjugated secondary antibody, except for anti-Ykt6 which
was visualised using a Texas Red-conjugated anti-chicken secondary. The colour
overlays show KChIP1-EYFPin green, the SNARE in red, and co-localisation in yellow.
Thescale bars represent 10um in the main images, and 2m in the enlargedinserts.
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Jacques Monod,Paris, and used for immunostaining (Figure 3.9B). This antibody
appeared to be less effective, and not all punctae visible in the KChIP1 image
had a corresponding VAMP7 puncta. It was therefore not used further. However,
all the VAMP7 visualised did co-localise with KChIP1, supporting the idea that
VAMP7is localised to the same vesicles as KChIP1-EYFP. To further confirm
this, immunostaining was performed with a mouse monoclonal antibody against
Vtila, the second unique member of this ER-Golgi SNARE complex (Figure
3.9C). This also revealed a punctate distribution, with co-localisation between
Vtila and KChIP1-EYFP.
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3.9: Co-localisation of KChIP1-EYFP with VAMP7and Vtila.
HeLa cells were transfected with KChIP1-EYFP and immunostained against the SNAREs
VAMP7and Vtila.
A) HeLa cells were transfected with KChIP1-EYFP (Green) and immunostained with a
mouse monoclonal antibody against VAMP7(Red).
B) HeLacell transfected with KChIP1-EYFP (Green), and immunostained with a rabbit
polyclonal against VAMP7(Red).
C) HeLacell transfected with KChIP1-EYFP (Green), and immunostained with a mouse
monoclonalagainst Vtila (Red).
Co-localisation is shown as yellow in the colour overlays. Scale bars represent 10um in
main image, and 2m in enlargedinsert.
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3.10: Co-localisation of KChIP1-EYFP with VAMP7andVtila in PC12cells.
PC12 cells were transfected with KChIP1-EYFP and immunostained against the SNAREs
VAMP7and Vtila.
A) PC12 cell transfected with KChIP1-EYFP (Green), and immunostained with a
mouse monoclonal against VAMP7(Red).
B) PC12 cell transfected with KChIP1-EYFP (Green), and immunostained with a
mouse monoclonalagainst Vtila (Red).
Co-localisation is shown as yellow in the colour overlays. Scale bars represent 5um in
main image, and 1pm in the enlarged insert.
This co-localisation between KChIP1-EYFP and the SNAREs VAMP7 and
Vtila was surprising, as the PCTV SNARE complex wasoriginally described as
being specific to the intestine (Siddiqi et al. 2006b). Further control experiments
were therefore performed. PC12 cells are often used as a model neuronalcell line
(Handley et al. 2007), and are therefore more representative of the endogenous
location of KChIP1 and Kv4.2. As seen in Figure 3.10, KChIP1-EYFP was
punctate in these cells. There was also co-localisation between KChIP1-EYFP
and immunostaining against VAMP7 (Figure 3.10A) and Vtila (Figure 3.10B).
These cells are thicker and more rounded than HeLa cells, making the confocal
imagesless clear. They were therefore not used in further experiments. Also, the
KChIP1-EYFP-positive vesicles appear larger in this cell type — this could be due
to differences in cell type, aggregation of vesicles, or simply due to the lack of
clarity in the confocal images. However, these results are supportive of an
association between KChIP1-EYFP and VAMP7 and Vtila. In addition, in
experiments described above EF-hand mutants of KChIP1 had a punctate
distribution when expressed alone in HeLacells (Figure 3.5), similar to that seen
for the wild-type protein. It was therefore decided to investigate whether these
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3.11: Co-localisation between EF-hand mutants of KChIP1-EYFP and VAMP7or
Vtila.
HeLa cells were transfected with EF-hand mutants of KChIP1 and immunostained for
VAMP7orVtila.
HeLacell transfected with KChIP1EF3-EYFP (Green), and immunostained
against VAMP7 (Red).
HeLacell transfected with KChIP1EF3-EYFP (Green), and immunostained
against Vtila (Red).
HeLa cell transfected with KChIPIEF2-4-EYFP (Green), and
immunostained against VAMP7 (Red).
HeLa cell transfected with KChIPIEF2-4-EYFP (Green), and
immunostained against Vtila (Red).
Antibodies were visualised using a TRITC-conjugated secondary antibody. Co-
localisation is shownas yellow in the colour overlays. Scale bars represent 10m.
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mutant proteins could also co-localise with VAMP7 and Vtila. HeLa cells were
transfected with KChIP1EF3-EYFP, fixed and immunostained with antibodies
against VAMP7 (Figure 3.11A) or Vtila (Figure 3.11B). In both cases, KChIP1
was punctate in cells, and showedclear co-localisation with the two SNAREs of
interest. These experiments were also repeated with KChIP1EF2-4-EYFP and
VAMP7 (Figure 3.11C) or Vtila (Figure 3.11D), and again, there was co-
localisation. This further supports an association between these SNAREs and
KChIP1, and also confirms that the EF-hand mutant proteins are able to access
the same cellular compartmentas the wild-type protein (Hasdemir etal. 2005).
Next, it proved possible to obtain a GFP-tagged construct of VAMP7, and look
for co-localisation in HeLa cells between this overexpressed SNARE, and
KChIP1-HcRed (Figure3.12A) or KChIPIEF2-4-HcRed (Figure 3.12B).
Overexpression of VAMP7-GFP gave a much brighter signal than when
endogenous protein was detected with antibodies. Unfortunately, this made it
harder to visualise punctate structures in these cells. However, a small number of
punctae were observedin the very perinuclear region of the cells in the KChIP1
images, and there was co-localisation with VAMP7. There was also no
COS|)  Overlay
3.12: Co-localisation between VAMP7-GFP and KChIP1.
HeLacells were transfected with VAMP7-GFPand wild-type or mutant KChIP1-HcRed.
A) HeLacell transfected with VAMP7-GFP (Green), and KChIP1-HcRed (Red).
B) HeLa cell transfected with VAMP7-GFP (Green), and KChIP1EF2-4-HcRed
(Red).
Co-localisation is shown as yellow in the colour overlays. Scale bars represent 10um.
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difference between wild-type and EF2-4 mutant KChIP1, as would be expected
from the results in Figure 3.11. However, immunostaining against VAMP7 gave
clearer images, and looking at endogenousprotein should be more representative
of the situation in vivo than with overexpressed protein, so for further work the
antibody approach waspreferred.
For further confirmation of an association between KChIP1 and VAMP7/Vtila,
co-localisation studies were repeated in fixed Neuro2A cells. These were
transfected with either wild-type KChIP1-EYFP, or KChIP1EF2-4-EYFP, and
then immunostained for SNAREs(Figure 3.13). There was clear co-localisation
between wild-type KChIP1 and either VAMP7 (Figure 3.13A) or Vtila (Figure
3.13B). These images were very similar to those with HeLacells in Figure 3.9,
although the KChIP1 punctae were more confined to the perinuclear region as
had been seen previously (Figure 3.2). There was also no difference between the
wild-type and mutant proteins, with KChIP1EF2-4-EYFP also showing co-
localisation with VAMP7 (Figure 3.13C) and Vtila (Figure 3.13D).
These data further confirmed an association between KChIP1 and
VAMP7/Vtila. However, as well as forming a complex with rBetl and syntaxin
5 for the trafficking of intestinal PCTVs (Siddiqi et al. 2006a), these SNAREs
are better known fortheir role in late endocytic endosomal/lysosomaltrafficking,
with syntaxins 7 and 8 (Bogdanovic et al. 2002). To investigate the possibility of
KChIP1 being associated with endosomes or lysosomes,or utilising this better
known SNARE complexfortrafficking, co-localisation studies were performed
in fixed HeLacells transfected with wild-type KChIP1, and immunostained with
rabbit antiserum against syntaxin 7 (Figure 3.14A) or a rabbit antiserum against
syntaxin 8 (Figure 3.14B). Whilst there was some overlapping localisation with
both SNAREsin the perinuclear region, there were clearly two populations of
punctae, with those labelled with KChIP1 distinct from those labelled with anti-
syntaxin 7 or anti-syntaxin 8. This was especially clear in the enlarged regions of
each cell shown in Figure 3.14. Also, previous work with overexpressed VAMP7
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KChIPIEF2-4 Overlay KChIPILEF2-4 Vtila3.13: Co-localisation of KChIP1-EYFP with VAMP7 and Vtila in Neuro2A
cells.
Neuro2A cells were transfected with wild-type or mutant KChIP1
immunostained for VAMP7orVtila.
A)
B)
C)
D)
Neuro2A cell transfected with KChIPI-EYFP (Green),
immunostained against VAMP7 (Red).
Neuro2A cell transfected with KChIPI-EYFP (Green),
immunostained against Vtila (Red).
Neuro2A cell transfected with KChIPIEF2-4-EYFP (Green),
immunostained against VAMP7 (Red).
Neuro2A cell transfected with KChIPIEF2-4-EYFP (Green),
immunostained against Vtila (Red).
and
and
and
and
and
Antibodies were visualised using a TRITC-conjugated secondary antibody.
Co-localisation is shown as yellow in the colour overlays. Scale bars
represent 10um.
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3.14: Lack of co-localisation between KChIP1 and syntaxins 7 or 8, or
between VAMP7 and LAMPI1.
HeLa cells were transfected with KChIP1 and immunostained for syntaxin 7 or
8, or immunostained against VAMP7and the lysosomal marker LAMP1.
A) HeLacell transfected with KChIP1-EYFP (Green), and immunostained
with rabbit antiserum against syntaxin 7 (Red), detected with a TRITC-
conjugated secondary antibody.
B) HeLacell transfected with KChIP1-EYFP (Green), and immunostained
with a rabbit polyclonal antibody against syntaxin 8 (Red), detected
with a TRITC-conjugated secondary antibody.
C) HeLa cell immunostained against VAMP7 (Green), detected using an
Alexa Fluor® 488-linked secondary antibody, and against the
lysosomal marker LAMP1 (Red), detected using an Alexa Fluor® 594-
linked secondary antibody.
Co-localisation is shown as yellow in the colour overlays. Scale bars
represent 10um in the main images, and 2um in the enlargedinserts.
had shown it associated with markers of lysosomes (Advani et al. 1998; Advani
et al. 1999). However, in HeLa cells immunostained against endogenous
VAMP7, and against the lysosomal marker LAMP1 (Figure 3.14C) (Advani et
al. 1999), there wasverylittle co-localisation, with the majority of staining being
distinct VAMP7 and LAMP! punctae. This work argues against KChIP1 being
localised to lysosomes, or requiring the better characterised
VAMP7/Vtila/syntaxin 7/syntaxin 8 SNARE complexfortrafficking.
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Previous work on VAMP7hasshown it to belong to the longin subfamily of the
VAMP/synaptobrevin SNAREs, and suggested this N-terminal longin domain
may inhibit SNARE complex formation (Martinez-Arca et al. 2003), and neurite
outgrowth in neurons (Wang and Tang 2006). Comparisons were therefore made
between thetrafficking of Kv4.2 with KChIP1-EYFP in control HeLa cells, and
those co-transfected with either full-length VAMP7-GFP(as used in Figure 3.12)
or a GFP-tagged version of the longin domain of VAMP7. Images of a TRITC-
conjugated secondary antibody against an anti-Kv4.2 primary antibody were
obtained for a control cell (Figure 3.15A), and cells co-transfected with VAMP7-
GFP (Figure 3.15B) or its longin domain (Figure 3.15C). These showed the
channel at the plasma membranein all cases. The percentage of Kv4.2 localised
to the plasma membrane was quantified for 20 cells from each condition, and
normalised to the control cells, as shown in Figure 3.15D. This showsthat the
longin domain did not have an inhibitory effect on Kv4.2 trafficking in this
system. Neither did overexpression of full-length VAMP7 potentiate Kv4.2
trafficking. Together these results suggest that availability of VAMP7 is not a
limiting factor in Kv4.2/KChIP1 trafficking, and that whilst such trafficking may
require VAMP7,this pathwayis not regulated by the longin domain of VAMP7
itself.
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3.15: The longin domain of VAMP7 does not inhibit Kv4.2/KChIP1
trafficking to the plasma membrane.
HeLa cells were co-transfected with Kv4.2, detected with anti-Kv4.2
immunostaining, and a TRITC-conjugated secondary antibody. All cells
werealso transfected with KChIP1-EYFP.
A) Control cell
B) Cell co-transfected with VAMP7-GFP
C) Cell co-transfected with VAMP7 longin domain-GFP.
Scale bars represent 10um.
D) Quantification of the normalised trafficking of Kv4.2 to the plasma
membrane in the presence of KChIPI-EYFP alone (Cont), co-
transfected with VAMP7-GFP (VAMP7), or co-transfected with GFP-
tagged longin domain from VAMP7 (Longin). Data is shown as the
meansof20 cells for each condition, + S.E.M.
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3.2.5 siRNA knockdown of VAMP7 or Vtila inhibits trafficking of
Kv4.2/KChIP1-EYFP
Work in section 3.2.4 highlighted the co-localisation between KChIP1-labelled
punctae and the SNARE proteins VAMP7and Vtila. This suggested that these
SNAREs might play a functional role in the non-conventional trafficking of
Kv4.2 and KChIP1 to the plasma membrane. To investigate this, an RNA
silencing approach was used to knock down the levels of various SNAREs, and
look at the effects of this on trafficking.
Initially, HeLa cells were transfected with Kv4.2 and KChIP1-EYFP, and then
fixed and immunostained with anti-Kv4.2. A control cell is shown in Figure
3.16A, with both channel and KChIP co-localised to the plasma membrane. As a
further control, a silent RNAi construct was obtained, to rule out non-specific
effects of RNAi (Figure 3.16B), and this also showed Kv4.2/KChIP1-EYFP
trafficking to the plasma membrane. Three RNAi constructs were obtained
against Vtila, and three against VAMP7.In all cases, cells were left 72 hours
post-transfection. A typical cell transfected with the first of these constructs
against Vtila is shown in Figure 3.16C, whilst a cell co-transfected with VAMP7
RNAiconstruct 1 is shown in Figure 3.16D. In both cases the channel and
KChIP1 were intracellular, and in fact appeared to be in perinuclear punctate
structures. The proportion of Kv4.2 present at the plasma membrane for cells
from each condition was quantified, and normalised relative to control cells, for
both Vtila RNAi (Figure 3.16E) and VAMP7 RNAi(Figure 3.16F). In each
case, the silent RNAi had noeffect on Kv4.2 trafficking, whilst all three siRNAs
against each SNARE significantly inhibited trafficking, often down to
background levels. This supports a functional role for VAMP7 and Vtila in
Kv4.2/KChIP1 trafficking.
In addition, RNAi experiments were repeated in the mouse neuronal Neuro2A
cell line. As can be seen from thecells in Figure 3.17A, Kv4.2 was present on the
plasma membranein the presence of KChIP1-EYFP,in both a control cell, and
onetreated with silent RNAi. One RNAiconstruct (construct 1) against Vtila or
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3.16: VAMP7 and Vtila siRNA inhibits traffic of Kv4.2/KChIP1 to the plasma
membranein HeLacells.
HeLa cells were co-transfected with to express KChIP1-EYFP (Green) and Kv4.2 (Red)
and immunostained with anti-Kv4.2 and a TRITC-conjugated secondary so that
localisation of KChIP1 and Kv4.2 could be visualised. Cells were left 72 hours post-
transfection
A) Controlcell, expressing KChIP1-EYFP and Kv4.2.
B) Cell co-transfected with a silent RNAi as a control.
C) Cell co-transfected with Vtila RNAi 1.
D) Cell co-transfected with VAMP7 RNAi 1.
Co-localisation is shown as yellow in the colour overlays. Scale bars represent 10pm.
E) Normalised traffic of Kv4.2 in control cells, and cells transfected with either silent
RNAi,or three different siRNAsagainst Vtila, shown as means + S.E.M for20cells.
F) Normalised traffic of Kv4.2 in controlcells, and cells transfected with either silent
RNAi, or three different siRNAs against VAMP7, shown as means + S.E.M. for 25
cells.
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3.17: VAMP7and Vtila siRNAinhibit traffic of Kv4.2/KChIP1 to the plasma
membranein Neuro2Acells.
Neuro2A cells were transfected with Kv4.2 and KChIP1-EYFPin the absence or presence
of RNAi, and channeltrafficking was quantified 72 hours post-transfection.
A) Neuro2A cells were transfected to express Kv4.2 and immunostained with anti-
Kv4.2, visualised with a TRITC-conjugated secondary antibody, in the presence
of KChIP1-EYFP. A control cell is shown, as well as one co-transfected with
silent RNAi, Vtila RNAi 1, or VAMP7 RNAilas indicated. Scale bars represent
10pm.
B) Normalised traffic of Kv4.2 to the plasma membrane in the presence of KChIP1-
EYFP was quantified for control (cont) cells, and for those co-transfected with
siRNAs. Results are shown as the means of 30 cells for each condition, + S.E.M.
RNAi = RNAinterference.
VAMP7waspicked for these studies. In general, the VAMP7 and Vtila genes
share 85 to 90% overall identity with the human equivalents. Of the 19
nucleotides targeted by the RNAi constructs, 16 nucleotides were identical
between the mouse and human sequences for each RNAi used. Cells co-
transfected with these showedan intracellular localisation for the Kv4.2 channel.
The normalised proportion of Kv4.2 trafficked to the plasma membrane under
each condition was quantified, as shown in Figure 3.17B. As in HeLacells, the
silent RNAi had no significant effect on channel trafficking, whilst RNAi
knockdown ofeither Vtila or VAMP7significantly reduced the proportion of
channel fluorescence at the plasma membrane.It should be noted that the effects
of the RNAi in Neuro2A cells were quantitatively not as great as in HeLacells,
which could reflect cell-type specific differences in transfection efficiency, or in
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the lifetime of Vtila and VAMP7.Also, the lack of total conservation between
the mouse and human sequences targeted by the RNAi would makeitlesslikely
to work in this cell type, and the activity of the RNAiin this cell type was not
explicitly shown. However, the significant difference in trafficking in the
presence of RNAi again points to a role for these SNAREs in this non-
conventionaltrafficking route.
To confirm that the RNAi was knocking down levels of each SNARE as
expected, and that this was not having adverse effects on the cell, a number of
control experiments were performed. In all cases, experiments were performed
with cells left for 72 hours post-transfection with RNAi. Firstly, HeLa cells were
transfected with KChIP1, and immunostained for VAMP7 either in the absence
(Figure 3.18A) or presence (Figure 3.18B) of VAMP7 RNAiconstruct 1. Images
were obtained with identical microscope settings, and all images had their
brightness and contrast adjusted equally. In the presence of RNAi the VAMP7
image appeared much fainter. However, the KChIP1 remained constant as
expected, and the morphology and localisation of the KChIP1-labelled punctae
was unaffected by the RNAi. Also, the low levels of remaining VAMP7 were
still co-localised with KChIP1. The mean fluorescence of the anti-VAMP7
TRITC signal wascalculated for both sets of cells and normalised to control cells
(Figure 3.18C). This confirms the significant reduction in VAMP7 fluorescence
due to RNAi. Also, real-time PCR was used to show significant reduction in
the relative level of VAMP7 mRNA in VAMP7 RNAi-treated cells compared to
those treated with the silent RNAi construct (Figure 3.18D). Finally, HeLa cells
were transfected with Kv4.2 pcDNA and KChIP1-EYFPeither alone, or in the
presence of VAMP7or Vtila RNAi. Cells were then lysed for Western blotting
with an anti-Vtila antibody (Figure 3.18E). This showed a lower level of Vtila
in cells treated with Vtila-specific RNAi, whilst RNAi against VAMP7 had no
effect on Vtila levels, as expected. A blot for B-actin (Figure 3.18F) confirmed
equal loading of protein in each lane. These results confirm the effective and
specific nature of the RNAi used, and show that this RNAiis not disrupting the
localisation of KChIP1in cells.
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3.18: Confirming the specific effects of VAMP7 and Vtila RNAi in HeLacells.
The effect of RNAi against VAMP7 or Vtila in HeLa cells was assessed by fluorescence
measurements, real-time PCR and Western blotting.
A)
B)
HeLacell transfected with KChIP1-EYFP (Green), and immunostained with a mouse
monoclonal antibody against VAMP7, visualised using a TRITC-conjugated
secondary antibody (Red).
HeLacell transfected with KChIP1-EYFP (Green), and immunostained with a mouse
monoclonal antibody against VAMP7, visualised using a TRITC-conjugated
secondary antibody (Red), in the presence of VAMP7 RNAi construct 1. The
VAMP7signal appears fainter than in A. Microscope settings, brightness and
contrast adjustments wereidentical for images in A) and B).
Co-localisation is shown as yellow in the colour overlays. Scale bars represent 10pm.
C)
D)
E)
F)
Quantification of the mean anti-VAMP7 TRITC fluorescence of cells in the absence
(Cont) or presence of VAMP7 RNAiconstruct 1. Data shownis the mean of 20cells
for each condition, +S.E.M.
Quantification of the relative mRNA levels of VAMP7in HeLacells transfected with
silent or VAMP7siRNA,as determined using real-time PCR.
Western blot of Vtila expression in HeLacells transfected with Kv4.2 and KChIP1-
EYFPalone,or in the presence ofVAMP7or Vtila siRNA.
Western blot of B-actin expression in HeLa cells transfected with Kv4.2 and
KChIP1-EYFPalone, orin the presence ofVAMP7or Vtila siRNA.
RNAi = RNAinterference.
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3.19: VSVGtrafficking to the plasma membraneis unaffected by Vtila or VAMP7 RNAi.
HeLacells were transfected with VSVG-GFPin the absence or presence of RNAi and channel
trafficking was quantified 72 hours post-transfection.
A) HeLacells were transfected to express VSVG-GFP and imaged. A control cell is
shown, as well as cells co-transfected with silent RNAi, Vtila RNAi 1, or VAMP7
RNAi 1, as indicated. Scale bars represent 10um.
B) Normalised trafficking of VSVG-GFP to the plasma membrane was quantified for
control (Cont) cells, and cells co-transfected with silent RNAi, Vtila RNAi, or
VAMP7RNAi1.
Data shown is the mean of 20 cells for each condition, + S.E.M. RNAi = RNA
interference.
Asa further control, the effects of Vtila and VAMP7 RNAionthetrafficking of
VSVG-GFPin HeLa cells were tested. The images in Figure 3.19A show HeLa
cells fixed 72 hours after transfection with VSVG-GFPeither alone (Control) or
with silent, Vtila or VAMP7 RNAi. In all cases, VSVG-GFP waslocalised to
the plasma membrane. This showed that these siRNAs were not generally
disrupting trafficking in cells. The proportion of VSVG-GFP at the plasma
membrane was quantified for 20 cells from each condition, and normalised to
control cells (Figure 3.19B). This confirmed that the trafficking of VSVG was
unaffected by knockdown of VAMP7 or Vtila, as would be expected, as VSVG
is known to traffic via a SNARE complex containing Sec22 and membrin (Zhang
et al. 1999; Xu et al. 2000).
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3.20: The effects of Sec22 RNAi on VSVG and Kv4.2/KChIP1 trafficking to the plasma
membrane.
HeLa cells were transfected with VSVG-GFP or Kv4.2/KChIP1 in the absence or presence of
Sec22 RNAi, and channeltrafficking was quantified. Scale bars represent 10um.
A)B)C-E)
F-H)
HeLacell transfected VSVG-GFP, detected by confocal microscopy.
HeLacell transfected with VSVG-GFP,in the presence of Sec22 RNAiconstruct1.
HeLacell transfected with KChIP1-EYFP (C, Green) and Kv4.2 (visualised using anti-
Kv4.2 immunostaining, with a TRITC-conjugated secondary antibody, D, Red), and with
co-localisation shown as yellow in the colour overlay (E).
HeLacell transfected with KChIP1-EYFP (F, Green) and Kv4.2 (visualised using anti-
Kv4.2 immunostaining, with a TRITC-conjugated secondary antibody, G, Red), and with
co-localisation shown as yellow in the colour overlay (H), in the presence of Sec22
RNAiconstruct 1.
Normalised traffic of VSVG-GFP in the absence (Cont) or presence of Sec22 RNAi
construct 1 was quantified. Data shown is the mean of 20 cells for each condition, +
S.E.M.
Normalised traffic of Kv4.2, with KChIP1-EYFP,in the absence (Cont) or presence of a
silent RNAi construct or Sec22 RNAi construct 1 was quantified. Data shown is the
mean of 20 cells for each condition, + S.E.M. RNAi = RNAinterference.
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Whilst Sec22 is known to be important in VSVG-GFPtrafficking (Xu etal.
2000), the above work suggests it does not play a role in Kv4.2/KChIP1
trafficking. To confirm this, Sec22 was knocked down by RNAi,andits effects
on both VSVG-GFP and Kv4.2/KChIP1 were investigated 72 hours post-
transfection. Initially, two RNAi constructs were tested, but one of these failed to
have an effect on VSVG-GFPtrafficking as expected and so was not considered
further. In contrast, whilst VSVG-GFP wasclearly at the plasma membranein a
control cell (Figure 3.20A), in a cell co-transfected with Sec22 RNAi construct 1
the majority of VSVG was intracellular, in the perinuclear region. The level of
plasma membrane fluorescence was quantified and normalised (Figure 3.20])
revealing a significant inhibition of trafficking in the presence of Sec22 RNAi. A
control cell transfected with KChIP1 and Kv4.2 (Figure 3.20C-E), showed their
typical co-localisation at the plasma membrane, whilst a cell co-transfected with
Sec22 RNAi (Figure 3.20F-H) also had both proteins localised at the plasma
membrane. The proportion of Kv4.2 at the plasma membrane was quantified and
normalised for control cells, and those transfected with either the silent RNAi
construct, or Sec22 RNAiconstruct 1 (Figure 3.20J). Whilst the level of Kv4.2 at
the plasma membrane appeared slightly lower in Sec22 RNAi-treated cells, this
was not significant, confirming that VSVG-GFP and Kv4.2/KChIP1 are
trafficking via different exocytic pathways, dependent on Sec22 and
VAMP7/Vtila respectively.
As a further control, the effect of knocking down GOS28 on VSVG and
Kv4.2/KChIP1 trafficking was investigated using two RNAiconstructs in HeLa
cells. Again, experiments were performed with cells transfected for 72 hours.
This SNARE has been implicated in ER-Golgi trafficking (Zhang and Hong
2001), but has not been shown to have a role in VSVGtrafficking, and does not
co-localise with KChIP1 (Figure 3.8C). As expected, VSVG-GFP waslocalised
to the plasma membrane in both control cells (Figure 3.21A), and those
transfected with either GOS28 RNAi construct 1 (Figure 3.21B) or 2 (Figure
3.21C). Quantification of this data (Figure 3.21M) revealed no significant
difference on VSVG-GFPtrafficking in the three conditions tested. In addition,
Kv4.2 and KChIP1 were co-localised at the plasma membranein controlcells
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3.21: Effects of GOS28 RNAi on VSVG and Kv4.2/KChIP1 trafficking to the plasma
membrane.
HeLacells were transfected with VSVG-GFP or Kv4.2/KChIP1 in the absence or presence of
GOS28 RNAi, and channel trafficking was quantified. Scale bars represent 10um.
A-C) HeLacells were transfected to express VSVG-GFP either alone (A), or in the
presence of GOS28 RNAiconstruct 1 (B) or 2 (C).
HeLa cells were transfected to express KChIP1-EYFP (Green, D, G, J) and Kv4.2 (visualised
using anti-Kv4.2 immunostaining with a TRITC-conjugated secondary antibody, Red, E, H, K),
and co-localisation is shown as yellow in the colour overlays(F,I, L).
D-F) Control HeLacell expressing KChIP1-EYFP and Kv4.2 only.
G-I)_ HeLa cell also expressing GOS28 RNAiconstruct 1.
J-L) HeLacell also expressing GOS28 RNAiconstruct2.
M) Normalised traffic of VSVG-GFP in the absence (Cont) or presence of GOS28
RNAiconstructs 1 or 2 was quantified.
N) Normalised traffic of Kv4.2, with KChIP1-EYFP, in the absence (Cont) or presence
of a silent RNAi construct or GOS28 RNAiconstructs 1 or 2 was quantified.
Data shownis the mean of 30 cells for each condition, + S.E.M. RNAi = RNAinterference.
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3.22: VAMP7and Vtila siRNA does not inhibit the traffic of Kv4.2/KChIP2 to the plasma
membranein HeLacells.
HeLacells were transfected with Kv4.2 and KChIP2-ECFP,andthe effects of VAMP7or Vtila
RNAiwereobserved and quantified.
A) HeLacell co-transfected with KChIP2-ECFP and Kv4.2.
B) HeLa cell co-transfected with KChIP2-ECFP, Kv4.2 and a silent RNAiconstruct.
C) HeLa cell co-transfected with KChIP2-ECFP, Kv4.2 and Vtila RNAi construct 1.
D) HeLa cell co-transfected with KChIP2-ECFP, Kv4.2 and VAMP7 RNAiconstruct1.
Cells were visualised by confocal microscopy, with KChIP2-ECFP shown as green in the
colour overlays. Kv4.2 was detected by anti-Kv4.2 immunostaining, with a TRITC-
conjugated secondary antibody, and is shown as red in the colour overlay. Co-localisation is
shown as yellow in the colour overlay. Scale bars represent 10um.
E) Normalisedtrafficking of Kv4.2 in the presence of KChIP2 alone (Cont), or with silent
RNAi, or with Vtila RNAi construct 1 or VAMP7 RNAiconstruct 1. Data shown is the
mean of 30 cells for each condition, + S.E.M. RNAi = RNAinterference.
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(Figures 3.21D-F), and those co-transfected with either GOS28 RNAi construct 1
(Figures 3.21G-I) or 2 (Figures 3.21 J-L). Quantification of the proportion of
anti-Kv4.2 TRITC fluorescence at the plasma membrane (Figure 3.21N)
confirmed that whilst there were some differences between cells from the
different conditions tested, these were not significant. This supports the idea that
neither VSVG nor Kv4.2/KChIP1 requires a GOS28-containing SNARE
complex for their trafficking to the plasma membrane.
Having shown that KChIP1 and Kv4.2 were trafficking via a non-conventional,
VAMP7and Vtila-dependent pathway different from that used by VSVG-GFP,
it was interesting to ask if all stimulated traffic of Kv4.2 channels wasvia this
pathway. Other members of the KChIP family are also able to traffic Kv4
potassium channels to the plasma membrane (An et al. 2000). However, only
KChIP1 is myristoylated and shows localisation to intracellular vesicles
(O’Callaghan et al. 2003), whilst KChIP2 is palmitoylated and localised to the
plasma membrane when expressed alone (Takimoto et al. 2002; Venn et al.
2008). It was therefore not clear if the stimulation of Kv4 trafficking by these
KChIPs would occur via the same non-conventional pathway, or whether
interaction with the channel would occur in distinct cellular compartments. This
was investigated by co-transfecting HeLa cells with Kv4.2, KChIP2-ECFP and
either VAMP7 or Vtila RNAi. Cells were left for 72 hours post-transfection
before fixation. In a control cell (Figure 3.22A), both KChIP2-ECFP and Kv4.2
were co-localised at the plasma membrane, highlighting the ability of KChIP2 to
promote channel trafficking. Co-transfection with silent RNAi (Figure 3.22B)
had no effect. However, both the channel and KChIP2 werealso co-localised to
the plasma membranein cells co-transfected with either Vtila RNAi (Figure
3.22C) or VAMP7 RNAi(Figure 3.22D). The normalised trafficking of Kv4.2
was quantified for 20 cells from each condition, as shown in Figure 3.22E. This
confirms that there was no change in the plasma membranelocalisation of Kv4.2
in response to RNAi whenco-transfected with KChIP2. This again confirms that
these siRNAare not disrupting general trafficking pathways.It also suggests that
distinct pathways are utilised by KChIPs 1 and 2 to traffic Kv4 potassium
channels to the plasma membrane.
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3.3 Discussion
The functional kinetics of ion channels, and their trafficking to the plasma
membrane, are key aspects where regulatory proteins can exert their effects.
Manypreviouspapers have studied a range of regulatory proteins associated with
the Kv4 family of voltage-gated potassium channels (Birnbaum et al. 2004),
perhapsthe best characterised of which are the KChIPs. In continuing this work,
it was important to first confirm that previous findings could be replicated. As
expected, KChIP1 showed a typical punctate distribution, both in previously
studied HeLacells, and an alternative neuronalcell type, Neuro2A cells. KChIP1
was also able to increase trafficking of Kv4.2 to the plasma membrane,in line
with previous findings (Hasdemir et al. 2005). Previous work, however,left
several unanswered questions.
Firstly, there has been some debate about the localisation of Kv4.2 when
expressed alone in cells. Many transmembraneproteins are retained in the ER
until association with an escort or accessory protein masks their ER retention
signal to allow onward exocytic trafficking (Misonou and Trimmer. 2004).
KChIP1 wasinitially proposed to act in this way, as an accessory protein to
Kv4.2 to allow its ER exit (Bahring et al. 2001). The localisation of Kv4.2 is
clearly perinuclear in all cell types tested, and Shibata et al. (2003) claimed co-
localisation between Kv4.2 and the ER marker calnexin. However, other papers
have shown that Kv4.2 co-localises not with calnexin, but with markers of the
Golgi, including the cis-Golgi protein B-COP and the trans-Golgi network
protein y-adaptin (O’Callaghan et al. 2003; Hasdemir et al. 2005). The work
presented in Figures 3.1 and 3.2 argues in favour of Kv4.2 being localised to the
Golgi, showing co-localisation with Golgi-localised EYFP, and the Golgi
resident protein ARF1. This would be in keeping with the finding that the
proposed RXR ERretention motif in Kv4.2 is non-functional (Shibata et al.
2003). It remains unclear how this localisation is achieved or maintained by
Kv4.2. It suggests, however, that interaction between Kv4.2 and the KChIPs,
allowing the channel’s onward traffic to the plasma membrane, occurs at or
before the Golgi.
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Another question raised by previous work centred on the Ca**-binding EF-hand
domains of the KChIPs. One possibility is that these domains act as calcium
sensors in the protein, and the binding of Ca’* ionsalters the conformation ofthe
KChIP,allowing it to bind to target proteins and mediate an effect. However,it
could be that these domains are simply required for the structural integrity of the
protein. When the KChIPs were originally discovered (An et al. 2000), it was
shown that mutant KChIP1EF2-4 did not bind radioactive Ca**, and could not
modulate channel kinetics or increase current density. However, this triple EF-
hand mutant was able to co-localise with Kv4, and was efficiently co-
immunoprecipitated with Kv4 a-subunits. Also, it was shown by confocal
microscopy that whilst KChIP1EF2-4 could not traffic Kv4.2 to the plasma
membrane, the channel changed from a perinuclear localisation to be co-
localised with KChIP1EF2-4 punctae (Hasdemir et al. 2005). This argues that
trafficking of the channel is Ca**-dependent, whilst interaction between the
channel and KChIP is not. In further support of this, experiments have been
performed with KChIP2d, an isoform with only one EF-hand domain. Whenthis
domain was mutated, the usual slowing of Kv4.3 inactivation caused by the
KChIP wasabolished. However, the KChIP retained its ability to accelerate the
channel’s recovery from inactivation (Patel et al. 2002b). This suggests that the
KChIP-Kv4 interaction has both Ca’*-dependent and independent functions
(Patel et al. 2004). More recently, however, Pioletti et al. (2006) created
combinations of mutations in EF-hands 2, 3 and 4 of KChIP1. Whilst the single
mutants, and EF2EF3 or EF2EF4 mutants showed normal binding to the N-
terminus of Kv4.3, the EF3EF4 double and EF2-4 triple mutant had impaired
binding. It was argued that this was due to the proteins unfolding in the absence
of Ca?*. It was also shown that these mutants, but not the less severe single and
double mutants, were unable to affect the properties of the full-length protein.
However, the interaction between these mutants and the full-length protein was
not assessed.
The data shown in Figures 3.5 and 3.6 confirm that KChIP1EF2-4 is unable to
traffic Kv4.2 to the plasma membraneaseffectively as wild-type KChIP1, but
also show that the single EF3 mutant has this same effect. Expressing thetriple
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mutant with VSVG-GFP had no effect on its trafficking, confirming that
KChIP1EF2-4-EYFP is not disrupting general trafficking pathways. However,
these data also reveal that both the single and triple mutants are punctate like
wild-type KChIP1, and when co-expressed with Kv4.2, cause the channel to
becomepunctate in its localisation. This suggests that being unable to bind Ca**
does not prevent the mutant KChIPs from accessing the same cellular
compartments as the wild-type protein, and a Western blot confirms that
expression of these mutants is not impaired (Figure 3.5C). The redistribution of
the channel away from its usual perinuclear Golgi localisation, to a KChIP1-like
punctate distribution, also suggests that the mutants are still able to bind the
channel, leading to this change in localisation. Finally, in Figures 3.11 and 3.12,
it was shown that the vesicles accessed by the EF-hand mutants of KChIP1 are
co-localised with the same SNARE proteins as wild-type KChIP1 vesicles.
Overall, these data, combined with previousliterature in the field, would argue
that whilst mutations in the Ca’*-binding EF-hands of KChIP1 preventit from
trafficking Kv4.2 to the plasma membrane, they do not impair the interaction of
the channel and KChIP. The differences seen in Pioletti et al. (2006) could be
due to the interaction studies being performed with only a truncated N-terminal
portion of the Kv4.3 a-subunit. In fact, it has been shown that the C-terminal of
the Kv4.2 channelis also important for interactions with KChIPs (Callsen et al.
2005; Han et al. 2006), which could explain why binding studies with only the
N-terminus of the channel were unsuccessful.
It has been shown that Kv4.2/KChIP1 trafficking is different to that of VSVG-
GFP because oftheir differing requirement for COPII (Hasdemir et al. 2005),
and the work with EF-hand mutants also differentiates between these pathways.
However, the requirement of Kv4.2/KChIP1 for COPI shows there is some
overlap with VSVG-GFPtraffic, and this was also the case with the requirement
for Rab1 (Figure 3.7). Rabl is known to be critical for general ER-Golgi
trafficking, shown by using dominant negative mutants (Tisdale et al. 1992), and
altering active Rab1 levels by using its Rab-GAP perturbs the Golgi and ERGIC
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(Haas et al. 2007). However, several proteins are known to beable to traffic
through the cell in a Rabl-independent manner, including CFTR (Yooetal.
2002) and the o2p-adrenergic receptor (Wuet al. 2003). Expression of the ER-
resident GAP TBC1D20 allowed the specific inhibition of Rab1l (Haaset al.
2007), and this was able to block both VSVG-GFP and Kv4.2/KChIP1
trafficking to the plasma membrane (Figure 3.7). If further Rab-GAPs can be
characterised, then the specificity of this approach makes it an ideal way of
investigating the role of Rabs elsewhere in cellular trafficking, and could shed
light on the post-Golgitrafficking of Kv4.2. It also suggests that Kv4.2/KChIP1
may utilise the conventional, COPI-dependent pathway from ERGIC to cis-
Golgi, and that this might be the ER-Golgi step requiring active Rab1.
The major finding from this work is that KChIP1 is co-localised in vesicles with
the two SNAREs VAMP7and Vtila, further differentiating this pathway from
that used by VSVG-GFP. Antibodies against Sec22b inhibit the ER-Golgi
trafficking of VSVG-GFP (Zhanget al. 1999), and Sec22 is enriched at ER-exit
sites and on COPII-coated vesicles (Chao et al. 1999), where it forms a complex
with membrin, syntaxin 5 and rBetl (Xu et al. 2000). There was no co-
localisation between KChIP1-EYFP and antibodies against either Sec22b or
membrin (Figure 3.8), and whilst RNAi knockdown of Sec22 inhibited VSVG-
GFPtrafficking, it had no significant effect on KChIP1/Kv4.2 (Figure 3.20). This
confirms that these trafficking pathways differ not only in their COP coat
requirements, but in their SNARE proteins as well.
Two alternative SNARE complexes found in the literature were also assessed.
One, containing Ykt6, GOS28, syntaxin 5 and rBetl, has been argued to be
localised to the cis-Golgi (Zhang and Hong 2001). This was also of interest as
the longin domain of Ykt6 has been shown to direct it into punctate structures in
neuronal-like PC12 cells (Hasegwa et al. 2004). However, there was no co-
localisation between KChIP1-EYFP and antibodies against GOS28 or Ykt6
(Figure 3.8), and in non-neuronal HeLacells, Ykt6 was clearly perinuclear rather
than punctate. Also, RNAi against GOS28 had nosignificant effect on either
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VSVG-GFP or KChIP1/Kv4.2 trafficking, which would argue that this SNARE
is not a significant regulator of either of the trafficking pathwaysinvestigated.
In contrast to the above, there was clear co-localisation between KChIP1 and
antibodies against endogenous VAMP7and Vtila (Figures 3.9-3.13) in a variety
of cell types, for both wild-type and mutant KChIP1, and between over-
expressed VAMP7 and KChIP1 as well (Figure 3.12). Knockdown of these
proteins using RNAi revealed that they also had a functional role in
Kv4.2/KChIP1 trafficking, but not in VSVG-GFPtrafficking (Figures 3.16, 3.17,
3.19). This was a surprising result, as the role of VAMP7and Vtila in ER-Golgi
trafficking had only been shown for PCTVtrafficking in the intestine (Siddiqi et
al. 2006a; Siddiqi et al. 2006b). These papers showed VAMP7wasin the ER of
the intestine, but not of the kidney or liver, and hence argued that this VAMP7-
dependent pathway was intestine-specific. However, three different cell types
were investigated in this thesis, and the same co-localisation between KChIP1
and VAMP7/Vtila was seen in all. In addition, VAMP7 is more commonly
associated with the endosomal/lysosomal pathway, as VAMP7 has been shown
to co-localise with lysosomal markers 1gp120 (Advani et al. 1998) and LAMP1
(Advani et al. 1999), to be enriched in secretory lysosomes (Caseyet al. 2007),
and to form a complex with Vtila, syntaxin 7 and syntaxin 8 on Dictyostelium
endosomes (Bogdanovic et al. 2002). However, whilst there was clear co-
localisation between KChIP1 and VAMP7/Vtila, there were clearly distinct
populations of KChIP1-EYFPvesicles and those labelled with either syntaxin 7
or 8. In addition, whilst some endogenous VAMP7co-localised with LAMP1,
much ofthe staining was separate (Figure 3.14). Combined with previous work
showing that KChIP1 does not co-localise with Rab proteins associated with the
endosomal pathway (O’Callaghan et al. 2003), it therefore seems unlikely that
the punctate KChIP1 structures are endosomal in origin, and more likely that
VAMP7andVtila are also regulating an ER-Golgitrafficking pathwayincells.
In support of this, one isoform of Vtila has been shown to be perinuclear in
localisation in neuronal cells (Antonin et al. 2000), and VAMP7 has been found
in punctate and tubulovesicular structures around the cell body and in proximal
dendrites of neurons, which were not ER, Golgi or lysosomal in origin (Coco et
104
al. 1999). Also, in HeLacells, it has been claimed that only over-expressed
VAMP7co-localised with LAMP1, whilst endogenous protein did not, although
these data were not presented in the paper (Coco et al. 1999). Finally, a
proteomic map of the secretory pathway found Vtila in the smooth ER, Golgi
and COPI-coated vesicles, and VAMP7 in COPI-coated vesicles also (Gilchrist
et al. 2006). Together, this data argues that VAMP7 and Vtila are regulating a
non-conventional, Rabl- and COPI-dependent ER-Golgitrafficking pathway for
Kv4.2/KChIP1.
Two further points of interest were raised by this characterisation of a novel
intracellular pathway. Firstly, VAMP7 belongs to the VAMP/synaptobrevin
family of SNAREs, which share a C-terminal coiled-coil SNARE domain, but
differ in having either a short (brevin) or long (longin) N-terminal domain. The
~150 amino acid longin domain of VAMP7 has been shown to inhibit SNARE
complex formation (Martinez-Arca et al. 2003), and inhibit the outgrowth and
morphogenesis of neuronal neurites (Wang and Tang 2006). However, over-
expression of just the GFP-tagged longin domain, or over-expression of full-
length VAMP7-GFP had noeffect on Kv4.2/KChIP1 trafficking (Figure 3.15).
This suggests that the longin domain of VAMP7 doesnotplay a regulatory role
in this pathway.
Secondly, having shown that this non-conventional pathwayis not confined to
PCTVsin the intestine, but is also active in neuronal cells expressing Kv4.2 and
KChIP1, it was interesting to ask whether other KChIP proteins stimulate Kv4.2
traffic via this route. KChIP2 was an obvious protein to investigate, as it has
many similarities to KChIP1, being able to interact with Kv4 channels andtraffic
them to the plasma membrane (Shibata et al. 2003; Venn et al. 2008), and so
could be investigated with the same assays. However, whilst KChIP1 expressed
alone is found on punctate vesicular structures (Figure 3.2) due to its
myristoylation (O’Callaghan et al. 2003), KChIP2 is palmitoylated and found on
the plasma membrane of COS-7 cells (Shibata et al. 2003) and Neuro2A cells
(Figure 3.2). It was therefore possible that KChIP2 could traffic Kv4.2 to the
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plasma membrane using the same pathway as KChIP1, or that interaction with
the channel might occur in a distinct intracellular compartment. The knockdown
of VAMP7 or Vtila by RNAi, which had inhibited Kv4.2 trafficking with
KChIP1, had no effect on the channel reaching the plasma membranein the
presence of KChIP2 (Figure 3.22). This suggests that the KChIPs and Kv4
channels are interacting in different compartments of the exocytic pathway, due
to their differing intrinsic localisations. One possibility is that KChIP1, localised
to punctate trafficking vesicles, interacts with the channel at this pre-Golgi stage,
whilst KChIP2 interacts with the channel at the level of the Golgi, where the
channel accumulates when expressed alone, and where KChIP2 is post-
translationally modified by palmitoyltransferases (Greaves et al. 2008).
Interestingly, KChIP2 is most highly expressed in the heart (Pruunsild and
Timmusk 2005) and is the predominant KChIP for regulating Kv4 channel
cardiac transient outward current(I;.) (Kuo et al. 2001), whilst VAMP7 seems
not to be found in the heart (Advani et al. 1998). There could, therefore, be
tissue-specific differences in trafficking pathways, as well as differences due to
cellular compartmentalisation.
In conclusion, KChIP1-EYFPtraffics Kv4.2 to the plasma membraneofcells via
a non-conventional, VAMP7- and Vtila-dependent pathway, which is different
from that used in the constitutive secretion of the well-characterised marker
protein VSVG-GFP. This trafficking, but not the interaction of the KChIP and
channel, can be disrupted by mutation of just one of the Ca’*-binding EF-hand
domains of KChIP1, or by reducing the levels of active Rab1 in the cell. There is
neither full co-localisation between KChIP1 and the endosomal/lysosomal
SNAREssyntaxins 7 and 8, nor between VAMP7 and LAMP! in HeLacells.
Finally, this KChIP1 pathway is distinct from that used by the related protein
KChIP2to traffic Kv4.2 to the plasma membrane.
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Chapter 4
Investigating potential interactions between
Kv4.2, KChIP1 and scaffolding proteins
107
4.1 Introduction
The trafficking of Kv4 channels to the plasma membrane, or their retention
within the cell, is one of the key ways a neuron can control the size of the
functional plasma membrane poolof the rapidly-inactivating, A-type currents
(An et al. 2000; Tkatch et al. 2000). The KChIPs, discussed in Chapter 3, are
important regulators ofthis trafficking. However, there are many other proteins
described as affecting Kv4.2 trafficking in the literature (Maffie and Rudy 2008).
The physiological significance of these is not clear (Deschenes and Tomaselli
2002). Also, little work has been carried out on potential ternary complexes of
Kv4.2, KChIP1 and these alternative accessory proteins. The aim ofthis section
of the thesis wasto investigate two families of scaffolding proteins — the 14-3-3
proteins and the PSD-95 family of MAGUKproteins — that may interact with
Kv4.2 or KChIP1 to influence their trafficking and clustering at the plasma
membrane.
The KChIPs have a major role in regulating Kv4 channels (An et al. 2000;
Misonou and Trimmer 2004), but may also have several other roles in cells,
including regulating transcription of some genes (Spreafico et al. 2001), and
interacting with the presenilin proteins implicated in Alzheimer’s disease
(Buxbaum et al. 1998). Discovering new interacting partners of the KChIPs
could thus shed light on how they achieve these different functions in vivo, or
even reveal possible new roles. A yeast two-hybrid screen was therefore
performed in the lab by Dr Lee Haynes,using full-length KChIP1 anda library
of mouse foetal brain cDNA. One interesting, and repeated, hit from this study
was with 14-3-3y (Dr L. Haynes, personal communication). This was ofinterest
as the 14-3-3 family of proteins have known roles in ion channel trafficking
(O’Kelly et al. 2002; Trombetta and Parodi 2003), making them credible binding
partners of the KChIPs, which also have such a function.
The 14-3-3 family of proteins are known for their ability to bind to
phosphorylated target proteins. The 14-3-3 proteins are dimers, and act as
scaffolding proteins, bringing two target proteins together or masking signalling
sequences within proteins (Shikano et al. 2006). This is important for the
trafficking of many ion channels, including various forms of potassium channel
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(O’Kelly et al. 2002; Trombetta and Parodi 2003). There is as yet no record of an
interaction between 14-3-3 proteins and Kv4 channels in the literature. The yeast
two-hybrid interaction with KChIP1 thus suggested that regulation of Kv4.2
could occur through the KChIP, as has been documented for several other Kv4
regulators (Holmqvist et al. 2001; Bowlby et al. 2005). The KChIPs can be
phosphorylated (Ruiz-Gomezet al. 2007), but do not have a consensus ModeI or
II binding site for 14-3-3 proteins. They would thus require non-consensus
binding, as has been reported for other proteins in in vitro studies (Tzivion and
Avruch 2001). A first aim was therefore to confirm whetherthe yeast two-hybrid
interaction could be replicated by alternative methods. To do this, antibodies
against 14-3-3y were used to look for co-localisation of the protein with KChIP1
in transfected cells. Subsequently, pull-down experiments were performed with
GST-tagged KChIP1 against bovine brain cytosol, to look for interactions of
KChIP1 with 14-3-3y and B.
Another interesting group of proteins are the PSD-95 family of MAGUKs, and
especially SAP97. These proteins are best known fortheir role in trafficking and
clustering neurotransmitter receptors on the plasma membraneofpost-synaptic
densities (Kim and Sheng 2004; Bats et al. 2007; Jeyifous et al. 2009). Having
several protein interaction motifs means they can cluster together a number of
related proteins, for example membersofa signalling pathway,or bring proteins
into association with the cytoskeleton to ensure their intracellular position (Feng
and Zhang 2009).
Both SAP97 and PSD-95 have been shown to interact with Kv4 channels, and
promote their trafficking to, and clustering at, the plasma membrane (Gardoniet
al. 2007; El-Haouet al. 2009). A potential role for the related protein PSD-93 has
not been investigated, however. Also, the Kv4 channels are most likely
associated with a KChIP in vivo, and studies have not looked at the effects of
having both KChIPs and SAP97interacting with the channel. There were several
strandsto this investigation, all based on expressing Kv4.2 in cells with KChIP1,
a PSD-95 family protein or both, and quantifying levels of trafficking to the
plasma membrane.Firstly, the effects of SAP97 alone on Kv4.2 were compared
to its effects in the presence of KChIP1. Secondly, similar experiments were
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performed with three isoforms of PSD-93, to see if this protein could promote
channel trafficking, and to investigate any isoform specific effects. Finally,
possible interactions between SAP97 and KChIP1 were investigated. This work
potentially reveals a novel interaction between SAP97 and KChIP1 that may
affect the distribution of Kv4 channelsin cells.
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4.2 Results
4.2.1 14-3-3 proteins as potential interacting partners of KChIP1
The KChIP proteins have many potential intracellular roles (Buxbaum et al.
1998; An et al. 2000; Spreafico et al. 2001), and identifying their interacting
partners is important for understanding these functions. Totry and identify novel
binding partners, a yeast two-hybrid screen was performed by Dr Lee Haynes,
using KChIP1 and a mousefoetal brain cDNAlibrary. This identified 14-3-3y as
a potential binding partner. This was of interest because several hits gave the
same protein, and the gammaisoform wasthe only one detected (Dr L. Haynes,
personal communication). Also, the 14-3-3 proteins are known to play important
roles in ion channeltrafficking (O’Kelly et al. 2002; Rajan et al. 2002; Bergetal.
2003), and so could be linked to KChIP1’s role in the trafficking of Kv4
channels. Experiments were therefore performed to try and confirm this
interaction.
Firstly, the localisation of 14-3-3y in cells was compared to KChIP1. HeLacells
were transfected with KChIP1-EYFP, and after fixation, these cells were
immunostained with an antibody against endogenous 14-3-3y. Twotypicalcells
are shown in Figure 4.1. KChIP1-EYFP showedits usual punctate distribution.
Overlay
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4.1: Co-localisation between KChIP1-EYFPand 14-3-3y in HeLacells.
HeLacells were transfected with KChIP1-EYFP and immunostained for 14-3-3y.
A) and B) show twoseparate HeLacells.
In all cells, endogenous 14-3-3y protein was detected by immunostaining with
anti-14-3-3y antibodies and a TRITC-conjugated secondary. KChIP1-EYFPis
shown as green, 14-3-3y immunostaining in red, and co-localisation in yellow
in the colour overlays. The scale bars represent 10um.
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The 14-3-3y was present at regions of the plasma membrane. However, it also
showeda punctate distribution within cells that at least partially co-localised with
KChIP1-EYFP (as shown by yellow in the colour overlay) in some punctate
structures. This data is therefore supportive of a potential interaction between
KChIP1 and 14-3-3y.
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4.2: Production of GST and GST-KChIP1 proteins, and a pull-down assay with these
proteins against bovine whole brain lysate.
GST-KChIP1 and GST proteins were produced, and used in a pull-down assay against bovine
whole brain lysate in the presence and absence of Ca””.
A) Production ofGST protein, with an expected molecular weight of ~26kDa.
B) Production of GST-KChIP1 protein, with an expected molecular weight of ~51kDa.
kDa = molecular weight markers in kiloDaltons. Pre = pre-induction. Post = post-protein
induction. S/N = supernatant. P = pellet. U = unboundfraction. E1/2/3 = elutions.
C) Coomassie-stained gel of a pull-down assay with GST or GST-KChIP1, showing Ca’*-
dependent (+) or independent(-) interactions against whole brain lysate. A sample of the whole
brain lysate was loadedas a control.
kDa = molecular weight markers in kiloDaltons.
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To investigate this interaction further, pull-down assays were used to look for an
interaction between GST-tagged KChIP1, immobilised on beads, and 14-3-3
proteins present in bovine brain extracts. In order to perform these experiments,
purified GST and GST-KChIP1 proteins were required. BL21 E. coli cells
transformed with plasmids encoding GST or GST-KChIP1 were available in the
laboratory. These were grown up, and protein production induced with IPTG.
The protein was then purified using a cell disruptor, and affinity chromatography
using Glutathione Sepharose. Theresults ofthis purification are shown in Figure
4.2A for GST,and Figure 4.2B for GST-KChIP1. In both cases, there was a large
concentration of protein in the three elution fractions, at the expected molecular
weight of ~26kDa for GST, and ~51kDa for GST-KChIP1. There was very little
contamination in the GST elutions, although the GST-KChIP1 did show some
proteins at ~26kDa, which were likely degradation products. A pull-down
experiment was then performed, using these proteins attached to Glutathione
Sepharose beads to pull out binding partners from bovine whole brain lysate.
Bound proteins were eluted in either the absence of Ca** (Ca?*-dependent
interactions) or in high salt (Ca’*-independent interactions) (Figure 4.2C).
However, the bands seen in the eluates on this gel were broadly the same for
GST as for GST-KChIP1. The only obvious additional band was seen at ~51kDa,
so corresponding to the GST-KChIP1 itself.
There were two potential problems with this experimental approach. In order to
produce whole brain lysate, detergents are used. It has been observed previously
that NCS family proteins are unable to bind their interacting partners in the
presence of some detergents (Dr L. Haynes, University of Liverpool, personal
communication). To avoid these issues, the experiment was repeated with bovine
brain cytosol, which can be produced without such harsh detergents. In addition,
14-3-3 proteins may require their targets to be phosphorylated in order to bind,
although KChIP1 is lacking a consensus 14-3-3 binding site. The pull-down
experiment wastherefore repeated in the presence of Mg”*.ATP,to allow kinases
in the bovine brain cytosol to phosphorylate their target proteins. These
experiments were also performed to look for Ca”*-dependent and Ca’*-
independent interactions, and with immobilised GST as a control. Figure 4.3A
shows a Coomassie blue stained gel of the results of this pull-down. This result
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was muchcleaner than that seen in Figure 4.2C, and there were some bands
specific for GST-KChIP1, either as Ca’*-dependent interactions, or in both the
Ca’*-dependent and independent interaction lanes. These are highlighted with red
dots in the figure. To confirm if there was any binding in this experiment
GST- BrainA GST KCHIP! cytosol
kDa + a + ~ Ca
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4.3: Pull-down assays with GST and GST-KChIP1 against bovine brain cytosol.
Both GST-KChIP1 and a GST control were used in pull-down assays against bovine brain
cytosol, in the presence ofMg”’.ATP,and the presence or absence of Ca".
A) Coomassie-stained gel of a pull-down assay using GST and GST-KChIP1 against
bovine brain cytosol, showing Ca”*-dependent (+) or independent(-) interactions. A
sample of bovine brain cytosol wasalso loaded as a control. Bands presentonly in the
GST-KChIP1 lanes are highlighted with a red dot.
kDa = molecular weight markers in kiloDaltons.
B) Western blot of samples from the pull-down, using anti-14-3-3y antibodies. Lanes
correspond to those in A). A band was detected at the expected molecular weight of
~30kDain the bovine cytosollane.
C) Western blot of samples from the pull-down, using anti 14-3-3B antibodies. Lanes
correspond to those in A). A band was detected at the expected molecular weight of
~30kDain the bovine brain cytosollane.
114
between KChIP1 and 14-3-3 proteins, Western blots were performed using
samples of the pull-down. Bovine brain cytosol was used a positive control, to
confirm the 14-3-3 proteins were present and detectable in the input. The blots
were probed with two different antibodies against isoforms of 14-3-3. As the
target of the yeast two-hybrid screen, 14-3-3y wasinvestigated (Figure 4.3B). An
alternative protein, 14-3-3B was also investigated, to confirm any isoform
specificity (Figure 4.3C). As expected, a band wasvisible in the brain cytosol
lane, at the expected molecular weight of ~30kDa, for both isoforms. However,
there were no bandsin any of the otherlanes, for either 14-3-3y or 14-3-3p. It
was nottherefore possible to confirm the interaction seen in the yeast two-hybrid
screen, and so the 14-3-3 family of proteins was not considered anyfurther.
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4.2.2 Interactions between SAP97 and Kv4.2 in the absence and presence of
KChIP1
The PSD-95 family of MAGUKproteins are known to have importantroles in
trafficking ion channels and receptors to the plasma membrane of neurons and
clustering them at particular polarised locations, such as post-synaptic densities
(Kim and Sheng 2004). Plasmids encoding tagged versions of these proteins
were kindly provided by Prof L-Y. Lian, University of Liverpool. Of this family
of proteins, SAP97 wasofparticular interest as it is thought to have an important
role in neuronaltrafficking (El-Haouet al. 2009). In work with Kv4 channels,
RNAi knockdown of SAP97 reduced levels of Kv4.2 in the post-synaptic
compartment (Gardoni et al. 2007). Also, SAP97 was shown to promote Kv4
trafficking to the plasma membrane,and increase current density (El-Haouet al.
2009). This data is difficult to interpret, though, as some experiments were
performedin cells stably transfected with KChIP2, and the separate contributions
of these proteins were notfully assessed. The aim of this thesis was to compare
the effects of SAP97 on Kv4.2 to the effects of KChIP1, and to look at the
combinedeffects of both together.
Asa first step, the trafficking of untagged Kv4.2 to the plasma membrane of
HeLacells was investigated in the presence of either KChIP1-EYFP or EGFP-
SAP97. A typical cell expressing KChIP1-EYFP and Kv4.2 detected by anti-
Kv4.2 immunostaining is shown in Figures 4.4A-C. As expected, both the
KChIP1 and the Kv4.2 were localised to the plasma membrane. The experiment
wasrepeated,this time with Kv4.2 and EGFP-SAP97, as shown in Figures 4.4D-
F. In this typical cell, the EGFP-SAP97 was visible at the plasma membrane,
although it was also present in the intracellular perinuclear region, possibly
associated with intracellular membrane-bound compartments such as the ER or
Golgi. This cell also showed some Kv4.2 at the plasma membrane,although this
appeared less than with KChIP1. The trafficking of Kv4.2 to the plasma
membrane was quantified by calculating the percentage of the total fluorescence
in a region of interest corresponding to the plasma membrane. Data for 20 cells
from each condition are shown in Figure 4.4K, with the background level of
Kv4.2 at the plasma membrane subtracted, and then results normalised to cells
with Kv4.2 and KChIP1-EYFP. Hence a valueof 1 on the y-axis meansthat the
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4.4: The trafficking of untagged Kv4.2 to the plasma membrane in the presence ofKChIP1-EYFP, EGFP-SAP97or both.
HeLa cells were transfected to express untagged Kv4.2, in the presence of KChIP1-EYFP,
EGFP-SAP97 or both, and the level of channel trafficking to the plasma membrane was
assessed.
A-C) HeLacell expressing KChIP1-EYFP (Green) and Kv4.2 (Red), with co-localisation
shown in the overlay in yellow.
D-F) HeLacell expressing EGFP-SAP97 (Green) and Kv4.2 (Red), with co-localisation
shownin the overlay in yellow.
G-J) HeLa cell expressing EGFP-SAP97 (Blue), KChIP1-EYFP (Green) and Kv4.2
(Red).Partial co-localisation is seen as yellow, purple or cyan in the colour overlay,
with co-localisation ofall three proteins in white.
In all cases, Kv4.2 was detected using anti-Kv4.2 immunostaining with a TRITC-
conjugated secondary. Thescale bars represent 10um.
K) Quantification of the percentage of Kv4.2 TRITC fluorescence at the plasma
membrane.
Data is shown as the means from 20 cells for each condition, shown +S.E.M, with a
background measurement subtracted, and normalised to the leftmost column ofcells co-
transfected with KChIP1-EYFP.p-valuesare given relative to this column.
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percentage of Kv4.2 trafficking is equal to that occurring in the presence of
KChIP1, whilst a value of 0 meansthetrafficking matches that seen in control
cells expressing the channel alone. The EGFP-SAP97 caused a significant
(p<0.01) increase in the percentage of Kv4.2 found at the plasma membrane,
compared to cells expressing Kv4.2 alone. This increase in trafficking was
similar to cells with Kv4.2 and KChIP1-EYFP.This suggests that both KChIP1
and SAP97 mayplay role in regulating thetrafficking of Kv4 channels to the
plasma membrane.
As a continuation of this study, cells were transfected with Kv4.2 pcDNA,
KChIP1-EYFP and EGFP-SAP97. Cells were carefully visualised, with
measurements of narrow emission ranges, to ensure the GFP and EYFPsignals
were separate (see Chapter 2). A typical cell is shown in Figures 4.4G-J. Unlike
the doubly transfected cells, none of the proteins were present at the plasma
membrane, including SAP97. This was confirmed by quantifying the trafficking
of Kv4.2, as shown in Figure 4.4K. This showed that trafficking of Kv4.2 to the
plasma membraneintriply transfected cells was significantly lower than in cells
expressing Kv4.2 with KChIP1-EYFP.It was also lower than in cells expressing
Kv4.2 with EGFP-SAP97. Together, these data suggested that EGFP-SAP97 was
somehow able to inhibit the stimulation of Kv4.2 trafficking caused by KChIP1-
EYFP when the three proteins were expressed together. This led to further
experiments to confirm and investigate this observation.
The above work confirmed that EGFP-SAP97 can stimulate the trafficking of
Kv4.2 to the plasma membrane (El-Haou et al. 2009). However, the data in
Chapter 3 show that the trafficking of Kv4.2 with KChIP1 is via a non-
conventional, VAMP7- and Vtila-dependent pathway. It was therefore
interesting to ask whether the trafficking of Kv4.2 with EGFP-SAP97 also
required this non-conventional SNARE complex. As a control, HeLa cells were
first transfected with Kv4.2 pcDNA and KChIP1-EYFPalone (Figure 4.5A), or
with VAMP7 RNAiconstruct 1 (Figure 4.5B). As expected, when co-expressed,
both the Kv4.2 and the KChIP1 were at the plasma membrane (Figure 4.5A),
whilst this was inhibited in the presence of the RNAiconstruct. Then cells were
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4.5: Trafficking of untagged Kv4.2 to the plasma membrane byKChIP1-EYFP or EGFP-
SAP97in the absence or presence of VAMP7 RNAi.
The importance of VAMP7in thetrafficking of Kv4.2 to the plasma membranein the presence
of either KChIP1-EYFP or EGFP-SAP97was assessed in HeLacells.
A) HeLacell transfected with KChIP1-EYFP (Green) and Kv4.2 pcDNA (Red).
B) HeLacell transfected with KChIP1-EYFP (Green) and Kv4.2 pcDNA (Red) in the
presence of VAMP7 RNAiconstrust1.
C) HeLa cell transfected with EGFP-SAP97 (Green) and Kv4.2 pcDNA (Red).
D) HeLacell transfected with EGFP-SAP97 (Green) and Kv4.2 pcDNA (Red) in the
presence ofVAMP7 RNAiconstruct1.
Kv4.2 localisation was determined using anti-Kv4.2 immunostaining with a TRITC-
conjugated secondary. Cells were left 72 hours post-transfection. Co-localisation is shown
as yellow in the colour overlays. Scale bars represent 10m.
E) Quantification of the normalised percentage of Kv4.2 at the plasma membrane under
each condition, A)-D), as described above.
Data shown is the meansfor 20 cells from each condition, +S.E.M.
transfected with Kv4.2 pcDNA and SAP97alone (Figure 4.5C), or with VAMP7
RNAi construct 1 (Figure 4.5D). Both the EGFP-SAP97 and Kv4.2 were
detectable at the plasma membrane in cells under both conditions. The
percentage of Kv4.2 immunostained fluorescence at the plasma membrane was
quantified for cells from each condition, and the data normalised, as shown in
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Figure 4.5E. This confirms that whilst the VAMP7 RNAiinhibited trafficking of
Kv4.2 in the presence of KChIP1-EYFP,it had noeffect on the ability of EGFP-
SAP97to stimulate this trafficking. This suggests SAP97/Kv4.2 is nottrafficked
via the non-conventional pathway characterised in Chapter3.
The above work used Kv4.2 expressed from a pcDNA constructdetected using
an anti-Kv4.2 antibody, and TRITC-conjugated secondary. However, an
antibody based approach can give high backgrounds in images. To try and
improve on this, andto aid in the clarity of images from triply transfected cells,
an mCherry-tagged version of Kv4.2 was prepared. As a first test of this
construct, HeLa cells were transfected with mCherry-Kv4.2 alone (Figure 4.6A).
The Kv4.2 waslocalised to the perinuclear region, a distribution matching that
seen with untagged Kv4.2 (as in Figure 3.1). The percentage of fluorescence in
the region of the plasma membrane wasquantified for these cells at around 9.7%,
similar to the results with untagged Kv4.2 in Figure 3.3. This quantification is
shown in Figure 4.6L. Next, HeLa cells were co-transfected with mCherry-Kv4.2
and KChIP1-EYFP (Figures 4.6B-D). As seen previously, the Kv4.2 was
localised to the plasma membranein thesecells, as was the KChIP1. Next, cells
were transfected with mCherry-Kv4.2 and EGFP-SAP97 (Figures 4.6E-G), and
although less clear than the images with KChIP1, it was still possible to see
regions of the plasma membrane with both EGFP-SAP97 and mCherry-Kv4.2
fluorescence. Finally, cells were triply transfected with mCherry-Kv4.2,
KChIP1-EYFP and EGFP-SAP97 (Figures 4.6H-K). Once again, cells
surprisingly showed none ofthe three proteins at the plasma membrane, with
them insteadall localised to an intracellular perinuclear region. The percentage
of mCherry-Kv4.2 at the plasma membrane was quantified for cells from all of
these conditions, as shown in Figure 4.6L. In this case, both the KChIP1
(p<0.01) and SAP97 (p<0.05) could significantly increase the levels of Kv4.2 at
the plasma membrane, although SAP97 was significantly less effective than
KChIP1 in this case (p<0.05). In contrast there was no significant increase in
Kv4.2 at the plasma membraneoftriply transfected cells. This supports the
finding with untagged Kv4.2 above that co-expression of SAP97 and KChIP1
inhibits the ability of either to promote Kv4.2trafficking.
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4.6: Trafficking of mCherry-Kv4.2 to the plasma membrane when expressed with
KChIP1-EYFP, EGFP-SAP97or both.
HeLacells were transfected with mCherry-Kv4.2, and either KChIP1-EYFP, EGFP-SAP97 or
both, and the levels of channeltrafficking to the plasma membrane were quantified. Scale bars
indicate 10m. Co-localisation is shown as yellow in colour overlays D and G, and white in
colour overlay K.
A) HeLa cell transfected with mCherry-Kv4.2.
B-D) HeLa cell transfected with KChIP1-EYFP (Green) and mCherry-Kv4.2 (Red).
E-G) HeLacell transfected with EGFP-SAP97 (Blue) and mCherry-Kv4.2 (Red).
H-K) HeLa cell transfected with EGFP-SAP97 (Blue), KChIP1-EYFP (Green) and
mCherry-Kv4.2 (Red).
L) Quantification of the percentage of mCherry-Kv4.2 at the plasma membrane in
cells from each condition. Data is shown as the means from 20 cells for each
condition, +S.E.M. The displayed p-values are relative to cells expressing Kv4.2
alone, or relative to cells expressing Kv4.2 and KChIP1-EYFP (shown bythe
black line).
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All of the proteins investigated are expressed in vivo in neurons. So next these
experiments were repeated in Neuro2A cells, to investigate any cell-type specific
effects. Again, cells were transfected with mCherry-Kv4.2, and either KChIP1-
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4.7: Trafficking of mCherry-Kv4.2 in Neuro2A cells when expressed with KChIP1-EYFP,
EGFP-SAP97or both.
Neuro2A cells were transfected with mCherry-Kv4.2, and either KChIP1-EYFP, EGFP-SAP97
or both, and the levels of channeltrafficking to the plasma membrane were quantified. Scale
bars indicate 10um. Co-localisation is shown as yellow in Figures C and F, andtriple co-
localisation as white in Figure J.
A-C) Neuro2Acell transfected with KChIP1-EYFP (Green) and mCherry-Kv4.2 (Red)
D-F) Neuro2Acell transfected with EGFP-SAP97 (Green) and mCherry-Kv4.2 (Red).
G-J) Neuro2A cell transfected with EGFP-SAP97 (Blue), KChIP1-EYFP (Green) and
mCherry-Kv4.2 (Red).
kK) Quantification of the percentage of mCherry-Kv4.2 at the plasma membrane in
cells from each condition. Data is shown as the means from 20 cells for each
condition, +S.E.M. The displayed p-values arerelative to cells expressing Kv4.2
alone, orrelative to cells expressing Kv4.2 and KChIP1-EYFP (shown bythe black
line).
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EYFP (Figures 4.7A-C), EGFP-SAP97 (Figures 4.7D-F) or both (Figures 4.7G-
J). mCherry-Kv4.2 wasclearly at the plasma membrane with KChIP1-EYFP,but
very little was visible at the plasma membrane with EGFP-SAP97. The EGFP-
SAP97 did show a clear plasma membranelocalisation. Unlike in HeLacells,all
three proteins were visible to some extent at the plasma membraneoftriple
transfected cells. However, the majority of protein fluorescence was visible in
the perinuclear region. This was quantified in terms of the percentage of
mCherry-Kv4.2 fluorescence at the plasma membrane (Figure 4.7K). In this cell
type, EGFP-SAP97 did not significantly increase the trafficking of Kv4.2 to the
plasma membrane. This could indicate a difference in the action of SAP97
between HeLacells and Neuro2Acells, although the SAP97 was localised to the
plasma membrane in both cell types. One possibility is that other proteins or
post-translational modifications in this cell type affect the interaction of SAP97
with Kv4.2. However, the inhibition of Kv4.2/KChIP1 trafficking in the presence
of SAP97 wasseen in this cell type. The quantification revealed that although
some Kv4.2 was at the plasma membranein the triply transfected cells, the
majority wasintracellular.
To extend upon this observation, it was decided to test the effects of KChIP2-
ECFP. This wasofinterest, because the results of Chapter 3 highlight differences
in the mechanisms oftrafficking of Kv4.2 between KChIP1 and KChIP2.
Although the data in Figure 4.5 confirmed that EGFP-SAP97 did not need the
non-conventional SNARE complex required by KChIP1, it was possible that
SAP97 wasaffecting the ability of KChIP1 to traffic Kv4.2 via this pathway.
Experiments with KChIP2-ECFP could shed light on how general the SAP97
effect is. Firstly, HeLa cells were transfected with mCherry-Kv4.2 and KChIP2-
ECFP (Figure 4.8A), and the Kv4.2 wasseen trafficked to the plasma membrane,
although not as clearly as with KChIP1. Next, HeLa cells were transfected with
mCherry-Kv4.2, KChIP2-ECFP and EGFP-SAP97(Figure 4.8B), and as seen in
the experiments with KChIP1 above, all three proteins were co-localised within
the cell, with little to no Kv4.2 at the plasma membrane. However, much more of
the KChIP and SAP97 wasseen to be retained at the plasma membrane than in
the experiments with KChIP1 above. The same two experiments were repeatedin
Neuro2Acells, with a doubly transfected cell shown in Figure 4.8C,and a triply
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4.8 Trafficking of mCherry-Kv4.2 with KChIP2-ECFPin the absence or presence of EGFP-SAP97.
Both HeLa and Neuro2Acells were co-transfected with mCherry-Kv4.2 and KChIP2-ECFP,
with or without EGFP-SAP97. The trafficking of Kv4.2 to the plasma membrane was
quantified. Scale bars represent 10m. Co-localisation is shown in yellow in Figures A and C,
and white in Figures B and D.
A) HeLacell expressing KChIP2-ECFP (Green) and mCherry-Kv4.2(Red).
B) HeLacell expressing EGFP-SAP97 (Blue), KChIP2-ECFP (Green) and mCherry-Kv4.2
(Red).
C) Neuro2Acell expressing KChIP2-ECFP (Green) and mCherry-Kv4.2 (Red).
D) Neuro2A cell expressing EGFP-SAP97 (Blue), KChIP2-ECFP (Green) and mCherry-
Kv4.2 (Red).
The percentage of mCherry-Kv4.2 fluorescence at the plasma membrane was quantified for
20 cells from each condition, shown for HeLa cells in E) and Neuro2A cells in F). Data
shown is the means +S.E.M.p-values are shown relative to cells expressing mCherry-Kv4.2
alone,orrelative to the doubly transfected cells (shown bythe black line).
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transfected cell shown in Figure 4.8D. Again, the KChIP2 and Kv4.2 channel
were at the plasma membrane in the doubly transfected cells, but all three
proteins were mostly perinuclear in the triply transfected cells. The normalised
trafficking of mCherry-Kv4.2 to the plasma membrane was quantified for both
HeLacells (Figure 4.8E) and Neuro2A cells (Figure 4.8F). This confirmed the
inhibition in Kv4.2 trafficking in the triple transfected cells compared to those
| expressing Kv4.2 with KChIP2. It also highlighted the independence of this
inhibition from the non-conventional trafficking pathway utilised by KChIP1. It
maytherefore have a potentially wider importance,as it mayaffecttraffic in cells
expressing SAP97 along with either KChIP1 or KChIP2.
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4.2.3 Interactions between Kv4.2/KChIP1land PSD-93 and PSD-95
The work above had confirmed the ability of EGFP-SAP97 to promote the
trafficking of Kv4.2 to the plasma membrane, and suggested a novel inhibitory
action when in a ternary complex of Kv4.2, SAP97 and KChIP1/2. However,
whilst interactions between Kv4 channels and SAP97 or PSD-95 are known in
the literature (Gardoni et al. 2007; El-Haouetal. 2009), there has been less work
on the related protein PSD-93.In particular, there are a large number of PSD-93
isoforms (Parker et al. 2004), but little is known about any isoform specific
effects they may have, even though they appear to have different intracellular
localisation signals (Parker et al. 2004). There were several questions ofinterest
to be addressed. Is PSD-93 able to promotethetrafficking of Kv4.2 to the plasma
membrane? Does the co-expression of PSD-93 with Kv4.2 and KChIP1 prevent
channeltrafficking, as was seen with SAP97? Do the different isoforms of PSD-
93 give different effects in these experiments? Is the localisation of PSD-93
altered in triply transfected cells, as was seen with SAP97 above? Finally, is
there any similarity with the better characterised PSD-95?
To begin with, HeLa cells were transfected with mCherry-Kv4.2, and GFP-
tagged versions of PSD-93 in the absence or presence of KChIP1-EYFP. Typical
cells from these experiments are shown in Figure 4.9, with cells expressing the 5
isoform in Figures 4.9A and B,the ¢ isoform in 4.9C and D,andthe ¢ isoform in
4.9E and F. In the doubly transfected cells (Figures 4.9A, C and E), both the
GFP-tagged PSD-93 isoforms and the mCherry-Kv4.2 were found intracellularly,
with the Kv4.2 showing a perinuclear localisation similar to that seen whenit is
expressed alone (e.g. Figure 4.6A). This shows that unlike SAP97, these three
isoforms of PSD-93 cannot promote the trafficking of Kv4.2 to the plasma
membrane. Moreover,in the triply transfected cells (Figures 4.9B, D and F), the
PSD-93-GFP, mCherry-Kv4.2 and KChIP1-EYFPareall retained within thecell,
in the perinuclear region. The trafficking of mCherry-Kv4.2 to the plasma
membranein 20 cells from each condition was quantified, and is shown in Figure
4.9G. This confirms that the isoforms of PSD-93 are unable to promote the
trafficking of mCherry-Kv4.2, as there is no significant difference in plasma
membranefluorescence between cells expressing mCherry-Kv4.2 alone, or with
the three isoforms of PSD-93-GFPtested. It also confirms that each of
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4.9: HeLa cells transfected with mCherry-Kv4.2 and isoforms of PSD-93-GFP, in the
absence or presence of KChIP1-EYFP.
HeLacells were transfected with mCherry-Kv4.2 and isoforms of PSD-93-GFP,but this did not
significantly stimulate channel trafficking. Cells were also co-transfected with KChIP1-EYFP
and the PSD-93 prevented the stimulation of Kv4.2 trafficking by KChIP1.
A,C,E) HeLacells co-transfected with an isoform of PSD-93-GFP as shown (Green)
and mCherry-Kv4.2 (Red). Co-localisation is shown as yellow in the colour
overlays. Scale bars represent 10um.
B,D, F) HeLa cells co-transfected with KChIP1-EYFP (Green), an isoform of PSD-93-
GFP as shown (Blue) and mCherry-Kv4.2 (Red). Triple co-localisation is
shown as white in the colour overlays. Scale bars represent 10m.
G) Quantification of the percentage of mCherry-Kv4.2 at the plasma membranefor
cells from each condition shown above. 5,¢,¢ = PSD93-GFP isoform ofthat
name. Data shownis the mean of 20 cells, +S.E.M.
the tested PSD-93 isoformsis able to inhibit the trafficking of mCherry-Kv4.2 to
the plasma membrane when expressed with KChIP1-EYFP. These results are
particularly interesting. They confirm that different members of the PSD-95
family of MAGUKproteins have different roles and interacting partners, as
SAP97can bind or influence Kv4.2, whilst these isoforms of PSD-93 cannot. In
addition, no isoform specific effects were seen with the three forms of PSD-93
tested, as all three isoforms wereable to alter the localisation of mCherry-Kv4.2
and KChIP1-EYFPin triply transfected cells. This may reflect the ability of these
proteins to form a ternary complex, or for the PSD-93 to bind the KChIP1. It also
supports the findings with SAP97 presented above, and may reflect a more
general mechanism of Kv4.2 trafficking inhibition in cells expressing both a
KChIP and a PSD-95 family member. As further confirmation, these experiments
with PSD-93-GFP, mCherry-Kv4.2 and KChIP1-EYFP were also repeated in
Neuro2A cells, which gave similar results (data not shown).
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4.10: HeLacells expressing PSD-935-GFP with KChIP1, or KChIP1 and Kv4.2.The localisation of PSD-935-GFP in HeLacells was investigated when expressed alone, orwith KChIP1-EYFP,or with both KChIP1-EYFP and mCherry-Kv4.2.
A) HeLacell transfected with PSD-935-GFPalone.
B) HeLacell co-transfected with PSD-935-GFP (Red) and KChIP1-EYFP (Green). Co-
localisation is shown asyellow in the colour overlay.
C) HeLacell co-transfected with PSD-935-GFP (Blue), KChIP1-EYFP (Green), and
mCherry-Kv4.2 (Red). Triple co-localisation is shown as white in the colour
overlay.
In all images, scale bars represent 10um.
Oneinteresting aspect of the above work wasthe observation that although both
PSD-93 and Kv4.2 were localised to the perinuclear region when co-expressed,
they did not completely co-localise. In addition, co-expression had no functional
effect. This suggested that the two proteins did not interact. However, in triply
transfected cells, the PSD-93 was able to prevent Kv4.2/KChIP1 trafficking to
the plasma membrane, suggesting some kind of interaction. One possibility,
therefore, is that the PSD-93 interacts with KChIP1. To investigate this, it was
decided to concentrate on just one of the isoforms used above, as all three
seemed to have broadly similar effects under these experimental conditions.
Therefore, HeLa cells were transfected with either PSD-933-GFP alone (Figure
4.10A), with KChIP1-EYFP (Figure 4.10B), or with both KChIP1-EYFP and
mCherry-Kv4.2 (Figure 4.10C). The PSD-935-GFP alone showed a bright,
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diffuse intracellular localisation, particularly around the nucleus. This was
perhaps surprising for a protein thought to exert its effects at the plasma
membrane of the post-synaptic density (Parker et al. 2004; DeGiorgis etal.
2006). Interestingly, the distribution was altered in the presence of KChIP1-
EYFP. The KChIP1-EYFP showeda punctate distribution as expected. However,
the PSD-935-GFP was also more punctate in these cells, and there was at least
partial co-localisation between the KChIP1-EYFP and PSD-935-GFP. In the
triple transfected cells, all three proteins were intracellular, as seen previously,
with none of them associated with the plasma membrane. The change in PSD-
936 localisation when co-expressed with KChIP1, and their co-localisation,
suggests an interaction between PSD-935 and KChIP1-EYFP. This interaction
could give rise to the lack of Kv4.2 trafficking in thetriply transfected cells. In
support of this, both the PSD-93 and KChIP1 also appeared topartially co-
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4.11: The localisation of PSD-935-GFP in Neuro2Acells.
The localisation of PSD-935-GFP in Neuro2A cells was investigated when expressed alone, or
with KChIP1-EYFP,or with both KChIP1-EYFP and mCherry-Kv4.2.
A) Neuro2A cell transfected with PSD-935-GFP alone.
B) Neuro2A cell co-transfected with PSD-935-GFP (Red) and KChIP1-EYFP (Green).
Co-localisation is shown as yellow in the colour overlay.
C) Neuro2Acell co-transfected with PSD-935-GFP (Blue), KChIP1-EYFP (Green), and
mCherry-Kv4.2 (Red). Triple co-localisation is shown as whitein the colour overlay.
In all images,scale bars represent 10um.
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localise in punctae in the triply transfected cells. The mechanisms underlying this
are unclear however, and the significance of such an interaction in vivo will need
further investigation.
This experiment was also repeated in Neuro2A cells, and interestingly, some
differences were observed. Figure 4.11A showsa cell expressing PSD-935-GFP
only, with the protein showing a diffuse intracellular localisation, with the
brightest signal seen in the perinuclear region. This was less bright and less
clustered than in the HeLa cells above, but generally showed a similar
distribution. Figure 4.11B showsa cell co-transfected with both PSD-935-GFP
and KChIP1-EYFP. As with the HeLa cells above, the KChIP1-EYFP was
punctate in distribution, and the PSD-935-GFP was co-localised with the
KChIP1-EYFP in these perinuclear punctae. Figure 4.11C showsa cell triple
transfected with PSD-935-GFP, KChIP1-EYFP and mCherry-Kv4.2. All three
proteins were co-localised in the perinuclear region ofthese cells. In particular,
the PSD-935-GFP in the triply transfected cells was mainly in the perinuclear
region, clearly co-localised with some of the KChIP1-EYFP,and notdiffuselike
in Figure 4.11A. This would again suggest an interaction between the KChIP and
PSD-93. However,all three proteins were also visible at the plasma membrane.
This is similar to the experiments with SAP97 in Neuro2A cells shown abovein
Figure 4.7. This plasma membrane localisation was especially prominent for
KChIP1 and Kv4.2. This suggests that any inhibitory action of members of the
PSD-95 family on Kv4.2/KChIP1-EYFPtrafficking may be less significant in
Neuro2A cells than in HeLacells.
The above work suggested an interaction between KChIP1 and SAP97 or PSD-
93. It is already known in the literature that PSD-95 can interact with Kv4.2
channels (Gardoni et al. 2007). However, as with the other PSD-95 family
proteins, potential interactions with the KChIPs have not been investigated.
Therefore, HeLa cells were transfected with either mCherry-PSD-95 alone
(Figure 4.12A), or with KChIP1-EYFP (Figure 4.12B). However, unlike PSD-
93, PSD-95 wasat least partially associated with the plasma membrane even
when expressed alone. When co-expressed with KChIP1-EYFP, the KChIP1
retained its usual punctate perinuclear distribution. The PSD-95 also showed a
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4.12: The localisation of mCherry-PSD-95 in HeLacells, in the absence and presence ofKChIP1-EYFP.
HeLacells were transfected with mCherry-PSD-95, either alone, or with KChIP1-EYFP.
The percentage of mCherry-PSD-95 fluorescence at the plasma membrane wasquantified.
Scale bars represent 10um.
A) HeLa cell transfected with mCherry-PSD-95. Someprotein was seen localised at
the plasma membrane.
B) HeLacell co-transfected with KChIP1-EYFP (Green) and mCherry-PSD-95 (Red),
with co-localisation shownin yellowin the colour overlay. The PSD-95is seen at
the plasma membrane.
C) Quantification ofthe mean percentage of mCherry-PSD-95at the plasma
membranein 20 cells from each condition, +S.E.M. Co-expression with KChIP1-
EYFPhadnosignificant effect on PSD-95 localisation.
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low level of perinuclear distribution, similar to in the control cell, whilst
retaining its plasma membranelocalisation. The data from 20 cells for each
condition were quantified as shown in Figure 4.12C. This confirms than co-
expression with KChIP1 has no effect on PSD-95 localisation. This experiment
wasalso repeated in Neuro2Acells, and gave the sameresults (data not shown).
The fact that PSD-95 and KChIP1 are mostly found in separate compartments of
the cell suggests that they may not interact in vivo. Nor did KChIP1 promote
internalisation of PSD-95, as was seen for SAP97in triply transfected cells in
Figures 4.4G-J. However, these experiments do not preclude a low level of
interaction between PSD-95 and KChIP1. More direct investigations would be
required to confirm orrefute this.
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4.2.4 Interactions between SAP97 and KChIP1
Whencells weretriply transfected with Kv4.2, SAP97-GFP and KChIP1-EYFP,
it was noticed that SAP97-GFPwaslocalised to the perinuclear region within the
cell, as opposed to a plasma membrane localisation when expressed with just
Kv4.2. SAP97-GFP could also promote thetrafficking of Kv4.2 to the plasma
membrane when they were co-expressed, as could KChIP1, but when all three
were co-expressed, this trafficking was inhibited. This suggested that there was
an interaction between SAP97 and KChIP1, and it was this that prevented the
trafficking of Kv4.2 by either of these accessory proteins. The potential for this
interaction with SAP97 to be importantin regulating Kv4 trafficking madeit of
Overlay 
4.13: The localisation of EGFP-SAP97 in HeLacells in the presence of KChIP1.
HeLa cells were transfected with EGFP-SAP97, either alone, or in the presence of two
forms of KChIP1.
A) HeLa cell transfected with EGFP-SAP97 alone, which showed somelocalisation
to the plasma membrane.
B-D) HeLacell co-transfected with EGFP-SAP97 (Red) and KChIP1-EYFP (Green).
Co-localisation is shown as yellow in the colour overlay.
E)  HelLacell co-transfected with EGFP-SAP97 and KChIP1 pcDNA.
In all images, the scale bar represents 10um.
134
interest and it was therefore investigated in moredetail.
To begin with, HeLa cells were transfected with EGFP-SAP97 alone (Figure
4.13A). This confirmed that EGFP-SAP97 in these cells was at least partially
associated with the plasma membrane. This matched the localisation seen in cells
co-transfected with Kv4.2, as seen in Figure 4.4 above. This suggests that any
interaction between SAP97 and Kv4.2 is not responsible forits internalisation in
triply transfected cells. Furthermore, when cells were co-transfected with
KChIP1-EYFP (Figures 4.13B-D), the EGFP-SAP97 wasnolonger seen at the
plasma membrane. KChIP1-EYFP showeda typical punctate distribution, and
this was now at least partially matched by the distribution of EGFP-SAP97.
However, the EYFP and GFP emission spectra are very close. To confirm that
the partial co-localisation was not due to bleed through between the KChIP1-
EYFP signal and the GFP channel, the experiment was also repeated with
untagged KChIP1 (Figure 4.13E). Once again, the SAP97 was no longerat the
plasma membrane, and showed a punctate, perinuclear distribution, similar to
that seen with the tagged KChIP1. These data suggest an interaction between the
two proteins, that may also be responsible for the changein distribution seen in
the triply transfected cells in Section 4.2.2.
As this was an unexpected result, these experiments were repeated in Neuro2A
cells, to test the effects in a neuronal background. As was seen in HeLacells, a
Neuro2A cell transfected with EGFP-SAP97 alone (Figure 4.14A) showed the
protein localised to the plasma membrane. When co-transfected with KChIP1-
EYFP (Figures 4.14B-D), much less EGFP-SAP97 was seen at the plasma
membrane. Instead, some of the EGFP-SAP97 wasvisible in perinuclear punctae
that co-localised with KChIP1-EYFP. This supports the data from HeLa cells
suggesting an interaction between SAP97 and KChIP1. However, some EGFP-
SAP97 did remain at the plasma membraneinthis cell type. This could reflect a
reduced level of interaction between KChIP1 and SAP97 in this cell type, or
perhapsa higher level of SAP97 expression compared to KChIP1.
The above experiments suggested an interaction between KChIP1 and SAP97,
and it seemedlikely that this could be contributing to the inhibition of Kv4.2 and
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4.14: The localisation of EGFP-SAP97 in Neuro2Acells in the presence of KChIP1-EYFP.
Neuro2A cells were transfected with EGFP-SAP97, either alone, or in the presence of
KChIP1-EYFP.
A) Neuro2A cell transfected with EGFP-SAP97 alone, which showed somelocalisation
to the plasma membrane.
B-D) Neuro2Acell co-transfected with EGFP-SAP97 (Red) and KChIP1-EYFP (Green).
Co-localisation is shown asyellow in the colour overlay.
In all images, the scale bar represents 10pm.
 
  KChIP2 Overlay4.15: The localisation of EGFP-SAP97in HeLacells in the presence of KChIP2.
HeLa cells were transfected with EGFP-SAP97, either alone, or in the presence of KChIP2-
ECFP.
A) HeLacell transfected with EGFP-SAP97alone, which showed somelocalisation to the
plasma membrane.
B-D) HeLacell co-transfected with EGFP-SAP97 (Red) and KChIP2-ECFP (Green). Co-
localisation is shown as yellow in the colour overlay.
In all images, the scale bar represents 10um.
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KChIP1 trafficking in the presence of SAP97. In Section 4.2.2 it was shown that
cells transfected with EGFP-SAP97, mCherry-Kv4.2 and KChIP2-ECFP also
showed this reduction in channel trafficking. It was therefore possible that
SAP97 could also be interacting with KChIP2. Experiments were therefore
performed in HeLacells to see what effect co-expression of KChIP2 had onthe
localisation of EGFP-SAP97. Figure 4.15A shows a control cell expressing
EGFP-SAP97 alone, and as expected from the experiments above, this was
localised to the plasma membrane. Next, cells were co-transfected with EGFP-
SAP97 and KChIP2-ECFP (Figures 4.15B-D) and the EGFP-SAP97 wasalso
localised to the plasma membrane, as was the KChIP2-ECFP. This work was
also repeated in Neuro2A cells, with the same results (data not shown). The
absence of a change in localisation may well be because KChIP2 is plasma
membrane associated in cells (see Figure 3.02D). Therefore, the SAP97 and
KChIP2 mayin fact be interacting, but remaining at the plasma membrane. This
will need confirming by other, more direct biochemical methods. However,if
these proteins do interact, it could also explain why SAP97 and KChIP2 remain
at the plasma membrane in triple transfected cells, whilst the Kv4.2 is
intracellular. This would not be observed with KChIP1,as this appearsto interact
with SAP97 in KChIP1-positive punctate vesicles in the perinuclear region.
These data also suggest that the lack of Kv4.2 trafficking may be due to the
interaction of the SAP97 with the KChIP,resulting in both of these proteins
being unable to bind the channel, and thus being unable to promote its
trafficking.
Having shown this potential interaction, it was interesting to investigate ways in
which it might be regulated by the cell. The KChIPsare calcium sensor proteins,
as discussed in Chapter 3. One intriguing area for an initial study was whether
the calcium binding EF-hand domains of KChIP1 needed to be functional and
able to bind to Ca”* in order for the KChIP to interact with SAP97. The two EF-
hand mutant versions of KChIP1 used in Chapter 3 were also used here. These
experiments were performed in both HeLa (Figures 4.16A and B) and Neuro2A
cells (Figures 4.16C and D), to comparethe effects of a neuronal background on
protein localisation. Figures 4.16A and C showcells transfected with EGFP-
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SName BS Overlay 4.16: Cells expressing EGFP-SAP97 with EF-hand mutants of KChIP1-EYFP.Both HeLa and Neuro2A cells were transfected with EGFP-SAP97 and one of two EF-hand
mutants of KChIP1-EYFPto assess the requirement for KChIP1 to have intact EF-hands in order
to influence the localisation of EGFP-SAP97.
A) HeLacell co-transfected with EGFP-SAP97 (Red) and KChIP1-EF3-EYFP(Green).
B) HeLacell co-transfected with EGFP-SAP97 (Red) and KChIP1-EF2-4-EYFP (Green).
C) Neuro2A cell co-transfected with EGFP-SAP97 (Red) and KChIP1-EF3-EYFP (Green).
D) Neuro2A cell co-transfected with EGFP-SAP97 (Red) and KChIP1-EF2-4-EYFP
(Green).
In all images,the scale bar represents 10m. Co-localisation is shown as yellowin the colour
overlays.
138
SAP97 and KChIP1-EF3-EYFP, and Figures 4.16B and D show cells co-
transfected with SAP97-GFP and KChIP1-EF2-4-EYFP. In all cases, the
KChIP1-EYFP waslocalised to perinuclear punctae. This was as expected, as the
EF-hand mutants of KChIP1 show the same punctate distribution as the wild-
type protein (Figure 3.5). However, the SAP97-GFP also showed a punctate
distribution, and the colour overlays showed co-localisation between the SAP97
and KChIP1 mutants. This is different from the plasma membrane localisation of
SAP97-GFP when expressed alone (Figure 4.13). This suggests that the EF-hand
mutants of KChIP1 are able to bind to SAP97, thusaltering its localisation, as
does wild-type KChIP1 (see Figures 4.13 and 4.14). It therefore seemsthatthis
interaction is not dependent on KChIP1 binding to Ca”. Generally, the
localisation of the two proteins was similar in both the HeLa and Neuro2Acells.
One difference, however, was that some SAP97-GFP remainedlocalised to the
plasma membranein the Neuro2Acells in the presence of either KChIP1 mutant.
This was also seen with wild-type KChIP1-EYFP (Figure 4.14), supporting the
idea that there may beless interaction between KChIP1 and SAP97in this cell
type. The reasons for this remain unclear.
Finally, to try and confirm this potential interaction between SAP97 and KChIP1
a numberofbiochemical interaction experiments were performed. Samples from
the pull-down experiments shown in Figure 4.3 were blotted to see if GST-
KChIP1 could bind SAP97 in bovine brain cytosol. In addition, radio-labelled
SAP97 was produced by in vitro transcription/translation experiments, and
interaction studies performed with GST-KChIP1. Finally, immunoprecipitation
experiments were performed using lysates from HeLa cells transfected with
SAP97-GFP and KChIP1 pcDNA,and antibodies against these twoproteins.It
wasnot possible to show a convincing interaction between SAP97 and KChIP1
using any of these methods. Further work will therefore be needed to show
whether such a direct or indirect interaction does in fact occur.
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4.3 Discussion
There are many proteins that can regulate the trafficking of Kv4 potassium
channels to the plasma membrane (see Chapter 1.4.2). This trafficking is a key
step for the regulation of neuronal A-type currents, and hence synapticplasticity,
learning and memory (An etal. 2000; Chenet al. 2006(2); Lauveretal. 2006).
The discovery of novel regulators of Kv4 trafficking, as well as an understanding
of how such regulators can exert their effects, is therefore important for our
knowledge of brain function at a cellular and molecular level. In particular,it is
becomingincreasingly clear that manyofthese proteins bind to Kv4 channels at
the same time and can have their effects modified by binding within such a
complex (Jerng et al. 2005). The interactions between KChIP1 and two protein
families, the 14-3-3 proteins and the PSD-95 family, were investigated in this
thesis.
The technique of yeast two-hybrid screens to look for novel protein interactions
has become increasingly popular, particularly because their high-throughput
nature allows for the testing of many potential target proteins (Bruckneretal.
2009). However, they can give false-positive results, and so all potential
interactions need to be verified by alternative means (Sanderson 2009). The
identification of 14-3-3y as a potential binding partner of KChIP1 in one such
screen seemed highly plausible, as both proteins are known to have roles in
regulating ion channeltrafficking (An et al. 2000; O’Kelly et al. 2002; Rajan et
al. 2002). There is no evidence of a direct interaction between 14-3-3 proteins
and the Kv4 channels in the literature, and so it was possible that 14-3-3y could
affect Kv4.2 trafficking by bindingto its accessory protein KChIP1. In support of
this, Figure 4.1 revealed co-localisation between KChIP1-EYFP and endogenous
14-3-3y detected by antibodies. However, assays with GST-KChIP1 and bovine
brain cytosol (Figure 4.3) did not pull down either 14-3-3y or an alternate
isoform 14-3-3B. The yeast two-hybrid interaction could therefore be due to a
false positive identification. Alternatively, the interaction could be specific for
another 14-3-3 isoform, although this seems unlikely, as all hits seen for 14-3-3
proteins in the yeast two-hybrid screen were for the y-isoform (Dr L. Haynes,
University of Liverpool, personal communication). The use of other biochemical
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binding assays, such as co-immunoprecipitation, could also help to investigate
this potential interaction further.
The second family of potential KChIP1/Kv4.2 interacting proteins investigated in
this thesis was the PSD-95 family of MAGUKproteins. These neuronal proteins
contain many protein binding domains, allowing them to scaffold together
several binding partners (Kim and Sheng 2004). This could bring downstream
regulators nearer to receptors at the plasma membrane, orlink proteins to the
cytoskeleton (Feng and Zhang 2009). They are perhaps best known for their
ability to cluster AMPA and NMDAreceptors in the post-synaptic density of
neurons (Kim and Sheng 2004; Batset al. 2007). It is thus likely that they have
some role in regulating Kv4 channeltrafficking, as these channels also require a
specific dendritic localisation (Birnbaum et al. 2004). Indeed, previous work has
suggested that both SAP97 and PSD-95 can bind Kv4 channels, and influence
their trafficking (Gardoni et al. 2007; El-Haouet al. 2009). It was SAP97 that
was particularly interesting for this study, as this seems to be more associated
with promotingor inhibiting trafficking, rather than just clustering proteins at the
plasma membrane (El-Haou et al. 2009). However, in some experiments the
response of Kv4.2 to SAP97 was examined in cells stably transfected with
KChIP2 (El-Haou et al. 2009), making it difficult to determine the separate
contributions of these two accessory proteins. A first step, therefore, was to
confirm that SAP97 could promote thetrafficking of Kv4.2 to the plasma
membrane. This was indeed the case in HeLacells, for both untagged Kv4.2
immunostained with anti-Kv4.2 antibodies, and an mCherry-tagged version of
the channel (Figures 4.4 and 4.6). These experiments also confirmed that the
tagged version of the channel showed the same localisation as untagged Kv4.2,
and had the same response to KChIP1-EYFP, validating its use in further
experiments. It should be noted that with the mCherry-Kv4.2, the EGFP-SAP97
was less effective at promoting the trafficking of the channel to the plasma
membrane than KChIP1 (Figure 4.6), suggesting that the KChIPs may be more
important regulators of trafficking in HeLa cells. This would be consistent with
the smaller size of electrophysiological effects seen with SAP97 (El-Haouetal.
2009) compared to those seen in other experiments with the KChIPs (An etal.
2000). However, the EGFP-SAP97still had a significanteffect, suggesting thatit
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should be considered a possible regulator of Kv4 channels, alongside those
discussed in Section 1.4.
In Chapter 3 it was shown that the trafficking of Kv4.2 by KChIP1 was via a
non-conventional pathway, requiring the SNARE proteins VAMP7and Vtila.
Having confirmed that SAP97 could also promote Kv4.2 trafficking, it was of
interest to determine whether it also occurred via this non-conventional route.
Figure 4.5 shows the effects of VAMP7 RNAi on the trafficking of untagged
Kv4.2 with either KChIP1-EYFP or EGFP-SAP97. Whilst the VAMP7 RNAi
could inhibit trafficking with KChIP1 as seen previously, it had no effect on
trafficking of the channel with EGFP-SAP97. This confirms that EGFP-SAP97
does not promote the trafficking of the Kv4.2 channel to the plasma membrane
via the same non-conventional pathway as KChIP1. It is, therefore, likely to
utilise the conventional COPII-coated vesicle pathway (Glick 2000), and this
could be confirmed by experiments with either Sec22 RNAi(Xuetal. 2000), or a
Sarl dominant negative mutant (Hasdemir et al. 2005). Whichever exocytic
pathwayis used,it is clear that EGFP-SAP97 can abolish the Golgi localisation
seen when the channelis expressed alone (O’Callaghan et al. 2003; Hasdemiret
al. 2005). This suggests that an interaction between SAP97 and Kv4.2 may be
occurring somewhereat or before the Golgi apparatus, even though the SAP97is
generally localised to the plasma membrane (Figure 4.13). This highlights an
important intracellular and trafficking role for SAP97, as has been discussed
elsewherein the literature (Horio et al. 1997; Tiffany et al. 2000; El-Haouetal.
2009), in addition to its role of clustering and scaffolding at the plasma
membrane(Horioetal. 1997).
A surprising finding was the inability of SAP97 to significantly promote Kv4.2
trafficking to the plasma membrane in Neuro2Acells, even though these should
be a better model cell type for neurons where these proteins are expressed in
vivo. These experiments (Figure 4.7) were performed with mCherry-tagged
Kv4.2, and this waslessefficiently trafficked to the plasma membrane by SAP97
in HeLa cells than the untagged form of the channel. It may be that this
difference is simply more marked in Neuro2Acells. Alternatively,it is possible
that the results reflect real differences between thecell types used. This could
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include different post-translational modifications of the proteins, affecting their
ability to interact. In particular, phosphorylation oftarget proteins is knownto be
a general mechanism for the regulation of MAGUKinteractions (Kim and Sheng
2004; Gardoni et al. 2007). Other proteins expressed by this cell type could also
possibly influence the interactions. It would, therefore, be interesting to carry out
further experiments to confirm this cell-specific difference. For example, does
SAP97 interact with Kv4.2 in co-immunoprecipitation experiments using
Neuro2A cell lysates? Also, could a non-phosphorylatable mutant of either
protein restore their interaction and trafficking?
Perhaps the most surprising and intriguing result of this chapter was the
observation that whilst either SAP97 or KChIP1 alone promoted Kv4.2
trafficking to the plasma membrane, when expressed together, all proteins
appeared trapped within intracellular compartments. That is, the co-expression of
SAP97 with KChIP1 seemed to antagonise the trafficking ability that either
protein has when expressed alone with Kv4.2. This occurred for both tagged and
untagged Kv4.2, and in both HeLa and Neuro2A cells (Figures 4.4, 4.6 and 4.7).
In addition, the trafficking of Kv4.2 by KChIP2 was also suppressed by co-
expression with SAP97 in both cell types used. These experiments were
important for several reasons. Firstly, KChIP2 does not require the same non-
conventional pathway as KChIP1, so it is clear SAP97 is not havinga specific
effect on that pathway. In addition, the SAP97 does not traffic Kv4.2 via a
VAMP7-dependent pathway, and yet its ability to traffic the channelis also lost
in the triply transfected cells. Moreover, whilst KChIP1 and SAP97are localised
intracellularly with Kv4.2 in the triple transfected cells (e.g. Figures 4.4G-J),
much of the KChIP2 and SAP97arestill localised to the plasma membrane in
triply transfected cells (e.g. Figure 4.8B). The most plausible explanation forthis
is that the SAP97 and KChIPs interact, and this prevents their interaction with
the Kv4.2 channel. In the case of KChIP1, this could occur in the intracellular
punctate vesicles where KChIP1 localises when expressed alone. KChIP2, on the
other hand, is associated with the plasma membrane, as is SAP97, and so their
interaction could occur there. An interesting area for further study would be to
investigate KChIPs 3 and 4, to see if SAP97 also prevented them from
stimulating traffic of Kv4 channels to the plasma membrane,and also where the
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three proteins localise. It seems, however, that further studies into the trafficking
of Kv4 channels need to investigate the combined effects of several regulatory
proteins to determinetheir full effects in cells. This is potentially of importance,
as the expression of SAP97 is widespread throughoutthe brain and myocardium
(Mulleret al. 1995; El-Haouetal. 2009),soit is likely that it will be expressedin
cells that are also expressing Kv4.2 and a KChIP. Thefindings also raise many
questions. If this co-expression of SAP97 prevents Kv4.2 trafficking to the
plasma membrane, there may be someregulation of this when neurons require
trafficking of the channel. This could for example be via phosphorylation,
altering the binding of SAP97, by changing calcium levels sensed by the KChIP,
or by someothersignalling mechanism. Understandingthis will be vital to fully
comprehendinganyrolefor this interaction in vivo.
As well as SAP97 having effects on both KChIP1 and 2, there are effects with
other members of the PSD-95 family. Unlike SAP97, the three isoforms of PSD-
93 that were tested could not promote thetrafficking of Kv4.2 to the plasma
membrane in HeLacells. They could, however,all prevent the trafficking of
KChIP1/Kv4.2 to the plasma membranein triply transfected HeLa cells (Figure
4.9). It seemslikely, therefore, that this inhibitory interaction is a general feature
of all KChIPs andall PSD-95 family members although more experiments would
be required to fully confirm this. It does at least seem likely that there is a shared
mechanism for this inhibitory action. Again, the most likely seems to be a direct
interaction between certain PSD-95 family members and KChIP1 that prevents
the KChIP from interacting with the channel. In support ofthis, experiments with
the 6-isoform of PSD-93 revealed that when it was expressed alone it was
diffusely intracellular in localisation, but when co-expressed with KChIP1-
EYFP, became punctate and co-localised with the KChIP1, in both HeLa and
Neuro2Acells (Figures 4.10 and 4.11). This would suggestthat the expression of
KChIP1 in these cells was ableto alter the localisation of the PSD-93, through
somekind ofinteraction. The related protein PSD-95 was also investigated. This
showed a plasma membrane localisation both in the presence and absence of
KChIP1 (Figure 4.11), and the two proteins showed a very low level of co-
localisation. This could indicate that binding to the KChIPsis specific to some
members of the PSD95-family. Alternatively, interactions could be occurring,
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that havelittle effect on the distribution of PSD-95. An important first step in any
future work would therefore be to confirm if there are any interactions between
KChIP1 and PSD-93 or PSD-95. This would best be achieved through direct
binding assays.
PSD-936 co-localised with KChIP1 in doubly transfected Neuro2A cells (Figure
4.11), as it did in HeLa cells (Figure 4.10). However, there were differences in
the localisation ofproteinsin thetriply transfected cells. Whilst all three proteins
were co-localised and intracellular in HeLacells (Figure 4.10), in Neuro2A cells,
some of each protein was present at the plasma membrane (Figure 4.1 1). This
wasparticularly noticeable for KChIP1 and Kv4.2, but was also the case for
PSD-936. This is similar to the experiments with SAP97 in triply transfected
Neuro2A cells (Figure 4.7), where more protein was plasma membrane
associated than in triply transfected HeLacells. There are several possibilities for
why these two cell types should show differing effects. One is that the relative
expression level of proteins in the two cell types may not be the same. For
example, KChIP1 may be expressed at a higher level than PSD-935. Whilst
much of the KChIP1 would therefore be bound to the PSD-938 and unable to
bind the Kv4 channel, the higher expression level would mean some would be
free to bind the Kv4.2 channel andtraffic it to the plaama membrane. Another
possibility is that the other proteins or signalling cascades in Neuro2A cells may
inhibit the interaction of the SAP97/PSD-93 with KChIP1, thus explaining why
some KChIP1 is able to traffic Kv4.2 to the membrane.It will obviously be
important to characterise such differences in future work, for example, by
comparing results using primary neurons, as the Neuro2A cells should be more
representative of neuronal cells where these proteins would be expressed
together.
The work discussed suggested that some members of the PSD-95 family of
proteins might be able to interact directly with the KChIPs. The clearest effects
had been seen with SAP97, and so this was investigated morefully. Firstly,
EGFP-SAP97 under these experimental conditions was associated with the
plasma membranein both HeLa and Neuro2A cells (Figures 4.13A and 4.14A).
This was also the localisation seen in cells expressing SAP97 with Kv4.2 (e.g.
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Figures 4.4D-F). It was therefore interesting to ask whether the co-expression of
EGFP-SAP97 with KChIP1 would lead to an interaction, and a change in the
localisation of SAP97 away from the plasma membrane, as seen in triply
transfected cells. This was indeed the case, in both HeLa and Neuro2A cells
(Figures 4.13 and 4.14). The punctate distribution of SAP97 in these cells, co-
localised with KChIP1-EYFP, is highly suggestive of a SAP97/KChIP1
interaction. An untagged version of KChIP1 was also used in HeLacells (Figure
4.13E), to ensure that there were no effects due to bleed through of the
fluorescence between EYFP and GFP signals. However, the localisation of
SAP97 was also changed to intracellular punctaein this experiment. In Neuro2A
cells, some SAP97 remainedat the plasma membranein the presence of KChIP1.
As discussed above, there do seem to be differences in the behaviour of these
proteins between the two cell types investigated. It will require further
investigation to discover the underlying mechanisms and significanceofthis.
The ability of KChIP1 to alter the localisation of EGFP-SAP97 suggested the
hypothesis that they could directly interact. In Figure 4.6, it was also shown that
SAP97 could reduce the level of Kv4.2 trafficking in the presence of KChIP2-
ECFP.It was therefore interesting to see what happened in cells co-transfected
with EGFP-SAP97 and KChIP2-ECFP. As shown in Figure 4.15, both the
SAP97 and KChIP2 were localised to the plasma membranein these cells. As
discussed previously, one possibility is that the SAP97is binding to the KChIP2
at the plasma membrane, preventing its interaction with the Kv4 channel, and
hence preventing the channeltrafficking. To fully confirm this, it would be
necessary to directly show a KChIP2-SAP97interaction.
If SAP97 can interact with the KChIPs, as suggested from this work, then it may
be necessary for the cell to have some mechanism to regulate this. One
possibility for this is that changes in the level of free Ca”* ions could be sensed
by the KChIP through its EF-hand domains, and this couldalterits ability to
interact with SAP97. To investigate this, the effects of EF-hand mutants of
KChIP1 onthe localisation of EGFP-SAP97 were investigated (Figure 4.16). As
shown in Figure 4.16, both the single (EF3) and triple (EF2-4) mutants of
KChIP1-EYFP caused a changein the localisation of SAP97 from the plasma
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membrane to intracellular punctae that co-localised with the mutant KChIPs.
This would argue that the binding of Ca”* by KChIP1 has noeffectits ability to
interact with SAP97, and hencethat it is not a mechanism forin vivo regulation.
A final set of experiments were performed, using biochemical techniques to look
for an interaction between KChIP1 and SAP97. This included blotting pull-
downs from bovine brain cytosol, performing binding assays with in vitro
transcribed and translated SAP97 protein, and trying immunoprecipitations with
lysates from transfected HeLa cells. None of these experiments produced
convincing evidenceofan interaction between KChIP1 and SAP97. The change
in localisation of SAP97 when co-expressed with KChIP1 would certainly
suggest some kind ofinteraction, and hence further work will be needed to see if
this can be replicated biochemically. It will also be important to show whether
such an interactionis direct, or requires other proteins to mediateit. The potential
importanceofsuch an interaction in regulating Kv4 channeltrafficking makethis
area highly interesting for future study.
The major findings from this chapter included the demonstration that EGFP-
SAP97 could promote the trafficking of Kv4.2 to the plasma membranevia a
VAMP7-independent pathway. Surprisingly, when EGFP-SAP97, KChIP1-
EYFP and Kv4.2 were all co-expressed, none of the proteins were localised to
the plasma membrane. In fact, co-expression of EGFP-SAP97 with KChIP1 was
also able to re-localise the SAP97 away from the plasma membrane, to a
punctate distribution co-localised with KChIP1. This suggests an interaction
between SAP97 and KChIP1, which prevents either protein from binding and
trafficking Kv4 channels. Finally, it appears that SAP97 can also bind KChIP2,
and that KChIP1 can also bind to at least some isoforms of PSD-93. Together,
the data presented here suggest a novel mechanism for the regulation of Kv4.2
trafficking, whereby either the SAP97 or the KChIP alone can promote channel
trafficking, but expression together leads to them binding each other rather than
the channel.
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5. Discussion
The work presented in this thesis has focussed on thetrafficking of Kv4.2
potassium channels from the ER to the plasma membrane. As members of the
Kv4 family of channels, these proteins are responsible for rapidly inactivating,
A-type potassium currents in both neurons (Hoffman et al. 1997; Tkatch etal.
2000; Birnbaum etal. 2004) and cardiac myocytes (Isbrandt et al. 2000; Rosatiet
al. 2001). Such currents have a role in regulating the excitability of the cell
(Maffie and Rudy 2008), and, in neurons, contribute to the modulation of
synaptic strength needed for learning and memory (Ramakers and Storm 2002).
The expression level of Kv4 channels at the plasma membrane determines A-
type currentdensity (An et al. 2000), and henceregulation of channel trafficking
to the plasma membraneis a key waythatthe cell can control such currents. To
facilitate this regulation, there are several accessory proteins that can bindto the
Kv4 channels to promoteorretard their trafficking (see section 1.4). The work
presented in this thesis has concentrated on a few groups of these proteins,
particularly the KChIPs, the 14-3-3 proteins, and the PSD-95 family ofMAGUK
proteins.
Oneof the most intriguing previous findings in the literature was that Kv4.2 and
KChIP1 traffic via a pathway that requires COPI but not COPII (Hasdemiretal.
2005). The work in this thesis has now also shown that the SNAREsinvolved in
this trafficking are different from the standard complex. This confirms the theory
that Kv4.2/KChIP1 trafficking is via a non-conventional pathway. The features
of this pathway do notfully fit with those of other known non-conventional ER-
Golgi routes (see section 1.5.6). However, the mechanisms used in these
alternate pathways suggest some possibilities for Kv4.2/KChIP1 trafficking. One
possibility is that vesicles bud directly from the ER with a COPIcoat, as seen in
yeast (Bednarek et al. 1995). This would then be the coat used for both the ER-
ERGIC and ERGIC-Golgistepsin trafficking. Anotheris that COPII may not be
required for trafficking, but maystill play a role in ER budding,as is the case for
procollagen (Stephens and Pepperkok 2002; Stephens and Pepperkok 2004). This
could explain why the experiments in Hasdemir et al. (2005) show partial
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inhibition of trafficking with the COPII mutant. Finally, COPII-independent
budding from sites away from ER exit sites has been shown for mis-folded
luminal glycoproteins. These vesicles have no discernable coat proteins (Zuberet
al. 2007). Immuno-electron microscopy has been used to show that KChIP1-
labelled vesicles are not COPII coated (Hasdemir etal. 2005), but this work
could be extended to look for alternative coat complexes, and to visualise
vesicles budding from the ER,to shedfurtherlight on this pathway.
Many of the proteins associated with non-conventional trafficking routes are in
some way unusual, for example because oftheir size (e.g. procollagen) or post-
translational modifications (e.g. GPI-anchored proteins) (Stephens and
Pepperkok 2002; Castillon et al. 2009). It is unclear whycells would have two
ER-Golgi pathways for transmembrane proteins on route to the plasma
membrane.It certainly seems that Kv4.2 and KChIP1 pass through the ERGIC,
and go to the Golgi (O’Callaghan et al. 2003), as well as going through a COPI-
coated vesicle stage (Hasdemir et al. 2005). In support of this, the work in this
thesis has shown a requirement for Rab1 in trafficking, a protein known to be
important in ER-Golgi trafficking (Tisdale et al. 1992). Also, the original
identification of the VAMP7/Vtila/rBet1/syntaxin 5 SNARE complex was in an
ER-Golgi pathway (Siddiqi et al. 2006a). Therefore the non-conventional
pathwayis not just used by proteins bypassing the Golgi. One possible answeris
that the cell uses alternative pathways to allow an early level of cargo sorting
before the Golgi. This certainly seems to be the case for some cargoes in yeast
(Castillon et al. 2009), and in mammalian cells (Takidaet al. 2008), although
there is no evidence in the literature of two vesicle populations for
transmembrane proteins. The non-conventional pathway described in Chapter 3
couldtherefore representthe trafficking of alternatively sorted cargo.
To determine if this non-conventional pathway does represent a preliminary
sorting of cargo from the ER,it will be important to identify other proteins
trafficking via this pathway. The ER-Golgi role of VAMP7 and Vtila was
discovered in the intestine for the trafficking of PCTVs (Siddiqi et al. 2006a;
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Siddiqi et al. 2006b). However, this represents a very unusual cargo, found only
in the intestine, in vesicles lacking COPI, and only needing COPII for fusion
with the Golgi, not for ER budding (Siddiqi et al. 2003). These original papers
argued that this pathway was specific to the intestine, as they could not find
VAMP7localised to the ER in liver or kidney cells (Siddiqi et al. 2006b).
However, the work in this thesis would argue that at least the SNARE complex
of this pathway is more widespread, present in HeLa and Neuro2A cells. What
remains unclear is the connection between PCTVs and Kv4.2/KChIP1, and what
allows them to traffic along a pathway using the same SNAREs.If other proteins
can be identified that also require this SNARE complex then commonfeatures of
cargo on this pathway, or a commonsignalling motif, could be identified. One
issue is that much previous work in the literature has concentrated on the
trafficking of VSVG (Katz et al. 1977a; Katz et al. 1977b; Presley et al. 1997)
but this is nottrafficked via the same pathway as Kv4.2/KChIP1. As more non-
conventional trafficking pathways are identified, it becomes increasingly
apparent that more work needs to be done to characterise the trafficking of
individual proteins, rather than simply relying on VSVG as a characteristic
exocytic marker. An intriguing possibility for further study would be the KCNE1
B accessory subunit for Kv7 channels. When expressed alone,this localises to an
unidentified compartment (Chandrasekhar et al. 2006), and so could be behaving
like KChIP1, and thus utilising the same pathways for exocytic trafficking of
potassium channels.
To try and characterise which other proteins could use this non-conventional
pathway, experiments were performed to look at the trafficking of Kv4.2 by
KChIP2. Surprisingly, this was not inhibited by the siRNA knockdown of
VAMP7 or Vtila. Although similar at their C-termini, KChIP1 and KChIP2
differ at their N-termini, and in the way in whichthey are post-translationally
modified (Burgoyne 2007). In particular KChIP1 is myristoylated (O’Callaghan
et al. 2003), whilst KChIP2 is palmitoylated (Shibata et al. 2003). It could bethis
modification and the difference in intracellular localisation that it causes that
underlies the different trafficking pathways used. In future, these trafficking
experiments could be repeated using the alternative splice isoform of KChIP2,
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KChIP2c, as this is not palmitoylated (Takimoto et al. 2002). This would
therefore reveal whetherit is in fact the palmitoylation of KChIP2, or some other
region of its sequence, that leads to it using a different trafficking pathway from
KChIP1. It would seem most likely that if KChIP2 does not use the non-
conventional pathway characterised in this study, it uses the standard COPII-
COPI-coated vesicle route. An interesting study could therefore be to use the
Sec22 RNAiused in this thesis, or the Sarl COPII dominant negative mutant
used in Hasdemir et al. (2005) to confirm any requirement for the standard
pathway. In addition, KChIP3 is palmitoylated (Takimotoetal. 2002), whilst the
other NCSproteins are predicted to be myristoylated (O’Callaghanetal. 2005)
(and NCS-1 has been shown totraffic Kv4.2 to the plasma membrane (Nakamura
et al. 2001b)). It would therefore be interesting to perform experiments with
these proteinsto see if they behave more like KChIP1 or KChIP2.
The KChIPs, as members of the NCS family of proteins, have highly conserved
EF-hand domainsable to bind to Mg”* and Ca”*, and mayact as Ca”*sensors
(Burgoyne 2004; Burgoyne 2007). Many NCSproteins are myristoylated, and
this myristoyltail is often only exposed whentheprotein is Ca**-bound, allowing
the protein to bind to cellular membranes (Ameset al. 1997: O’Callaghan etal.
2003). However, the myristoyl tail is constitutively exposed in KChIP1
(O’Callaghan et al. 2003), and the effects of Ca”* on KChIPstructure are debated
in the literature. The best studied work is on the dissociation of KChIP3 from
DNAin a Ca’*-bound state (Carrion et al. 1999; Osawaet al. 2001). In work on
Kv4 channels, it wasoriginally argued that intact EF-hand domains were needed
for KChIP1 to have effects on channel kinetics and trafficking, but not for
binding to the channel (An et al. 2000). Morerecently this has been disputed,
with experiments claiming that a triple EF-hand mutant could not bind Kv4.3
(Pioletti et al. 2006). In this thesis it was shown thateither a single or triple EF-
hand mutant of KChIP1 prevented Kv4.2 trafficking to the plasma membrane,
but both caused
a
redistribution of the channel to punctae co-localised with the
mutant KChIP1.This supports the idea of Ca”* dependent and independentroles
proposedbyPatel et al. (2004). Intriguingly, the reason why the channel does not
traffic with the mutant KChIP1 is not known.It may be that the KChIP can only
152
bind to an additional protein, for example a coatprotein,trafficking regulator, or
cytoskeleton binding protein, when in a Ca’*-boundstate. Performing pull down
assays with both the wild-type and mutantproteins, and determining differences
between their interactions, could help identify proteins important in channel
trafficking.
Twogroupsofproteins important in regulating intracellular trafficking were also
investigated for their role in Kv4.2/KChIP1 trafficking. These were the SNAREs
and the Rabs. As discussed above, the non-conventional trafficking pathway
characterised in Chapter 3 was shown to require the SNAREs VAMP7 and
Vtila. However, this was quite surprising, as both SNAREsare more commonly
associated with trafficking between the endosomes and lysosomes (Bogdanovic
et al. 2002; Pryor et al. 2004; Casey et al. 2007). It was possible to show that
VAMP?7only partially co-localised with the lysosomal marker LAMP1. Still,it
should be noted that in vitro SNARE complex formation is promiscuous, as long
as the general QaQgQcR formula is observed (Fasshaueret al. 1999; Yangetal.
1999(1)). It has been argued thatit is the localisation of the SNAREsthat gives
them their specificity, and hence that the complement of SNAREs on a
compartmentdefines it (Jahn and Scheller 2006). However, the work by Siddiqi
et al. (2006b) showed that VAMP7can bepresent in the ER ofintestinal cells, in
addition to its better characterised location on the lysosomes in manyothercell
types (Advaniet al. 1998; Advani et al. 1999; Martinez-Arcaet al. 2003). By
showing a requirement for VAMP7 in ER-plasma membranetrafficking, at least
in HeLa and Neuro2A cells, the work presented here suggests this SNARE is
present on at least two cellular compartments, fulfilling two separate roles. This
may suggest that the SNAREs are more multifunctional in the cell than has been
previously assumed. It may be that the SNAREs,whilst providing the machinery
for membrane fusion, are less important in determining specificity than tethers
and other proteins such as the Rabs.
In this study, the Rabl-GAP TBC1D20 wasused to reduce Rab] activity in cells
(Haas et al. 2007). This Rab is known to be important in ER-Golgi trafficking
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(Tisdale et al. 1992), but some Rabl-independent pathways are known in the
literature (Yoo et al. 2002; Wu et al. 2003). However, in this study, Rab1 was
required for KChIP1/Kv4.2 trafficking, and for the trafficking of VSVG. This
Rab doesnottherefore distinguish between the two pathways. This may highlight
the action of Rab1 atthelater trafficking step from ERGIC to Golgi, involving
COPIcoated vesicles, which may be shared by both pathways. Alternatively, by
reducing the level of active Rab1in these cells, the Golgi may be more generally
disrupted (Haaset al. 2007). Anotherinteresting protein for further study would
be Rab2.This is also associated with ER-Golgi trafficking (Tisdale et al. 1992),
and may be specific for one of the two pathways discussed in this thesis.
Discovering specific regulators of this non-conventional pathway would be very
useful for future studies.
Two other families of proteins that might regulate Kv4 trafficking were also
investigated in this thesis. These were the 14-3-3 proteins and the PSD-95 family
of MAGUKs. Importantly, it was not just the potential interaction of these
proteins with the Kv4 channel « subunits themselves that was of interest, but
potential interactions between these proteins and the KChIPs. There are several
examples of regulators in the literature that only appear to have their effects on
Kv4 channels in the presence of KChIP1 (see section 1.4), and others that have
differing effects on the channel when a KChIPis also present, forming ternary
complexes (for example the DPP proteins (Jerng et al. 2005; Radicke et al.
2005)). Whilst studying the effects of these proteins individually is important for
understanding their actions on the channel, in vivo the cell may well be
expressing a range of potential channelregulators. It is also therefore important
to study the effects of these proteins in combination. One of the best studied
complexes in the literature is of Kv4 channels with a KChIP and DPP family
protein (Jerng et al. 2005; Radicke et al. 2005). From the work in Chapter 3 it
would certainly be interesting to ask whether, whenthis complex contains Kv4.2
and KChIP1, it is trafficked via the non-conventional pathway characterised in
this thesis.
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To identify proteins that interact with KChIP1, and thus might be important forits intracellular functions, a yeast two-hybrid screen was performed by Dr L.
Haynes. This suggested that 14-3-3y could interact with KChIP1 (Dr L. Haynes,
personal communication), and so this was investigated further in this thesis. In
support of this, there was partial co-localisation between KChIP1-EYFP
expressed in HeLacells, and endogenous 14-3-3y detected by immunostaining.
However, pull-down assays using GST-KChIP1 and bovine brain samples did
not show an interaction with 14-3-3y, or the related isoform 14-3-3B8. Aninteraction between KChIP1 and 14-3-3y could not therefore be confirmed. It
would beinteresting to revisit the results of this yeast-two hybrid screen, orperform a newscreen, in the quest for novel KChIP1 binding proteins. A larger
scale study to comparethe interactomes ofthe 4 different KChIPs would also beinteresting, to determine which interactions are important for the various
functions of different KChIP isoforms. Also, the work in Chapter 4 suggests an
interaction between the KChIPs and PSD-95 family of proteins, and it would be
interesting to see if such interactions could also be shown using the yeast two-
hybrid method.
The PSD-95 family of MAGUKsare known for their functions in the post-
synaptic densities of neurons, where they have documented roles in clustering
transmembraneproteins (Kim and Sheng 2004; Batset al. 2007), and regulating
their trafficking to the plasma membrane (Jeyifous et al. 2009). There is evidence
that SAP97 can promote the trafficking of Kv4 channels to the plasma membrane
(Gardoniet al. 2007; El-Haouetal. 2009), and this was confirmedin this study,
at least in HeLacells. It was also shown, using VAMP7 RNAi, that it does not
use the same non-conventional trafficking pathway as KChIP1. However,little
work has been done on the combinedeffects of the KChIPs and PSD-95 family
of proteins on Kv4.2 trafficking and function (El-Haouetal. 2009). The work in
Chapter 4 suggests that in fact, there is an interaction between at least some
members of both protein families. The possible interaction is potentially
interesting and important to the in vivo regulation of Kv4 channel trafficking.
The expression of both these families of proteins is widespread in the brain, and
SAP97is also foundin the heart (Mulleret al. 1995; Rhodesetal. 2004), so it is
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likely that both will be expressed in the samecells. However, the above work
shows that when KChIP1 or 2 and SAP97 or PSD-936/e/¢ are expressed together,
they inhibit the ability of Kv4.2 to traffic to the plasma membrane. Both SAP97
and KChIP1 can, individually, promote channel trafficking, so when expressed
together, it could be assumed that there would be an additive effect of their
expression on channeltrafficking. This was not seen in either HeLa or Neuro2A
cells, using either tagged or untagged Kv4.2. Interestingly, this same inhibitory
effect was also seen for SAP97 with KChIP2, arguing that such effects are not
dependent on the non-conventionaltrafficking of KChIP1. This effect wasalso
seen with the three tested isoforms of PSD-93, even thoughthese were unable to
promote the trafficking of the channel to the plasma membrane on their own.
One likely possibility, then, is that SAP97 or PSD-93 binds to the KChIPs, and
that this interaction prevents either protein from interacting with the Kv4
channel. In support of this, co-expression with KChIP1 alters the localisation of
SAP97 from the plasma membranetointracellular punctae, and PSD-936 from a
diffuse distribution in the cytoplasm to distinct punctae. In both cases, the KChIP
and the MAGUKareat least partially co-localised when co-expressed. This
interaction does not appear to require the KChIP to have bound Ca**, as this
changein localisation was also seen with EF-hand mutants of KChIP1. Attempts
to demonstrate an interaction between KChIP1 and SAP97 by use of
immunoprecipitation were not convincingly successful and further work will be
requiredto establish if these proteins do indeedinteract directly or indirectly.
If an interaction between SAP97 and KChIP1, or a more general interaction
between membersof these protein families, can be confirmed, it will raise many
questions about how this is regulated in vivo. This observed inhibition of Kv4
channeltraffic would need to be overcomeforthecell to express the channelat
the plasma membrane and this could be further investigated. Some cell type
specific differences were observed in the experiments in this thesis which would
also warrant furtherinvestigation.
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Interestingly, the induction of long-term potentiation (LTP) in neurons is
associated with the insertion of AMPA receptors into the post-synaptic
membrane, and the internalisation of Kv4 channels (Kim et al. 2007). The
MAGUKproteins are known to havetrafficking and clustering roles associated
with AMPAreceptors (DeGiorgis et al. 2006; Bats etal. 2007). It could be that
the inhibition of Kv4trafficking seen in this thesis is also important in vivo for
regulating synaptic plasticity. The changes in signalling associated with LTP
induction could lead to the interaction of SAP97 with the KChIPs, and hence
prevent further trafficking of Kv4 channels to the plasma membrane. Again, an
understanding of the mechanisms for regulating this would be important for
future work. In addition, many cytoskeleton binding proteins have been
implicated in regulating Kv4 channel trafficking and function (Petrecca et al.
2000; Wanget al. 2004; Chu etal. 2006). SAP97 also interacts with the actin
motor myosin VI (Wuet al. 2002), and so could be important for associating the
Kv4 channels with the cytoskeleton. This could play a role in regulating either
exocytic trafficking, or channel internalisation away from the plasma membrane.
One well known mechanism of regulating MAGUK protein interactions is
through phosphorylation ofthe target protein, or MAGUKitself (Kim and Sheng
2004; Gardoni et al. 2007). Interaction experiments could thus be repeated with
mutantproteins to see if this is the case. These could have serine, threonine or
tyrosine residues that are potentially phosphorylated, mutated to residues suchas
alanine, which are not. Alternatively, such residues could be replaced with amino
acids with bulkier, phosphomimetic side chains, to see if this prevented an
interaction. These studies could also reveal whether the sites of interaction
between SAP97 and KChIP1are the same as thoseusedforinteraction with the
channel, which could explain why such an interaction prevents channel
trafficking.
In conclusion, the trafficking of Kv4.2 channels by KChIP1 to the plasma
membrane is via a non-conventional pathway, requiring Rab1 and the SNAREs
VAMP7and Vtila. Discovering other proteins that use this pathway will be
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important in further characterising it, and in determining how wide-spread and
conserved it is in cellular function. In addition, there is evidence to suggest an
interaction between SAP97 and KChIP1, that inhibits Kv4 channel trafficking.
This could play a role in the regulation of neuronal activity. Future work will
need to characterise this interaction, to determine if other members of these
protein families can also interact, and to establish the ways in which such
interactions are regulated within thecell.
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Publications
Someofthe work presented in this thesis has been previously published:
Flowerdew,S.E., and R.D. Burgoyne. 2009. A VAMP7/Vtila SNARE complex
distinguishes a non-conventionaltraffic route to the cell surface used by KChIP1
and Kv4 potassium channels. Biochemical Journal. 418:529-540.
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